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Abstract
Multiple sequence alignments (MSAs) of homologous proteins are useful tools to charac-
terize compensatory mutations between non-conserved residue sites. The identification of
these residue sites in MSAs is an important challenge for understanding the structural basis
and molecular mechanism of protein functions. Despite the rich literature on compensatory
mutations as well as sequence conservation analysis for the identification of those impor-
tant residue sites, previous methods often do not take into account biochemical constraints
of amino acids which are likely to be crucial for the detection of compensatory mutation sig-
nals. However, compensatory mutation signals in MSAs are often masked by noise. Thus,
another challenging problem in bioinformatics is the separation of significant signals from
the phylogenetic noise and unrelated pair signals.
The goal of this thesis is to develop such methods that incorporate biochemical constraints
like similarities or dissimilarities of amino acids in identifying compensatory mutations and
deal with the noise. Hence, we develop different methods based on classical and quantum
information theory and multiple testing procedures.
Our first method is based on classical information theory. It mainly focuses on BLOSUM62-
dissimilar amino acid pairs as a model of compensatory mutations and incorporates them in
the prediction of functionally and/or structurally important sites using a doubly stochastic
matrix. To complement this method, we develop our second method applying principles of
quantum information theory. The new method differs from the first one by simultaneously
modeling similar and dissimilar amino acid pair signals in the compensatory mutation anal-
ysis. Moreover, to separate method-based significant compensatory mutation signals from
background noise, we develop an MSA-specific statistical model devised for multiple test-
ing problems. By applying this model, we are capable of determining significant signals in
MSAs as well as quantifying the error made in terms of the false discovery rate.
To demonstrate the effectiveness of our methods, we evaluate those analyzing important
sites of two human proteins, namely epidermal growth factor receptor (EGFR) and glucok-
inase (GCK). Our results suggest that the MSA-specific statistical model is able to separate
significant compensatory mutation signals from the phylogenetic noise and unrelated pair
signals. Only considering the dissimilarities of amino acids, the first method successfully
deals with disease-associated important sites of both proteins. In contrast, simultaneously
focusing on similar and dissimilar amino acid signals, the second method is more sensible
to catalytic, allosteric and binding sites. The results further show that overlaps between
both methods are quite low, indicating that considerably different sets of residue sites are
detected by both methods as functionally and structurally important. As a result of this, we
can say that our second method complements the first method when it comes to predicting
important sites, rather than replacing it.

Zusammenfassung
Multiple Sequenzalignments (MSAs) von homologen Proteinen sind nützliche Werkzeuge,
um kompensatorische Mutationen zwischen nicht-konservierten Residuen zu charakter-
isieren. Die Identifizierung dieser Residuen in MSAs ist eine wichtige Aufgabe um die
strukturellen Grundlagen und molekularen Mechanismen von Proteinfunktionen besser zu
verstehen. Trotz der vielen Anzahl an Literatur über kompensatorische Mutationen sowie
über die Sequenzkonservierungsanalyse für die Erkennung von wichtigen Residuen, haben
vorherige Methoden meistens die biochemischen Eigenschaften von Aminosäuren nicht
mit in Betracht gezogen, welche allerdings entscheidend für die Erkennung von kompen-
satorischen Mutationssignalen sein können. Jedoch werden kompensatorische Mutation-
ssignale in MSAs oft durch das Rauschen verfälscht. Aus diesem Grund besteht ein weit-
eres Problem der Bioinformatik in der Trennung signifikanter Signale vom phylogenetis-
chen Rauschen und beziehungslosen Paarsignalen.
Das Ziel dieser Arbeit besteht darin Methoden zu entwickeln, welche biochemische Eigen-
schaften wie Ähnlichkeiten und Unähnlichkeiten von Aminosäuren in der Identifizierung
von kompensatorischen Mutationen integriert und sich mit dem Rauschen auseinandersetzt.
Deshalb entwickeln wir unterschiedliche Methoden basierend auf klassischer- und quantum
Informationstheorie sowie multiple Testverfahren.
Unsere erste Methode basiert auf der klassischen Informationstheorie. Diese Methode
betrachtet hauptsächlich BLOSUM62-unähnliche Paare von Aminosäuren als ein Modell
von kompensatorischen Mutationen und integriert sie in die Identifizierung von wichtigen
Residuen. Um diese Methode zu ergänzen, entwickeln wir unsere zweite Methode unter
Verwendung der Grundlagen von quantum Informationstheorie. Diese neue Methode un-
terscheidet sich von der ersten Methode durch gleichzeitige Modellierung ähnlicher und
unähnlicher Signale in der kompensatorischen Mutationsanalyse. Des Weiteren, um sig-
nifikante Signale vom Rauschen zu trennen, entwickeln wir ein MSA-spezifisch statistis-
ches Modell in Bezug auf multiple Testverfahren.
Wir wenden unsere Methode für zwei menschliche Proteine an, nämlich epidermal growth
factor receptor (EGFR) und glucokinase (GCK). Die Ergebnisse zeigen, dass das MSA-
spezifisch statistische Modell die signifikanten Signale vom phylogenetischen Rauschen
und von beziehungslosen Paarsignalen trennen kann. Nur unter Berücksichtigung BLO-
SUM62-unähnlicher Paare von Aminosäuren identifiziert die erste Methode erfolgreich die
krankheits-assoziierten wichtigen Residuen der beiden Proteine. Im Gegensatz dazu, durch
die gleichzeitige Modellierung ähnlicher und unähnlicher Signale von Aminosäurepaare ist
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Multiple sequence alignments (MSAs) of homologous protein sequences give us informa-
tion about two major features of the proteins of interest. The first one consists of easily de-
tectable highly conserved residue sites that are obviously important for the structure and/or
function of the protein while the second one corresponds to compensatory (coupled) muta-
tions between two or more non-conserved residue sites that also contain crucial information
on the structural and functional basis of proteins [3]. These compensatory mutations occur
according to the functional coupling of mutation positions which might be explained as one
mutation in a certain site affecting a compensating mutation at another site, even if both re-
lated residue sites are distantly positioned in the protein structure [4–8]. In particular, such
mutations at essential residue sites are likely to destroy the protein structure which often
results in loss of the protein’s function [9, 10]. Thus, for understanding the structural basis
and molecular mechanism of protein functions, determination of these compensatory mu-
tated residue sites is as important as strictly conserved sites [4,5,11,12]. These residue sites
might be disease-associated, responsible for the maintenance of internal protein volume, or
possibly form key sites for interactions within or between proteins [4, 8, 13–15].
Although strictly conserved residue sites are easily detectable and interpretable in MSAs,
the detection of important non-conserved compensatory mutation sites needs more complex
approaches. Until now, a variety of studies have employed Pearson’s correlation coefficient
methods [16–18], perturbation based methods [15, 19] and mutual information (MI) based
methods [8, 20–23] because of their simplicity and efficiency. However, these methods
strongly depend on the amino acid distributions observed in MSA columns rather than on
physical or biochemical similarities or dissimilarites of amino acids that are likely to be
crucial for the detection of functionally or structurally important compensatory mutations.
In addition, due to background noise, all of these methods interfere with the identification
of compensatory mutation signals [9,20,24]. Hence, the significant compensatory mutation
signals must be separated from the background noise that might occur as a result of: i) false
signals arising from insufficient data; ii) sites with low or high conservation biasing the
signal; iii) phylogenetic noise. While the first two types of noise can be easily overcome
by appropriately filtering the data [22], phylogenetic noise can only be eliminated to some
extent by excluding highly similar sequences from the MSA [9].
Recently, several methods such as bootstrapping, simulation, or randomization methods
have been utilized in order to minimize the influence of phylogenetic linkage and stochastic
noise [21, 25, 26]. Dunn et al. [9] have introduced the average product correction (APC)
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to adjust MI for background effects. In their study, Merkl and Zwick [22] have used a
normalized MI and focused on only the 75 residue pairs with highest normalized MI values
as significant for each MSA. Gao et al. [23] have pursued a similar approach, where they
have replaced the metric used in [22] with the amino acid background distribution (MIB).
While the reduction of background noise in the model of Dunn et al. is not quantified, the
approaches of Gao et al. and Merkl and Zwick appear to be over-conservative.
Despite the presence of a variety of different methods as mentioned above, to date, there
is still need for a method that contains powerful metrics to take into account biochemical
constraints of amino acids and deals with noise and background signals. As a consequence,
the main goal of this thesis was to develop classical information theory based methods
and quantum information theory based methods to incorporate biochemical similarities or
dissimilarities of amino acids in the prediction of functionally or structurally important
residue sites. Furthermore, we have developed an MSA-specific statistical model based on
multiple testing procedures described in [27, 28]. In this way, unlike previous information
theory based studies [22, 23], we can separate significant compensatory mutation signals
from background noise with respect to our MSA-specific statistical model that quantifies
the error made in terms of the false discovery rate.
To demonstrate the performance and functionality of our methods, we analyzed the struc-
turally or functionally important positions of two human proteins, namely epidermal growth
factor receptor (EGFR) and glucokinase (GCK). The proteins have been chosen because
their important positions experimentally investigated in previous studies [29–40]. As a
result, in both proteins our methods detect disease-associated amino acid mutations (non-
synonymous single nucleotide polymorphisms (nsSNPs)), not strictly conserved catalytic
or binding sites, and residues that are nearby one of these sites or in the close neighborhood
of a strictly conserved positions, which are likely to affect protein stability or functional-
ity [41–43].
1.1 Structure of the Thesis
The remainder of this thesis is organized as follows. In Chapter 2, we briefly introduce
the descriptions of some biological concepts, databases, and techniques of bioinformatics
which are required to motivate, and understand functionally or structurally important amino
acids in proteins. In the third chapter, we describe mathematical foundations of classical
information theory and quantum information theory, as well as the β -distribution, upon
which we develop our models for the prediction of significant compensatory mutation sig-
nals in MSAs. In Chapters 4 and 5, we describe and develop our new classical information
theory and quantum information theory based methods and MSA-specific statistical model.
In addition, we present the applications of these methods and discuss them in detail at the
end of the each chapter. In Chapter 6, we demonstrate the performance and functionality
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of our methods by applying them on the prediction of structurally or functionally important
positions of two human proteins. Afterwards, we discuss our results in Chapter 7. In this
chapter, we further put our work in the context of a related work which is also developed
using classical information theory based method, and compare our results with this related
work. Finally, we summarize our conclusions and close by highlighting some potential
avenues for further work in Chapter 8.
1.2 Impact
We have published the classical information theory based method and the MSA-specific sta-
tistical model in a scientific journal article. The quantum information theory based method
is also submitted to a scientific journal article and it is currently under review.
Journal Article
[1] Gültas M, Haubrock M, Tüysüz N, Waack, S: Coupled Mutation Finder: A new
entropy-based method quantifying phylogenetic noise for the detection of compensatory
mutations. BMC Bioinformatics 2012, 13:225.
[2] Gültas M, Düzgün G, Herzog S, Jäger SJ, Meckbach C, Wingender E, Waack S: Quan-
tum Coupled Mutation Finder: Predicting functionally or structurally important sites
in proteins using quantum Jensen-Shannon divergence and CUDA programming. BMC
Bioinformatics 2014, 15:96.
Conferences, Workshops, Meetings and Student’s thesis
• Statistical and dynamical models in biology and medicine (October, 2011, Göttin-
gen): Poster presentation
• Workshop über Algorithmen und Komplexität, 63. Theorietag (Januar, 2012, Bran-
dennburg): Oral presentation
• German Conference of Bioinformatics (September, 2012, Jena): Poster presentation
• Meeting Gene Regulation and Information Theory (April, 2013, Halle): Poster pre-
sentation
• German Conference of Bioinformatics (September, 2013, Göttingen): Poster presen-
tation
Furthermore, the author identified the topics with Prof. Dr. Stephan Waack for and super-
vised the following Project Works, Bachelor and Master’s thesis.
• Thomas Franke: Identifikation von korrelierten Mutationen auf Basis von H2r,
Project Work, 2010 - 2011
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• Thomas Franke: A New Entropy Based Model for the Detection of Correlated Muta-
tions in Multiple Sequence Alignments, Master Thesis, 2011
• Hendrik Kemper: Eine neue Entropie basierte Methode für die Erkennung von kom-
pensatorischen Mutationen: Alternative zu Coupled Mutation Finder, Bachelor The-
sis, 2011 - 2012
• Linh Dang Truong Khanh: Feature Selection for Compensatory Mutation Analysis in
MSAs using Random Forest, Project Work, 2012 - 2013
• Projekt Interdisziplinäres Lernen und Zusammenarbeiten (PILZ): Anwendung der
Quanteninformationstheorie für die Identifizierung von kompensatorischen Mutatio-
nen, 2012 - 2013
• On going projects
– Linh Dang Truong Khanh: Analysis and prediction of DNA-binding proteins
from MSAs using Random Forest , Master Thesis, 2013 -
– Hendrik Kemper: Prediction of functionally important amino acid positions in
MSAs using classical and quantum information theory based methods, Master
Thesis, 2013 -
– Cornelia Meckbach: Using machine learning methods to combine classical and
quantum information theory based metrics for prediction of functionally and/or




In this chapter, we will give a brief introduction to the key biological concepts and tech-
niques of bioinformatics necessary to motivate, develop, and understand functionally and/or
structurally important amino acids in proteins introduced in this thesis. The descriptions in
this chapter are based on [1, 44–47].
2.1 Amino Acids
Amino acids are organic molecules which have at least a central carbon atom (Cα ) attached
to a free carboxyl group (COOH), a free amino group (NH2), a hydrogen atom and a side
chain group (R) (Figure 2.1). R is specific to each amino acid and known as residue. The
amino acids differ from each other according to the chemical nature of R.
Figure 2.1: General structure of an amino acid.
There are 20 common (or primary) amino acids and each of them is found in proteins,
hence they are called proteinogenic1 amino acids. The names of all amino acids indicate
their first isolated source and they are often abbreviated with three-letters and/or one-letter
abbreviations (Table 2.1).
1Proteinogenic means protein building.
7
2 Biological Background
Full name Three-letter abbreviation Single-letter abbreviation
Alanine Ala A
Cysteine Cys C
Aspartic acid Asp D

















Table 2.1: The amino acids: Full names, three-letter abbreviations and single-letter abbre-
viations of primary amino acids.
All of the proteinogenic amino acids are vital for protein synthesis due to the optimal main-
tenance of body growth and function. Eleven out of the 20 amino acids: alanine, arginine,
asparagine, aspartic acid, cysteine, glutamic acid, glutamine, glycine, proline, serine, and
tyrosine are called non-essential amino acids since they are synthesized by the human body.
The remaining nine amino acids, histidine, isoleucine, leucine, lysine, methionine, pheny-
lalanine, threonine, tryptophan, and valine are called essential amino acids which cannot be
synthesized by the body and thus they must be taken from dietary sources [48].
Amino acids can be classified into hydrophobic and hydrophilic groups based on the physi-
cal and chemical characteristics of their residues as follows:
• Hydrophobic groups:
– nonpolar-aliphatic residues: glycine, alanine, proline, valine, leucine,
isoleucine, methionine
– aromatic residues: phenylalanine, tyrosine, tryptophan
• Hydrophilic groups:
– polar-charged residues: serine, threonine, cysteine, asparagine, glutamine
– positively charged residues: lysine, arginine, histidine
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– negatively charged residues: aspartate, glutamate
2.2 Proteins
Proteins are linear macromolecules made of one or more chains of amino acids arranged
in a specific order. Proteins are found in all living cells and are comprised of different
combinations of 20 amino acids. The individual side chain of amino acids has a protein-
specific spatial arrangement which defines structure and function of the protein.
According to the structural features, proteins are usually described at four levels of com-
plexity: primary structure, secondary structure, tertiary structure, quaternary structure.
Figure 2.2: Overview of the structural levels in proteins (image from [ [1], p.92]).
Primary Structure: The linear sequence of amino acid residues is referred to as the primary
structure of the protein.
Secondary Structure: is the local conformation of the primary structure which is mainly
stabilized by hydrogen bonds. There are two types of stable secondary structures:
alpha helices (α-helices) and beta-sheets (β -sheets) that are preferably located at the
core of the protein.
Tertiary Structure: is the final three-dimensional (3-D) structure of a protein which con-
sists of secondary structure elements. For stabilization of the protein, very favorable
residue interactions occur in this structure. Tertiary structure is unique for each pro-
tein and reflects its chemical or structural function.
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Quaternary Structure: is the arrangement of two or more 3-D structures in a protein com-
plex. The quaternary structure is also stabilized by similar interactions as in tertiary
structures.
Protein Structure and Function
Although almost all proteins share the same structural levels, they also contain various
chemical environments. Because of this, the behavior of their amino acids can be com-
pletely different. The most significant difference occurs between soluble proteins and mem-
brane proteins. While soluble proteins tend to be surrounded by water molecules and have
polar or hydrophilic amino acids on their surface, membrane proteins are surrounded by
lipids and they contain on their surface the hydrophobic amino acids which are interacting
with membrane [49].
The tertiary structure of soluble, membrane, and all other proteins provides essential in-
formation for the understanding of their functions. These functions often consist of the
reversible binding between protein molecules and other molecules. Such molecules which
are usually bound reversibly by proteins are called ligands. Ligands interact with proteins
to bind at their specific sites hence they are called binding sites, which are complementary
to the ligand size, shape, charge and character [49].
Another important factor for the protein function are enzymes which catalyze the reactions
of molecules. After these catalysis, the molecules are called reaction substrates rather than
ligands. In addition, ligand binding sites are called catalytic sites or active sites that are
crucial for the function and activity of a protein [1, 49].
2.3 Multiple Sequence Alignments
A multiple sequence alignment (MSA) of proteins contains a set of aligned amino acid
sequences in which homologous residues of different sequences are placed in same columns
(Figure 2.3). Therefore, functionally or structurally important amino acid positions are often
strictly conserved in MSAs [4]. These conserved positions often correspond to catalytic
sites, binding sites, sequence family signature, or possibly key sites for interactions within
or between proteins. Such conserved positions occur because all living organisms evolved
from a common ancestor. According to the common ancestor, it is assumed that all living
organism and their proteins are related to each other through evolution [50]. As a result of
this, the sequences of proteins are aligned in MSAs very well. In contrast, if the evolutionary
relationship between aligned amino acid sequences is distant, their sequences can be aligned
poorly. Consequently, for the aligning of these sequences a lot of insertions, deletions,
and substitutions (see Section 2.4) are needed in order to create the corresponding MSA.
Because of such insertions or deletions, beside of the common 20 amino acid a new element,
called gap (’-’), is required for these process.
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Figure 2.3: A small section of a multiple sequence alignment.
A more precisely definition of an MSA is given in [51] as follows;
Definition 2.1 Let A1, · · · ,Ar be r sequences over the alphabet of residues Σ. A multiple
sequence alignment (MSA) of A is a matrix which is obtained by inserting gaps (’-’) into the
original sequences such that all resulting sequences A∗i have equal length L, A
∗
i = Ai after
removal of all gaps from A∗i , and no column consist of only gaps
A =

A1 = (a11,a12, . . . ,a1n1)
A2 = (a21,a22, . . . ,a2n2)
...






















r2, . . . ,a
∗
rL)
MSAs are essential and one of the most important computational tools in bioinformatics
because they are used almost in every application of bioinformatics, e.g.:
• to visualize and reveal the degree of evolutionary relationship between amino acid
sequences,
• to determine the protein family of a newly sequenced protein with unknown structure,
function, or evolutionary history in order to get more crucial information about the
structure or function of this new protein,
• to predict the secondary structure of proteins, sometimes it even helps for the deter-
mination of the 3-D structure,
• to identify functional or structural sites of proteins,




• to locate DNA regulatory elements such as binding sites,
• to construct a tree for the phylogenetic analysis,
• to cluster proteins according to similar regions.
2.4 Mutations in Protein
A protein is a linear sequence over the alphabet of the 20 amino acids that are encoded by
the successive triplets of letters from the DNA sequence (Table 2.2). Therefore, mutations
in the DNA sequence can lead to variations or substitutions in the structure of correspond-
ing encoded proteins. These variations in the amino acid sequences may lead to a drastic
change in the functionality or structural stability of the protein and they can be responsible
for diseases. For instance, substitutions at certain positions like L858R, T 790M, or G719S
of the human epidermal growth factor receptor (EGFR) protein result in misregulation of
its activity or functionality [4, 52]. EGFR is a famous example in which a small alteration
affects protein function, also damages the structural stability of the EGFR protein and in-
creases susceptibility to diseases.
Mutations are generally assigned into three main categories: substitutions, insertions, and
deletions. The detailed explanation of these mutations can found in [46] which we highly
recommend to interested readers. However, reasons of mutations and how they in detail
occur, are out of scope of this thesis, thus we will briefly mention their short definitions.
Substitution: is also known as point mutation, which involve amino acid variations at a
certain position. These variations of amino acids in the sequence may produce one of
three types of mutation:
1. Missense mutation is also referred as non-synonymous single nucleotide poly-
morphisms (nsSNPs) that changes one amino acid into another amino acid in
proteins. As a result of missense mutation, the amino acid sequence of encoded
protein is changed and thus a residue substitution often impacts on the protein
structure and also can result in a change or loss of the protein function.
2. Nonsense mutation changes an amino acid into a STOP codon.
3. Frameshift mutation is a genetic mutation caused by a deletion or insertion in a
DNA. This mutation causes a change in the reading frame, leading to introduc-
tion of unrelated amino acids into the protein, generally followed by a STOP
codon.
Deletions: occur if an amino acid is removed from a certain position. As a result, the
positions of all the surrounding amino acids are changed.
Insertions: occur if an amino acid is added between two existing ones in sequence which
have similar effects like deletions.
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Second base
First base T C A G Third base
TTT Phe TCT Ser TAT Tyr TGT Cys T
TTC Phe TCC Ser TAC Tyr TGC Cys C
T TTA Leu TCA Ser TAA Stop TGA Stop A
TTG Leu TCG Ser TAG Stop TGG Trp G
CTT Leu CCT Pro CAT His CGT Arg T
CTC Leu CCC Pro CAC His CGC Arg C
C CTA Leu CCA Pro CAA Gln CGA Arg A
CTG Leu CCG Pro CAG Gln CGG Arg G
ATT Ile ACT Thr AAT Asn AGT Ser T
ATC Ile ACC Thr AAC Asn AGC Ser C
A ATA Ile ACA Thr AAA Lys AGA Arg A
ATG Met ACG Thr AAG Lys AGG Arg G
GTT Val GCT Ala GAT Asp GGT Gly T
GTC Val GCC Ala GAC Asp GGC Gly C
G GTA Val GCA Ala GAA Glu GGA Gly A
GTG Val GCG Ala GAG Glu GGG Gly G
Table 2.2: The standard genetic code: Triplet combinations of nucleotides into amino
acids. There are in total of 64 triplets, 61 of them encode the 20 amino acids and 3 of them
are stop codons which do not code for any amino acid.
Besides of these three main categories of mutations there is another type of mutation, called
correlated mutation, in proteins. Correlated mutations in proteins can be basically explained
if one mutation in a certain position occurs within a protein, this mutation can affect a com-
pensating mutation at another position, even if both related residue positions are distantly
positioned in the protein structure. For detection of correlated mutations, the basic ap-
proach is based on functional coupling of mutation positions in protein multiple sequence
alignments which often display correlations between columns [4]. This coupling between
residue positions can result from spatial, physical, or chemical restrictions or signaling of
allostery [4, 7, 47]. Thus, determination of these positions is as crucial as the recognition of
strictly conserved positions for the understanding the structural basis of protein’s function,
and for the identification of functionally important residue regions which might be disease
associated, responsible for the maintenance of internal protein volume, or possibly form key
sites for interactions within or between proteins [4].
2.5 Bioinformatics Databases and Tools
In this section, we introduce the databases which are used in this thesis to get 3-D structures
of proteins and MSAs.
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2.5.1 Protein Data Bank
Protein Data Bank (PDB), at the Research Collaboratory for Structural Bioinformatics
(RCSB), is the major database for the structural information of biological macromolecules
such as proteins, nucleic acids, or carbohydrates. The PDB database was established by
Walter Hamilton at the Brookhaven National Laboratory in 1971 and is freely accessible
at http://www.rscb.org. The PDB database contains all publicly available and experimen-
tally determined 3-D structures of approximately 90000 proteins, nucleic acids, protein/nu-
cleic acids complexes, and other biological macromolecules. Although, a large number of
database entries are 3-D structures of proteins, the protein structures are often redundant
indicating same protein structures which are often observed under different conditions or
experiments. In order to present structural information of proteins, PDB has a standard file
format in which:
• authors who solved the structure,
• atomic coordinates,
• literature references,
• experimental details about the structure determination,
• primary and secondary structure information such as disulfide bonds, helices, sheets,
• information about binding sites, active sites, as well as hyperlinks to many other
scientific databases
are included [2]. In PDB files, each of these information is presented in one line therefore
each line of information is called a record. In addition, each PDB file of proteins possesses
a name of four characters, known as PDB entry. The PDB entry can consist of either letters
A to Z or digits 0 to 9 like ”1V4S.pdb” for the human glucokinase (GCK) protein.
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2.5.1.1 PDB file format
There are several different types of records in PDB files, which are arranged in a specific
order to describe a structure. We will briefly describe some of the most important records
below. The following descriptions are based on Protein Data Bank Contents Guide [53]
where the explanations of all records can be found in detail.
HEADER and TITLE record
HEADER TRANSFERASE 19-NOV-03 1V4S
TITLE CRYSTAL STRUCTURE OF HUMAN GLUCOKINASE
The HEADER record describes the molecule, provides the deposition date of the PDB file
and repeats the PDB entry. The TITLE record describes the title of the experiment repre-
sented in the entry.
COMPND record
COMPND MOL-ID: 1;
COMPND 2 MOLECULE: GLUCOKINASE ISOFORM 2
COMPND 3 CHAIN: A;
· · · · · · ;
The COMPND record contains the description of macromolecular contents of an entry. This
record sometimes provides information that may also be found in the TITLE record.
JRNL and REMARK record
JRNL AUTH K.KAMATA,M.MITSUYA,T.NISHIMURA,J.EIKI,Y.NAGATA
JRNL TITL STRUCTURAL BASIS FOR ALLOSTERIC REGULATION OF THE
JRNL TITL 2 MONOMERIC ALLOSTERIC ENZYME HUMAN GLUCOKINASE
JRNL REF STRUCTURE V. 12 429 2004




REMARK 2 RESOLUTION. 2.30 ANGSTROMS.
REMARK 3 REFINEMENT.
REMARK 3 PROGRAM : CNX 2002
· · · · · · ;
The JRNL record contains the literature reference or publication in which the experiment
has been described. However, for more than two references the REMARK record is needed.
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The REMARK record was initially meant for various comments and annotations about the
structure of the entry but they are currently used for all general remarks.
HELIX and SHEET record
The HELIX and SHEET records describe the secondary structure of the protein and
polypeptide structures. The HELIX record indicates the location and type (right-handed
alpha, etc.) of helices in the molecule. The SHEET record is used to identify the location,
sense (anti-parallel, etc.) of the sheet in the molecule.
HELIX 1 1 THR A 14 ALA A 21 1 8
HELIX 2 2 GLU A 22 GLN A 24 5 3
· · · · · · ;
SHEET 1 A 6 LEU A 58 ARG A 63 0
SHEET 2 A 6 ARG A 250 ASN A 254 -1
· · · · · ·
ATOM record
The ATOM record describes the atomic coordinates containing the x,y,z orthogonal


















ATOM          1      N    THR   A  14            24.917   -32.817    78.840     1.00     51.62        N   
ATOM          2      CA  THR   A  14            24.314   -32.647    77.413     1.00     50.88        C
ATOM          3      C    THR   A  14            24.131   -32.303    76.523     1.00     51.03        C
2An angstrom is a unit of measurement for very small distances. One Angstrom is equal to 10−10 meter and
it is shown with the symbol of Å.
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The third item in the ATOM record shows the atom name that consists of the chemical
symbol for the atom type. The atom names begins either with ”C”, ”N”, or ”O” which indi-
cate carbon, nitrogen, or oxygen atoms, respectively. The next character is the remoteness
indicator code which is transliterated according to:
α β γ δ ε η ζ
A B G D E H Z
2.5.2 HSSP Database
The HSSP (homology-derived secondary structure of proteins) was created by Chris Sander
and Reinhard Schneider which is a derived database to merge primary structure information
and secondary/tertiary structure (2-D/3-D) information of proteins [54]. The HSSP database
is tightly coupled with the PDB and Swiss-Prot database3. While the former database is
used to get structural information of proteins, the latter is used to get primary structure
information of proteins. According to the structure information, HSSP database provides
a special HSPP file like ”1V4S.hssp” for each protein from PDB database. The HSSP file
contains a multiple sequence alignment of all available homologous that are very likely to
share the same 3-D structures [54].
2.5.2.1 HSSP file format
Each HSSP file includes the following four blocks: HEADERS, PROTEINS, ALIGN-
MENTS, and SEQUENCE PROFILE. While the HEADERS block is obligatory in every
HSSP file, the other three blocks are only found if there is at least one homologous align-
ment. Further, the blocks are separated from one others with the string ”##” in HSSP files.
Similar to the PDB files, the block information in HSSP files are presented in lines. Below,
we will briefly describe these four blocks according to [54].
HEADERS block
The HEADERS block begins with the version number of HSSP software (program Max-
Hom) that is used to generate this file. The PDBID (Protein Data Bank Identifier) stands
for the PDB entry of the test protein on which the HSSP file is based. The THRESH-
OLD line describes the homology threshold curve used. The REFERENCE, CONTACT,
and DATE lines are already self-explanatory. The header section goes on with informa-
tion about the PDB lines, including the HEADER, COMPND, SOURCE, and AUTHOR
each of them have been explained in the Section 2.5.1. Further, SEQLENGTH, NCHAIN,
3SWISS-PROT: A protein database that stores only the primary structures of proteins [55].
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HSSP Homology derived secondary structure of proteins, version 2.0 2011
PDBID 1V4S
THRESHOLD according to: t(L)=(290.15 * L ** -0.562) + 5
REFERENCE Sander C., Schneider R. : Database of homology-derived protein structures. Proteins
CONTACT Maintained at http://www.cmbi.ru.nl/ by Maarten L. Hekkelman
DATE file generated on 2012-11-25
HEADER TRANSFERASE 19-NOV-03 1V4S
COMPND MOLECULE: GLUCOKINASE ISOFORM 2
SOURCE ORGANISM-SCIENTIFIC: HOMO SAPIENS
AUTHOR K.KAMATA,M.MITSUYA,T.NISHIMURA,J.EIKI,Y.NAGATA
DBREF 1V4S A 12 465 UNP P35557 HXK4-HUMAN 13 466
SEQLENGTH 448
NCHAIN 1 chain(s) in 1V4S data set
NALIGN 308
NOTATION : ID: EMBL/SWISSPROT identifier of the aligned (homologous) protein
and NALIGN present the length of the sequence, number of distinct chains, and number of
aligned sequences in the MSA, respectively. Finally, the NOTATION lines contain some
general information about the header description of other blocks and names of the sequence
database from which the aligned sequences were obtained, e.g, EMBL/SWISS-PROT or
PIR/NBRF.
PROTEINS block
## PROTEINS : identifier and alignment statistics
  NR.    ID                          STRID    %IDE   %WSIM   IFIR   ILAS  JFIR     JLAS    LALI  NGAP  LGAP   LSEQ2   ACCNUM     PROTEIN
    1 : A7LFL1_HUMAN                     1.00    1.00         3      448    16     461      446     0           0        465       A7LFL1         OS=Homo sapiens 
    2 : F6PLG6_MACMU                    1.00    1.00         1      448    15     462      448     0           0        466       F6PLG6        OS=Macaca mulatta 
    3 : F6PLU3_MACMU                    1.00    1.00         3      448    16     461      446     0           0        465       F6PLU3        OS=Macaca mulatta 
    4 : F7I4E9_CALJA                          1.00    1.00         1      447    15     461      447     0           0        466       F7I4E9          OS=Callithrix jacchus
    …    …          …       …                          …                           …                                 …                                   ...
    …    …          …       …                          …                           …                                 …                                   ...
The second block of an HSSP file is the PROTEINS block. This block describes the pairwise
aligned data for each protein to the structurally homologous test protein. It begins with "##
PROTEINS:". The explanation of headers of columns, which is already described in the
NOTATION lines in HEADERS block, is following:
• NR: the line identifier,
• ID: the EMBL/SWISSPROT identifier of the aligned (homologous) protein,
• STRID: the PDB identifier of proteins with known 3-D structure,
• %IDE: the percentage of the alignment’s residue identity,
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• %SIM (%WSIM): the (weighted) similarity of the alignment,
• IFIR/ILAS: first and last residue of the alignment in the test sequence,
• JFIR/JLAS: first and last residue of the alignment in the aligned protein,
• LALI: length of the alignment excluding insertions and deletions,
• NGAP: number of insertions and deletions in the alignment,
• LGAP: total length of all insertions and deletions,
• LSEQ2: length of the entire sequence of the aligned protein,
• ACCNUM: Swiss-Prot accession number,
• PROTEIN: one-line description of aligned protein.
ALIGNMENTS block
## ALIGNMENTS    1 -   70
 SeqNo  PDBNo AA STRUCTURE  BP1  BP2  ACC  NOCC  VAR  ....:....1....:....2....:....3....:....4....:....5....:....6....:....7
     1        14 A   T        >           0   0       120    35      47   T T T    T T    T       T    A                                       
     2        15 A   L  H  >   +      0   0       116    83      55   L L L    L LM L L       L V LL    MM MMVMMM MMM                    
     3        16 A   V H  >  S+     0   0       19      229    26  VVVVVVVVVVVVVV AVAV    VVVVAVVVV VVV    IIII
     4        17 A   E  H  >  S+     0   0       76      238    68  EEEEEEE  EEEEEDEDDDEDKE EDDDEDEE     A AEEDE
     5        18 A   Q  H  <  S+     0   0       134    243    67  QQQQQQQQQQQ QQQQQQQQ     E EEEEL
     6        19 A   I H >< S+     0   0       12      253    45  IIIIIIIIIIIIIIIIIII IIIIIIIIIIIIIIIIIIIIIIIIIIIII IIIIIIII  I IT ITTTI
      …         …                       …                                          …                   …                      …
      …         …                       …                                          …                   …                      …    
The third section of an HSSP file is the ALIGNMENTS block which begins with "##
ALIGNMENTS". In this block, family alignment details are presented residue by residue.
The sequences of the test protein and the aligned database proteins are listed vertically, with
the leftmost entry at the top. The descriptions of the column headers are explained in the
NOTATION lines as following:
• SeqNo: the sequential residue number of the PDB protein as in DSSP 4 file,
• PDBNo: the residue number followed by the name as in the PDB file,
• AA: the amino acid type in the one-letter code,
• STRUCTURE: the summary of the secondary structure as in the DSSP file,
• BP1 and BP2: the β bridge partners as obtained from the DSSP file,
• ACC: the surface area of the residue in Å2,
4DSSP: A database of secondary structure, solvent accessibility and other information derived from 3-D struc-
tures in the Protein Data Bank [56].
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• NOCC: the number of aligned sequences at this position,
• VAR: the sequence variability derived from the NALIGN alignments.
In this block, while the pair of lower case characters in columns indicates an insertion
at corresponding position in the aligned sequence, the dots (· · ·) indicate deletions. In
addition, each line of this block contains at most 70 residues of aligned protein sequences.
If the total number of aligned sequences (NALIGN, see HEADERS block) is higher than
70 in HSSP files, the ALIGNMENTS block is divided into several intervals like [1 . . .70],
[71 . . .140] etc. until the number of aligned sequences is reached.
SEQUENCE PROFILE block
## SEQUENCE PROFILE AND ENTROPY
 SeqNo PDBNo   V   L   I   M   F   W   Y   G   A   P   S   T   C   H   R   K   Q   E   N   D   NOCC NDEL NINS ENTROPY RELENT WEIGHT
    1          14 A     0   0   0   0   0   0   0   3  29   0   3  60   0   0   0   0   0   0   0   6       35      0          0      1.031         34             0.52
    2          15 A    22  27 2  34   0   0   0   0   1   0   0   0   0   0   0   0   2  12   0   0       83      0          0     1.538          51            0.45
    3          16 A    55  10  29   2   0   0   1   0   2   0   0   0   0   0   0   0   0   0   0   0      229    0          0     1.144          38            0.74
    4          17 A    2   1   0   0   0   0   1   0  10   0   2   1   0   6  11  10   5  37   1  13    238    0          0      2.009          67            0.32
    5          18 A    0   2   0   0   0   0   0   0   9   0   5   3   0   3   5   9  27  29   5   4        243    0          0      2.024          67            0.33
    6          19 A    6  36  42   0   4   0   2   0   8   0   0   2   0   0   0   0   0   0   0   0        253    0          0      1.460          48            0.54
   …            …                     …               …                                          …                                  …                            …         
   …            …                     …               …                                          …                                  …                            …                          
The last section of an HSSP file is the SEQUENCE PROFILE block which begins as usual
with "## SEQUENCE PROFILE AND ENTROPY". In this block, the relative frequency
of all 20 amino acids at each position is summarized. These frequencies are obtained by
counting the amino acids in that position for all aligned sequences, including the test se-
quence. A frequency of 100 indicates that this position is conserved and consists of only
one amino acid. The headers are also explained in the NOTATION lines.
• SeqNo: residue number that is defined in the DSSP file for the test protein (sequence),
• PDBNo: residue number that is defined in the PDB file,
• Columns 3 to 22: the relative frequencies of 20 amino acids under the one letter code,
• NOCC: number of aligned sequences with amino acids in corresponding position
(including test sequence),
• NDEL: number of sequences with a deletion, relative to the test protein, at corre-
sponding position,
• NINS: number of sequences with an insertion, relative to the test protein, at corre-
sponding position,
• ENTROPY: measure of sequence variability at corresponding position,
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• RELENT: relative entropy scaled from 0-100,
• WEIGHT: conservation weight.
2.5.2.2 HSSP to MSA
Although an HSSP file contains all of the required information about the protein of interest
and its homologous, the format of HSSP files is not suitable to use it directly as an MSA.
Therefore, we use the MView algorithm [57] to rewrite an HSSP file in a common MSA file
format (fasta format). The MView algorithm is implemented in Perl, Version 5 for UNIX
to reformat the results of a sequence database search or a multiple alignment. However,
it is important to note that the MView is not a multiple alignment program [57]. For the
remainder of this thesis, we use these reformatted MSAs as input for our methods.
2.5.3 Catalytic Site Atlas and PDBsum
Catalytic Site Atlas (CSA) is a database which stores experimentally validated catalytic
residues in proteins. The database contains two types of validated catalytic residues.
While the first one consists of hand-annotated descriptions of catalytic residues, the sec-
ond type corresponds to equivalent sites in homologous proteins which are found subse-
quently by a sequence alignment with the original set of hand annotated entries [58]. In
the database, there are currently ∼ 6262 annotated catalytic reside sites according to 968
literature entries. The CSA database is freely available via http://www.ebi.ac.uk/thornton-
srv/databases/CSA/.
Like CSA, the PDBsum database is a part of the European Bioinformatics Institute (EBI)5.
The PDBsum includes more detailed information about each experimentally determined
3-D structure of proteins in the PDB database. Moreover, the PDBsum illustrates protein
structures thereby creates annotated plots for secondary structure of proteins, schematic di-
agrams of protein-ligand bindings and protein-DNA interactions [59, 60]. The PDBsum
database is also freely accessible via http://www.ebi.ac.uk/pdbsum/ where a variety of re-
lated bionformatics databases are further presented.
In this thesis, we have used both CSA and PDBsum databases in order to observe function-
ally important catalytic sites and ligand binding sites of proteins which are necessary for
the biological evaluation of our methods.
2.5.4 Calculation of Distances Between Residues using BioJava
BioJava is one of the most useful open-source bioinformatics library implemented in JAVA.
The BioJava library contains a variety of methods and packages each of them are very help-
5EBI is a center for research and services in bioinformatics.
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HEADER    TRANSFERASE                        1V4S              
TITLE     CRYSTAL STRUCTURE OF HUMAN GLUCOKINASE  
[...]
ATOM     2  CA      THR A 14      25.314   -32.647    77.413      1.00 50.88        
ATOM     3  C         THR A  14      24.131   -32.303    76.523     1.00 51.03        
ATOM     4  O        THR A  14      24.315   -31.749    75.441     1.00 52.24        
ATOM     5  CB      THR A  14      26.003   -33.915    76.860     1.00 51.19        
ATOM     6  OG1   THR A  14      27.422   -33.716    76.836     1.00 51.64        
ATOM     7  CG2    THR A  14      25.525   -34.221    75.451     1.00 50.32        
ATOM     8  N         LEU A  15      22.916   -32.623    76.962     1.00 49.78        












Figure 2.4: The distance calculation: The balls show the Cα atoms at positions 14 and 15
in human glucokinase protein with PDB entry 1V4S. Based on the x,y, and z coordinates of
these atoms, the Euclidean distance is calculated as 3.800095.
ful to process biological data, to parse common file formats, and to manipulate sequences
as well as 3-D structures [61].
In this thesis, we have used BioJava for parsing PDB files in order to get three dimensional
coordinates of atoms in amino acids. Using these coordinates, we calculate the Euclidean
distance between major carbon atoms (Cα ) of different amino acids based on the ”nearby”
definition of Nussinov et al. [62].
Definition 2.2 (Nearby amino acids) Two amino acids (residues) are defined to be in
contact or nearby when the distance between their (Cα ) atoms is less than 6Å.
It can be assumed that an atom seems likely to be a ball with its three dimensional x,y, and
z coordinates and according to these coordinates, the Euclidean distance is calculated.
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Definition 2.3 (Euclidean distance) Euclidean distance between two atoms in 3-D space
with Cartesian coordinates is defined as
Euclidean distance =
√
(x1− x2)2 +(y1− y2)2 +(z1− z2)2, (2.5.1)
where (x1,y1,z1) and (x2,y2,z2) are the x, y and z coordinates of both atoms under study
[63].
Figure 2.4 shows the distance calculation between two Cα atoms in different amino acids
of human GCK protein. However, it is important to note that in this distance calculation we
do not consider the van der Waals radius6.
Figure 2.5: BLOSUM62 matrix
2.5.5 BLOSUM Matrices
The BLOSUM (BLOcks SUbstitution Matrix) is a widely used scoring matrix for sequence
alignments of proteins which were first introduced by Henikoff et. al in 1992 [64]. In or-
der to construct BLOSUM matrices, Henikoff et al. have used the BLOCKS Database [65]
which contains a set of aligned and un-gapped regions from protein families. In BLOSUM




matrices, each substitution between amino acids is assigned a score according to their ob-
served frequencies in the data set of homologous sequences of proteins. The substitution
scores can be negative, zero, or positive. A positive score indicates that the occurrence of
substitutions between similar or identical amino acids is greater than that would have been
observed by random chance in the data set. In contrast, a negative score indicates that the
occurrence of substitutions between dissimilar amino acids is less than that would have been
observed by random chance. A score of zero means that the occurrence of weakly similar
amino acids is equal to that expected by chance.
The BLOSUM matrices are 20× 20 symmetric matrices and its columns and rows are in-
dexed by the elements of amino acids (see Figure 2.5). Further, each BLOSUM matrix
is denoted by BLOSUMr, where 0 < r < 100, like BLOSUM50 or BLOSUM62 which
indicates the percent identity level of sequences in the alignment. For example, for BLO-
SUM50, the sequences with approximately 50% identity were counted.
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In this chapter, we provide a basic introduction to information theory. In the first section
we start with the definitions of entropy, mutual information, Kullback Leibler divergence
and Jensen-Shannon divergence. Most of this section is based on Chapter 2 in [66] which
provides a friendly introduction to the concept of entropy. In the next section, we present
some of the fundamental principles of quantum mechanics which are further required to
explain the definitions of the quantum information theory. The introduced definitions and
notations in this section are based on [67–71].
3.1 Classical Information Theory
The Shannon entropy is the key concept of the classical information theory and it is a mea-
sure of the average uncertainty of a random variable. Assume that we have a random vari-
able X . The entropy of X quantifies the amount of information that we gain after we learn
the value of X . Alternatively, it can be explained that the entropy of X provides a measure
for the amount of uncertainty about X before we learn its value.
Definition 3.1 (Entropy) Let X be a discrete random variable with alphabet X and prob-
ability distribution p(x) = Pr{X = x}, x ∈ X, where probabilities satisfy 0≤ p(x)≤ 1 and
∑x∈X p(x) = 1. The entropy of X is denoted by H(X) and defined as
H(X) =−∑
x∈X
p(x) log p(x). (3.1.1)
In this definition, the log(x) indicates the log in base two. Further, we adopt the convention
that p(x) log p(x) = 0, if p(x) = 0 for realizations with zero probability. In the Equation
3.1.1, one can easily see that the computation of H(X) only depends on the probability
distribution of X and it takes its maximum value when all probabilities p(xi) are equal.
Definition 3.2 (Joint Entropy) Let X and Y two discrete random variables with alphabet
x ∈ X and y ∈Y. Further, let p(x) = Pr{X = x} and p(y) = Pr{Y = y} be their individual
probability distributions. The joint entropy H(X ,Y ) of X and Y with a joint probability
distribution p(x,y) is defined as




p(x,y) log p(x,y). (3.1.2)
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Definition 3.3 (Conditional Entropy) Let X and Y be discrete random variables with joint
probability distribution p(x,y) and conditional distribution p(x|y), then the conditional en-
tropy H(X |Y ) is defined as
H(X |Y = y) =−∑
x
p(x|y) log p(x|y). (3.1.3)
The conditional entropy H(X |Y ) (Equation 3.1.3) can be written as
H(X |Y ) = ∑
y









If X and Y are independent then
H(X |Y ) =H(X).
It is important to note that the conditional entropy is not symmetric, i.e., ∃ X ,Y such that
H(X |Y ) 6=H(Y |X).
Theorem 3.1 (Chain rule for entropy:) The joint entropy H(X ,Y ) of a pair of discrete
random variables X and Y can be defined according to H(X), H(Y ), H(X |Y ), and H(Y |X)
as follows
H(X ,Y ) =H(X)+H(Y |X) or H(Y,X) =H(Y )+H(X |Y ).
The additive property of Shannon entropy can be applied as
H(X ,Y ) =H(X)+H(Y ) ,
if X and Y are completely independent.
According to the Equation 3.1.2, we can show that H(X ,Y ) =H(Y,X), i.e.,
H(X ,Y ) =H(X)+H(Y |X) =H(Y )+H(X |Y ) =H(Y,X) ,
from which the following equation is obtained as
H(X)−H(X |Y ) =H(Y )−H(Y |X) . (3.1.4)
The Equation 3.1.4 is different but equivalent forms of mutual information which we will
introduce in the next section. The venn diagram in Figure 3.1 illustrates the relationships
between H(X), H(X), H(X ,Y ), H(X |Y ) and H(Y |X).
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Figure 3.1: Venn diagram visualization of entropy H(X), joint entropy H(X ,Y ), condi-
tional entropy H(X |Y ), and mutual information MI(X ;Y ).
Theorem 3.2 (Basic properties of Shannon entropy)
1. Non-negativity: The entropy is always non-negative for any p(x):
H(X)≥ 0.
2. Upper bound: The maximum value of H(X) for random variable X with alphabet size
n is log(n):
H(X)≤ log(n).
3. Conditioning reduces the entropy:
H(X)≥H(X |Y ) .
4. Subadditivity:
H(X ,Y )≤H(X)+H(Y ) .
The equality is only possible if and only if the random variables X and Y are inde-
pendent.
5. H(X)≤H(X ,Y ), the equality is only possible if and only if the random variable Y is
a function of X.
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6. The entropy H(X) is concave in the probability density function p(x).
3.1.1 Relative Entropy and Mutual Information
The relative entropy is another entropic measure that quantifies the difference between two
probability distributions over the same alphabet.
Definition 3.4 (Kullback Leibler divergence) Relative entropy or Kullback Leibler (KL)










In the Equation 3.1.5, we adopt the convention that 0 log0 = 0 and −p(x) log0 = ∞ if
p(x)> 0.
Theorem 3.3 (Basic properties of the Kullback Leibler divergence)
1. Non-negativity: KL(p||q)≥ 0.
2. KL(p||q) = 0 if and only if p(x) = q(x).
3. The KL divergence is not symmetric: KL(p||q) 6= KL(q||p) if p(x) 6= q(x).
4. The KL divergence does not satisfy the triangle inequality.
Definition 3.5 (Jensen-Shannon divergence) Jensen-Shannon (JS) divergence is a sym-
metrized, smoothed, and bounded version of the KL divergence between two (or more)
probability distributions. The JS divergence between two probability distributions p(x) and












where π1 and π2 satisfy the constraints π1 +π2 = 1, and 0≤ πi ≤ 1.











where H(p) =−∑i pi log pi is the Shannon entropy and π1 = π2 = 12 .
Theorem 3.4 (Basic properties of Jensen-Shannon divergence)
1. Non-negativity: JS(p||q)≥ 0.
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2. JS(p||q) = 0 if and only if p = q.
3. The JS divergence is symmetric and always well defined: JS(p||q) = JS(q||p).
4. The JS divergence is bounded 0≤ JS(p||q)≤ 1.
5. The square root of the JS divergence satisfy the triangle inequality but JS divergence
does not.
6. The JS divergence can be generalized in order to quantify the difference between
more than two probability distributions p1, p2, . . . , pm with weights π1,π2, . . . ,πm by















where ∑mi=1 πi = 1.
Definition 3.6 (Mutual Information ) Let X and Y be two random variables with a joint
probability distribution p(x,y) and marginal probability distributions p(x) and p(y). The
mutual information MI(X ;Y ) between X and Y is defined as








Alternatively, the MI(X ;Y ) between X and Y can be written according to H(X), H(Y ) and
H(X ,Y ) as
MI(X ;Y ) =H(X)+H(Y )−H(X ,Y ). (3.1.10)
The mutual information MI(X ;Y ) between two random variables X and Y is the reduction
in the uncertainty of Y due to the knowledge of X (or vice versa).
Theorem 3.5 (Basic properties of mutual information)
1. Non-negativity: MI(X ;Y )≥ 0.
2. MI(X ;Y ) = 0 if and only if X and Y are independent.
3. MI(X ;Y ) is symmetric: MI(X ;Y ) =MI(Y ;X).
4. MI(X ;Y ) =H(X)−H(X |Y ).
5. MI(X ;Y )≤H(X).
29
3 Theoretical Background
3.2 Quantum Information Theory
Before we begin to define quantum information theory, we firstly have to introduce some
of the basic principles and notations of quantum mechanics, which are necessary to explain
and to understand quantum information theory. The definitions and notations in this section
are based on [67–71]. Moreover, we do not consider in this thesis complex vector spaces
and only deal with real ones.
3.2.1 Basic definitions of quantum mechanics
Quantum bits
In computer science, the elementary unit of information is represented by a bit which is the
fundamental concept of classical computation and classical information. A bit describes
the unit information of a classical system being in one of two possible states, in either the
state 0 or the state 1. Like a classical bit, a quantum bit or short qubit is the elementary
unit of information describing two-state system in the quantum information theory. Two
possible states for a qubit are |0〉 and |1〉 which are equivalent to the states of a classical bit.
The notation, ”|.〉”, called as Dirac notation, is the standard notation of quantum mechanics.
Although classical bits and qubits look very similar at first glance, there exists a fundamental
difference between them. While a classical bit can be in either the state 0 or 1, a qubit can
also be in the state superposition which is a linear combination of the states |0〉 and |1〉,
|ψ〉= α |0〉+β |1〉 . (3.2.1)
Equation 3.2.1 shows that the |ψ〉 is in a superposition where α and β are coefficients with
unit norm
|α|2 + |β |2 = 1.
The coefficients α and β are referred to as quantum probability amplitudes and their square
magnitudes, |α|2 and |β |2, indicate the probability of |ψ〉 for being in states |0〉 and |1〉,
respectively.
Dirac notation
In quantum mechanics, Dirac notation is a very useful way of expressing unit-length vectors
that are used to represent the states of a physical system. Further, the Dirac notation is
especially nice to use because it provides a very helpful way of specifying vector and matrix
operations of quantum states. The notation consist of bras "〈.|" and kets "|.〉" therefore
it is also called as "braket (〈.|.〉) notation". Basically, a ket |.〉 indicates in this thesis a
column vector of a real column vector space A and a bra 〈.| is obtained by transposing a
ket |.〉. In quantum information theory it is usual to consider complex spaces. But for our
purposes it suffices to deal with real ones. The multiplication of bras by kets results in the
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brakets notation ”〈.|.〉” which is also referred as standard scalar product or inner product
on A. Suppose we have the vectors |u〉 and |v〉. Their inner product, 〈u|v〉 has the following
geometric interpretation. It is equal to ‖u‖‖v‖cosα , where α is the angle between the




〈v|v〉 are the Euclidean norms (lengths)
of |u〉 and |v〉.













The bras corresponding to the kets |0〉 and |1〉 can be shown as
〈0|= (1 0) , (3.2.4)
〈1|= (0 1) . (3.2.5)
Although a bra does not represent quantum states, it is required for performing calculations
like probability amplitudes in the quantum theory. Recall the qubit in the Equation 3.2.1, in
order to determine the probability of |ψ〉 for being in state |0〉, we will combine the state of
the |ψ〉 with the bra 〈0| in the following calculation as
〈0|ψ〉 = 〈0|(α |0〉+β |1〉) (3.2.6)
= α 〈0| |0〉+β 〈0| |1〉 (3.2.7)











= α ·1+β ·0 (3.2.9)
= α. (3.2.10)
Likewise, calculating the quantity 〈1|ψ〉 we can determine the probability of |ψ〉 for being
in states |1〉. Further, we can also calculate the quantities 〈0|1〉 and 〈1|0〉 as
〈0|1〉 = 0, (3.2.11)
〈1|0〉 = 0, (3.2.12)
which show the probability of |0〉 for being in state |1〉 and the probability of |1〉 for being
in state |0〉. Since the vectors |0〉 and |1〉 are orthogonal to each other and have no overlap,
their inner products are equal to zero. In contrast to this, the inner products 〈0|0〉 and 〈1|1〉
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are equal to one,
〈0|0〉 = 1, (3.2.13)
〈1|1〉 = 1. (3.2.14)
Outer product
In contrast to the inner product, the product of a ket |u〉 with a bra 〈v| results in a matrix. It
is defined as the outer product which is used to represent the density operator of a system.























We can perform the bras 〈.| and kets |.〉 to represent this matrix in Dirac notation as
|u〉〈v|= a0b0 |0〉〈0|+a0b1 |0〉〈1|+a1b0 |1〉〈0|+a1b1 |1〉〈1| . (3.2.16)
Recall the qubit in the Equation 3.2.1, combining |ψ〉= α |0〉+β |1〉 with the matrix |u〉〈v|,
we determine the effect of this matrix on |ψ〉 as
(|u〉〈v|)(|ψ〉) = |u〉〈v|ψ〉= 〈v|ψ〉 |u〉 . (3.2.17)
This means that |u〉〈v| is a projection of A onto the subspace spanned by |u〉. Every linear
operator on A can be represented by a linear combination of such products. The transpose
AT of a linear operator A = ∑i j ai j |ui〉
〈
v j
∣∣ equals ∑i j ai j ∣∣v j〉〈ui|.
Tensor product
The tensor product is a fundamental mathematical operation of combining vector spaces to











The tensor product of |u〉⊗ |v〉 is
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Likewise, we can derive the tensor product of two matrices that is referred to as the Kro-
necker product. Suppose we have two operators U = |u1〉〈u2| and V = |v1〉〈v2| and their












The matrix representation of the tensor product U⊗V can be written as









a11b11 a11b12 a12b11 a12b12
a11b21 a11b22 a12b21 a12b22
a21b11 a21b12 a22b11 a22b12
a21b21 a21b22 a22b21 a22b22
 .
In general, if |u1〉 , |u2〉 ∈ A1 and |v1〉 , |v2〉 ∈ A2 are states, then |u1v1〉= |u1〉⊗ |v1〉 ∈ A1⊗
A2 and |u2v2〉 = |u2〉⊗ |v2〉 ∈ A1⊗A2 are tensor products of column vectors. The tensor
products of row vectors 〈u1v1| = 〈u1|⊗ 〈v1| and 〈u2v2| = 〈u2|⊗ 〈v2| are the transposes of
|u1v1〉 and |u2v2〉, where 〈u1v1|u2v2〉= 〈u1|v2〉〈u1|v2〉.
The Density operator or matrix
The traditional quantum mechanics distinguishes between pure states and mixed states: pure
state of a quantum system is a vector (|.〉) with a unit length in a vector space (the quantum
states which we have considered until now are also pure states); mixed state is a statistical
mixture of two or more states. While the pure states are represented by state vectors, mixed
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states are described by density matrices. A density matrix ρ is an operator representing a
quantum state that describes a part of the composite system.
Suppose we have the following two state vectors:
|u〉 = α |x〉+β |y〉 , (3.2.18)
|v〉 = γ |x〉+δ |y〉 . (3.2.19)
The density matrix for each of these states is the outer product of the state vector with itself:
ρu = |u〉〈u| , (3.2.20)
ρv = |v〉〈v| . (3.2.21)
Now, we can generalize the density matrix for n possible states. Suppose we have n states
and a quantum system is in one of these states |ψi〉 where i = 1,2, . . . ,n with respective
probabilities pi. The notation {pi, |ψi〉} is called an ensemble of pure states. Then the





pi |ψi〉〈ψi| . (3.2.22)
Definition 3.7 (Eigenvalues and Eigenstates of the density matrix) Given a density ma-
trix ρ on a vector space, a non-zero state vector |ψ〉 is defined as eigenstate of ρ if the
following equation is satisfied
ρ |ψ〉= λ |ψ〉 , (3.2.23)
where λ is called an eigenvalue of ρ .
In order to determine eigenvalues of a density matrix ρ , the characteristic equation det|ρ−
λ I|= 0 is used, where det indicates the determinant of the matrix ρ−λ I and I denotes the
identity matrix. The values of λ are the eigenvalues which represent the solutions of this
characteristic equation.
Theorem 3.6 (Key properties of a Density operator) An operator ρ is called as a density
operator if and only if it satisfies the following properties:




pi |ψi〉〈ψi|)† = ∑
i
pi |ψi〉〈ψi|= ρ.
7A Hermitian matrix is a matrix which is equal to its own transpose.
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2. ρ is positive semi-definite for any state vector |ψ〉:
〈ψ|ρ |ψ〉 ≥ 0.
3. ρ has unit trace: Tr(ρ) = 1.
Entangled and Separable States
One of the most striking features of quantum mechanics is the fact that the systems can
become entangled. Suppose we have two systems A and B and their composite state is
given by a density matrix ρAB. We define these two systems to be entangled if they have
interacted sometime in the past and we cannot construct the individual systems again now.
According to this interaction, the values of certain properties of system A are correlated with
the values that those properties will assume for system B [71]. In contrast, we say that two
system are separable if they are not entangled indicating that the corresponding composite
state ρAB can be broken into tensor product of these two systems.















αi jβkl |ik〉〈 jl| (3.2.24)




pmρA,m⊗ρB,m (pm > 0, ∑
m
pm = 1). (3.2.25)
The reduced density operator: Partial Trace






γik jl |ik〉〈 jl| . (3.2.26)
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We define the reduced density operator of the system A and B as
ρA = trB(ρAB) = trB(ρA⊗ρB), (3.2.27)
ρB = trA(ρAB) = trA(ρA⊗ρB), (3.2.28)
where trA and trB are the partial traces over system A and B, respectively. The partial traces



























|i〉〈 j| . (3.2.29)
It is important to note that partial traces of density operators are also density operators.
3.2.2 Quantum Information and von Neumann Entropy
In this section, we will consider the basis of quantum information theory. We will begin
by defining the von Neumann Entropy of a density operator ρ that is the quantum analogue
of the Shannon entropy H. After that, we will go on with quantum definitions of relative
entropy, joint entropy, mutual information, and Jensen-Shannon divergence [67–71].
Definition 3.8 (Quantum Entropy: von Neumann Entropy) Let ρ be a density operator
on a n-dimensional space. The von Neumann entropy of ρ is denoted by VNE(ρ) and defined
as





where λ1, . . . ,λn are eigenvalues of ρ and we define 0log0 = 0.
Definition 3.9 (Joint Quantum Entropy) Let A, B be two subsystems and AB be their
composite system. Let ρAB, ρA, ρB be corresponding density operators of the system and its
subsystems. Quantum joint entropy is defined as
VNE(ρAB) =−tr (ρAB logρAB) . (3.2.31)
Definition 3.10 (Quantum Mutual Information) The quantum mutual information of a
composite system AB defined as
VNE(ρA;ρB) = VNE(ρA)+VNE(ρB)−VNE(ρAB). (3.2.32)
Theorem 3.7 (Basic properties of quantum entropy)




where the equality is only possible if and only if ρA is a pure state.
2. Upper bound: The maximum value of VNE(ρA) for a density operator ρA is log(n),
where n is the dimension of the system:
VNE(ρA)≤ log(n).




The equality is only possible if the composite system ρAB equal to the tensor product
of two subsystems
VNE(ρA⊗ρB) = VNE(ρA)+VNE(ρB),
which corresponds to two subsystems with uncorrelated information.
Definition 3.11 (Quantum Relative entropy) The quantum relative entropy between two
density operators ρ and σ is defined, analogously to the corresponding classical quantity,
as
RVNE(ρ||σ) = tr(ρ logρ)− tr(ρ logσ). (3.2.33)
Definition 3.12 (Quantum Jensen-Shannon divergence) Similar to the classical Jensen-
Shannon divergence, the quantum Jensen-Shannon divergence (QJSD(ρ||σ)) between two
density operators ρ and σ is a symmetrized and smoothed version of quantum relative



























In following we briefly introduce the definition of the β -distribution and its parameter esti-
mation which is necessarily for the development of our significant model. The descriptions
in this section are based on [74].
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Definition 3.13 (β -distribution) A continuous random variable X has a β -distribution







, 0≤ x≤ 1. (3.3.1)




tα−1(1− t)β−1dt, α > 0 and β > 0. (3.3.2)








(α +β )2(α +β +1)
. (3.3.4)







tα−1(1− t)β−1dt, 0≤ x≤ 1 and α, β > 0. (3.3.5)
For a given sample mean µ̂ and variance σ̂ of finite sample of size N, the shape parameters
































4 Applying Classical Information Theory for
the Compensatory Mutation Analysis
In this chapter, we will present two entropy-based metrics, namely U-metric and UD(α)-
metric, for the detection of compensatory mutations in MSAs. While the former one was
developed by Merkl et. al in [22], the latter has been developed during this thesis in order
to complete the U-metric. Further, we will present a new MSA-specific statistical model
based on multiple testing procedures in order to determine significant U and UD(α)-values,
respectively.
We previously published an important part of this chapter in [4] (see Appendix A 9.1). The
descriptions of both the U-metric and the UD(α)-metric as well as the new MSA-specific
statistical model approach are based on this publication.
4.1 Detecting compensatory mutations by the U-metric
Let M be an arbitrarily chosen but fixed MSA for the protein under investigation. In order
to determine the correlation between columns of M, Merkl et. al. used in [22] a normalized
measure of mutual information ranging over the interval [0,1]. It is denoted as U-metric and
defined as
U(k, l) = 2 · H(k)+H(l)−H(k, l)
H(k)+H(l)
= 2 · MI(k; l)
H(k)+H(l)
, (4.1.1)
where H(k) and H(l) are the entropy of the empirical amino acid distributions of the
columns k and l under study, and H(k, l) is their joint entropies. The empirical distribu-
tions of amino acids are observed based on the occurrence of each amino acid in columns
k and l (see Figure 4.1). Likewise, extending the concept of empirical amino acid distri-
butions, we can observe the empirical joint distributions of amino acid pairs in the column
pair (k, l).
It is important to note that during the observation of these amino acid distributions we only
take into account the standard 20 amino acids and do not consider the gaps (’-’) as a real
component of the protein. Hence, we exclude them when we determine distributions of
amino acids in columns or in column pairs.
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position:        k             l                                    m         
Figure 4.1: A small part of an MSA. The positions k and l show a strong correlation. At
position k the [A to E] mutation cause at position l the [V to G] mutation or vice versa. In
addition, the position m demonstrates an example for strictly conserved residues.
As mentioned above, the U(k, l)-value of a column pair (k, l) ranges from 0 to 1. According
to the Figure 3.1, one can easily see that if the columns k and l are completely dependent,
the individual column entropies are equal to their corresponding joint entropy, i.e.,
H(k) =H(l) =H(k, l) . (4.1.2)
In this case, we have U(k, l) = 1, which is the upper bound of the U-metric. On the other
hand, if both columns are completely independent, we can see according to the Figure 3.1
that the sum of individual column entropies corresponds to the their joint entropy, i.e.,
H(k, l) =H(k)+H(l) , (4.1.3)
where U(k, l) = 0, which is the lower bound of the U-metric.
Calculation of the column entropies
Since we utilize the concept of information theory, it is necessary to consider amino acids
as a set of a random variable in columns of MSAs. Like in Figure 4.1, let k and l be two
columns and n is the number of sequences in the MSA M under study. Further, we assume
that X and Y are two random variables with same alphabet X, where the alphabet size
corresponds to 20 amino acids (throughout the remainder of this thesis unless otherwise
noted, the alphabet size is always 20). The random variables X and Y characterize the
frequencies of amino acids in given columns k and l in M, respectively.
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According to this, we can write associated empirical amino acid distributions of each
columns as p̂(x) = Pr{X = x}, p̂(y) = Pr{Y = y}, x,y ∈ X. Further, the empirical joint
amino acid pair distribution is denoted by p̂(xi,yi) = p̂{X = x,Y = y}. Then, the marginal













where #(xi), #(yi), and #(xi,yi) are observed frequencies of amino acids (xi), (yi) and pair
of amino acids (xi,yi) in the given columns k and l and in column pairs (k, l).
Using the Equations 4.1.4 to 4.1.6, we calculate the corresponding column entropies H(X),





p̂(xi) log p̂(xi) (4.1.7)




p̂(y j) log p̂(y j) (4.1.8)







p̂(xi,y j) log p̂(xi,y j) (4.1.9)
Then, we calculate the















p̂(xi,y j) log p̂(xi,y j),
(4.1.10)
which can be rewritten as:











Finally, we determine the correlation between corresponding columns with U-metric as
U(X ,Y ) = 2 · H(X)+H(Y )−H(X ,Y )
H(X)+H(Y )
= 2 · MI(X ;Y )
H(X)+H(Y )
.
The higher the U(X ,Y ) value between columns k and l, the stronger the pair-wise co-
occurrence of amino acids at these columns.
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The alphabet size effect on the mutual information
The mutual information (MI) is a useful method in bioinformatics in order to measure
the correlation between two columns in MSAs. However, Martin et al. [8] have argued
and showed in detail that the normalizing MI values with the entropy makes them more
suitable than raw MI values for the correlated/compensatory mutation analysis. This is due
to possible differences in the alphabet size of a column.
Figure 4.2: An artificial MSA. The positions k1 and
l1 are slightly conserved and contain only two amino
acids. The positions k2 and l2 contain all 20 amino
acids. Since the computation of MI values strongly
depend on the empirical amino acid distributions of
the columns which is also related to the alphabet
size, both pairs of columns (k1, l1) and (k2, l2) have
completely different MI values. The more differ-
ent amino acids are included in a pair of columns,
the higher are their individual column entropy and
related joint entropy that often causes a greater MI
value. However, if a column pair is slightly con-
served like (k1, l1), the alphabet size in these column
pair is quite low which results in a less MI value.
Example: Let M be the MSA under study and let (k1, l1) and (k2, l2) be two different
column pairs in M, where the observed alphabet size of the first column pair is X(k1,l1) = 2
and the observed alphabet size of the second column pair X(k2,l2) = 20 (see Figure 4.2).
Further, suppose that the associated empirical amino acid distributions, p̂(xki), p̂(yli) and
p̂(xki ,yli), i = 1,2 are uniformly distributed in both pairs of columns which results in
H(Xk1) =H(Yl1) =H(Xk1 ,Yl1) , (4.1.12)
H(Xk2) =H(Yl2) =H(Xk2 ,Yl2) . (4.1.13)
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Now, we calculate the MI(Xki ;Yli) of both pairs of columns as











= log2 = log |X(k1,l1)| (4.1.14)















= log20 = log |X(k2,l2)| (4.1.16)




The Equations 4.1.14 and 4.1.16 clearly show the alphabet size effect on the MI. Although,
both column pairs (k1, l1) and (k2, l2) are perfectly correlated and have the same U value,
their raw MI-values reflect these correlations completely different because of the alpha-
bet size. Consequently, we can see that the higher is the alphabet size, the greater is the
corresponding mutual information. Thus, a normalization method was required in order to
reduce the effect of the alphabet size on the MI values which explains the reason of using
the U-metric in this thesis.
4.1.1 Filtering of an MSA
We filter MSAs before their analysis with an approach similar to [22].
First, we delete highly similar and dissimilar sequences in a given MSA to ensure that the
sequence identity between any two sequences is at least 20% and no more than 90%.
Second, we remove strictly conserved residue columns (see column m in the Figure 4.1). We
say a column is strictly conserved if the percentage of identical residues is greater than 95%.
The reason for this is two-fold. First, these strictly conserved columns occur because of the
common ancestor of all living organisms thus a compensatory mutation at that positions is
often not allowed through the evolution (see Section 2.3). Second, fully conserved columns
have an entropy of zero which results in a division through zero (see Section 3.1).
Third, we eliminate the columns which contain more than 25% gaps. As mentioned before,
we do not consider the gaps ’-’ as a real amino acid in a protein as well as in an MSA.
Therefore, rows with a gap at position k or l were excluded from the computation of U-
metric. If we incorporate them in the calculation, the gaps can provide wrong information on
the correlation between columns. As a result of this, the columns with a higher percentage of
gaps could be detected by the U-metric as highly correlated although only little information
is available in those columns.
Finally, we only consider MSAs that have at least 125 rows remaining after the filtering.
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4.2 Determining an MSA-specific lower bound for the
significance of U-values
Filtering an MSA ensures that there is always a correlation between each column pairs in
this MSA based on the definition of U-metric. However, a challenging problem in bioinfor-
matics is the separation of significant U-values between two or more column pairs from the
background noise and unrelated column pairs. Thus, we have developed an MSA-specific
statistical model based on multiple testing procedures that quantifies the error made in terms
of the false discovery rate described in [27,28]. Below, we will explain our statistical model
step by step. The result is an MSA-dependent threshold τ above which U-values are defined
as significant.
4.2.1 Step 1: Calculation of p-values
Let M be the MSA for the protein under study. We slightly extend the standard approach
of multiple testing procedures introduced in [27, 75–77] with the following assumptions
in mind. If regarded as random variables, M’s U(k, l)-values follow three different distri-
butions as demonstrated in Figure 4.3: i) a null distribution, F0 representing background
signals; ii) a distribution for those column pairs which are completely unrelated, G1; iii) a
distribution representing the correlation signals we are interested in, G2.
We assume F0 to be a β -distribution and M’s U(k, l)-values U1,U2, . . . ,Uµ be an indepen-
dent and identically distributed (i.i.d.) sample, although there are some weak dependencies
between them. With respect to the F0, we first determine the p-values of each U values.
p-values of U-values
The p-values of U depend on whether U-values are F0, G1 or G2-distributed. According to
Figure 4.4 and the definition of U-metric, we can say that while the G1-distributed unrelated
pair signals have a low U-value, the G2 distributed correlation signals of column pairs take
relatively high U-values, whereas the F0 distributed background signals have moderate U-
values.
Let M be an arbitrarily chosen but fixed MSA and U1,U2, . . . ,Uµ be M’s U-values. We
calculate the p-value for each U-value as
Xι = 1−F0(Uι) = P{random F0 -distributed value≥Uι}, (4.2.1)
where Xι is the p-value of Uι with respect to F0. If Uι is F0-distributed, then Xι is uniform
over [0,1] (Figure 4.3). If however, Uι is G1 distributed, then the corresponding Xι is rela-
tively high and tends to 1 (Figure 4.3). In contrast, if Uι is G2 distributed, then Xι becomes
a low score and tends to 0 (Figure 4.3).
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Figure 4.3: p-value distribution of U-values for human GCK protein (PDB Entry
1V4S). The p-values close to zero represent the significant pairs by means of which we
assess the individual residue position. In contrast, p-values of unrelated pairs tend to one.
As one can see, the p-values of F0 distributed U-values are approximately uniform.
Equation 4.2.1 shows that the p-values of the U-values can be calculated based on either the
cumulative distribution function of the β -distribution (see Equation 3.3.5) or by drawing
a random sample from the β -distribution with parameters α, β > 0. However, in both
cases we first need to know the α and β . According to equations 3.3.6 and 3.3.7, we can
estimate α and β from the expected value and the variance of M’s U-values. The expected
value is estimated by the sample mean of all U-values of M according to the Equation 3.3.8.
However, we do not estimate the variance directly using the Equation 3.3.9, instead we use
a more sophisticated approach. If we were to use the Equation 3.3.9 directly, we would get
relatively high sample variance because of the G1 and G2-distributed U-values. Then, the
β - distribution would not represent the F0- distribution. Hence, the corresponding p-values
do not follow the uniform distribution over [0,1] (see Figure 4.5).
follow the real scores (see figure 4.5).
In order to eliminate the effect of G1 and G2-distributed U-values on the sample variance
we take pattern from [78]. Having drawn an i.i.d. sample (C1,C′1),(C2,C
′
2), . . . ,(Cν ,C
′
ν) of
random column pairs of a sufficient size whose U-values fall in a preassigned subinterval
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Figure 4.4: U-value distribution for human GCK protein (PDB Entry 1V4S). The higher
the U-value between pairs of columns, the stronger the correlation of amino acids at these
columns.
of [0,1], we calculate D1,D2, . . . ,Dν by randomly shuffling the sequence C′ι , ι = 1,2, . . . ,ν .
The artificial variance is then estimated according to Equation 3.3.9 as the sample variance
of (C1,D1),(C2,D2), . . . ,(Cν ,Dν). Afterwards, we use the sample mean and the artificial
variance to estimate the parameters of the β -distribution.
In order to draw random numbers from the β -distribution, we apply the BN-algorithm in
[79], which is an acceptance-rejection technique using uniform and normal distributions to
generate β -distributed random numbers (see Algorithm 1).
4.2.2 Step 2: Setting an MSA-dependent threshold τ
After the computation of p-values of M’s U-values, we need a threshold τ to separate signif-
icant p-values of correlation signals from the background and unrelated pair signals. While
determining such a significant threshold τ , a certain amount of non-significant U-values is
accepted to be significant. The ratio of these falsely accepted values is defined as False Dis-
covery Rate (FDR). In order to determine an MSA-dependent threshold τ above which U-
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Figure 4.5: p-value distribution of U-values according to the sample mean and variance
for human GCK protein (PDB Entry 1V4S). The p-values are estimated based on the
sample mean and variance which is calculated using all U-values of M. As one can see, if
we use directly the sample variance for the estimation of shape parameters α and β of the
β -distribution, the p-values of U-values do not follow the uniform distribution over [0,1].
values are defined as significant, we generalize for a preassigned FDR the Storey-Tibshirani
procedure devised for multiple testing problems as follows [27, 28].
First, we estimate the fraction γ of the F0-distributed Uι ’s as
γ̂ =
number of p-values in [λ1,λ2]
n(λ2−λ1)
, (4.2.2)
where n is the total number of M’s U-values and λ1, λ2 are the tuning parameters. λ1 and λ2
are chosen such that the fraction of not uniformly distributed p-values that fall into [λ1,λ2]
is negligible. The selection of the tuning parameters requires an automated approach during
the analysis of M. Algorithm 2 presents our approach for determining λ1 and λ2.
Second, knowing the fraction γ̂ of the F0-distributed U-values, we say a U-value of sites
(i, j) is significant if and only if the p-value (1−F0(U(i, j))) is less than or equal to τ , for
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Algorithm 1 The BN-algorithm: to sample from β -distribution using only normally and
uniformly distributed random numbers [79].
1: Input: Shape Parameters α > 1 and β > 1
2: A← α−1, B← β −1
3: C← A+B, L←C · ln(C)
4: µ ← AC , σ ← 0.5√C
5: Take a sample s from the standard normal distribution
6: x← s ·σ +µ
if x < 0 or x > 1 then
7: Reject it and go to 8
else if Generate a uniform distributed random value then
8: u← Random value ∈ [0,1]
end if
if (ln(u)> (A · ln( xA)+B · ln(
(1−x)
B )+L+0.5 · s2)) then
9: Reject it and go to 8
else if Deliver x as a sample from the β -distribution with parameters α and β then
return x
end if
a threshold τ ≤ λ1 that ensures the input FDR, which is estimated by
F̂DR(τ) =
γ̂nτ
number of p-values ≤ τ . (4.2.3)
Finally, setting τ = 0 initially, we increase the τ step by step and solve the Equation 4.2.3
iteratively, as long as the result of this computation is less than the preassigned F̂DR. After
that, the last τ upon what the F̂DR exceeds its limit is defined as the significance threshold.
Assessment of individual residue sites
A significant U-value simply reflects the correlation between residue sites i and j in an
MSA M but does not provide enough information about the site i or j, alone. Because of
this, Merkl and Zwick have suggested a method based on concepts of network analysis to
characterize individual residue sites [22]. They argued that the consideration of U-values is
only a promising method if there is a strong correlation signal between residue sites i and j.
However, if all U-values are low in an MSA, a single U(i, j)-value can be easily misclas-
sified due to definition of U metric. To overcome this problem and to evaluate individual
residue positions i and j, we use the connectivity degree technique introduced in [22] and
further developed in [4].
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Algorithm 2 Determination of the λ1 and λ2 according to M’s p-values.
Input: All p-values of M’s U-values
λ1← 0, λ2← 1
γ1← 0, ε ← 0.01, η ← 0.01
accept← false
while (!accept and (λ1 < λ2)) do
Calculate γ2 using the Equation 4.2.2
δ = γ2− γ1











Definition 4.1 (Connectivity degree ) The connectivity degree of a site i with respect to
the metric U and the MSA M is defined as number of sites j such that the U(i, j)-value of
residue sites i and j is significant for M (see Figure 4.6).
Finally, the site i is defined to be (U,M)-significant, if i’s connectivity degree with respect
to U and M is greater than or equal to the n-th percentile, where we set n = 90 in this thesis.
4.3 Enhancing prediction by the UD(α)-metric that models
dissimilar compensatory mutations
In this section, we will present our new entropy based metric, called UD(α)-metric. The U
-metric introduced in Section 4.1 is defined as a normalized mutual information that uses
only the observed frequency of amino acids in the MSA columns. Thus, it does not consider
any physical or biochemical properties of amino acids which are likely to be crucial for the
detection of functional or structural important positions. Therefore, we have developed our
novel UD(α)-metric which differ from the U-metric by incorporating the significant BLO-
SUM62 dissimilar amino acid signals in the prediction of functional or structural important
residue sites. Basically, the calculation of the UD(α)-metric is based on transforming the
empirical pair distributions of column pairs with a doubly stochastic pair substitution ma-
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Figure 4.6: A small part of connectivity degree network of human GCK protein (PDB-
Entery 1V4S): The nodes represent individual residue sites and each vertex indicate a sig-
nificant correlation (U-value) between residue sites k and l. The vertex count of a node
indicates its connectivity degree. The red circles shows residue sites which have three high-
est connectivity degree in whole network and thus defined as (U,M)-significant.
trix. The doubly stochastic matrix reflects the BLOSUM62 dissimilar amino acid signals
which are observed according to the significant column pairs of training MSAs.
4.3.1 Training data set
In order to build our mathematical model we used approximately 1700 protein structures
which were randomly chosen from a redundancy free data set with more than 35000 protein
structures. The redundancy free data set was prepared by Rainer Merkl’s group University
of Regensburg. In order to construct the data set, the PISCES server [80] is firstly used with
a sequence-similarity cut-off of 25% for the elimination of redundant proteins. Afterwards,
we took the corresponding protein structures from the PDB database and the related MSAs
were gathered from the HSSP database for our training. Then, we filtered the MSAs in the
same way as described in the Section 4.1.1:
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• highly similar and dissimilar sequences in the MSAs are removed to ensure that the
sequence identity (si j) between any two sequences is 20%≤ si j ≤ 90%,
• strictly conserved columns in MSAs which contain same residue types more than
95% are removed,
• the columns which contain more than 25% gaps are removed,
• finally, all MSAs with less than 125 sequences are discarded.
More than 17000 MSAs survived the last filtering step. We used approximately 1700 MSAs
as training data which we randomly chose from this set. The pdb entries of the correspond-
ing protein structures are listed in Table 9.1.
4.3.2 Preparing substitution matrices
For our approach, we need to prepare a significant substitution matrix and a random substi-
tution matrix.
Let M be an arbitrarily chosen but fixed MSA with m sequences and let k and l be two
columns in M. To compute the pair-to-pair substitution scores of amino acid pairs in these
columns, we utilize standard concept of computational biology suggested in [81, 82]. For
the 20 amino acids, there are 400 different amino acid pairs and each of them can occur in
this column pair (k, l). Since we count pair-to-pair substitution of amino acid pairs, there
exist 160000 different possible substitution between amino acid pairs for which we use a
400× 400 symmetric matrix C. Having that, we calculate pair-to-pair substitution score
between pairs of amino acids [aki,ali] and [ak j,al j] occurring in columns k and l based on
counting the following four individual substitutions:
([aki,ali], [ak j,al j]), (4.3.1)
([ali,aki], [al j,ak j]), (4.3.2)
([ak j,al j], [aki,ali]), (4.3.3)
([al j,ak j], [ali,aki]), (4.3.4)
where i and j indicate the corresponding rows in M. We count the substitutions between
pairs of amino acids symmetrically since the correct order of the sequences in MSAs is
unknown. Finally, each of these substitution scores are summed up in the matrix C. In
Figure 4.7 we give an example in order to show how we count the pair-to-pair substitution
in a column pair.




(ai,a j),(ak,al)) of amino acid pairs is defined to be a formal dissimilar compen-
satory mutation, if the BLOSUM62 score of both (ai,ak) and (a j,al) is negative.
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  position:      k            l   
Pair to pair substition in 
the column pair (k,l)
1:    AV - EG
2:    VA - GE
3:    EG - AV
4:    GE - VA
Seq1 Seq2
Seq1 Seq3
1:    AV - AV
2:    VA - VA
3:    AV - AV
4:    VA - VA
Figure 4.7: Counting pair to pair substitution: In the column pair (k, l) occurs different
pair to pair substitution such as ([A,V ]↔ [E,G]), ([A,V ]↔ [A,V ])and([E,G]↔ [E,G]) or
vice versa. Since the correct order of the sequences in MSAs is unknown , we count the
substitutions symmetrically and store the occurrence values of substitutions in a matrix C.
We use the training data set to estimate a 400×400 doubly stochastic matrix DCompMut. This
matrix is our mathematical model of how dissimilar compensatory mutations have affected
genomic sequences in the course of evolution. Its construction consists of following five
steps.
Step 1:
We calculate a signal and a null set of column pairs. The signal set consists of all (U,M)-
significant column pairs, where M ranges over all training MSAs. Significant column pairs
of each training MSA M are determined individually using the MSA-specific statistical
model (see Section 4.2). The null set consists of sufficiently many non-significant column
pairs randomly chosen from every training MSA. For both the signal set and the null set we
compute a symmetric 400× 400 integer-valued matrix of frequencies of pair substitutions
Calt and Cnull as explained in Section 4.3.2.
Step 2:
We compare both Calt and Cnull matrices in order to find out if a substitution score of signal
pairs is smaller than pure chance.
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(ai′ ,a j′),(ak′ ,al′)
) > Cnull((ai,a j),(ak,al))
∑i′, j′,k′,l′Cnull
(
(ai′ ,a j′),(ak′ ,al′)
) .
Step 3:
We set all entries of the matrix Csig outside the main diagonal that do not represent a formal













This results in the compensatory mutation matrix CCompMut. By normalizing CCompMut,





represents an empirical probability distribution on pairs of amino
acid pairs.
Step 4:






















is the marginal distribution of PCompMut.
Step 5:
We set all negative entries of SCompMut to zero. Then we compute the doubly stochastic
matrix DCompMut by means of the canonical iterated row-column normalization procedure
[83].
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4.3.4 Application of doubly stochastic matrix DCompMut for the computation of
the new UD(α)-metric
In the previous Section 4.3.3, the matrix DCompMut has been estimated to model significant
and BLOSUM62 dissimilar compensatory mutation signals. Based on the matrix DCompMut,
we incorporate compensatory mutation signals in the computation of the U-metric that re-
sults in our novel UD(α)-metric. Consequently, for every column pair (i, j) of the input
MSA M, we linearly transform the associated empirical pair distribution with the doubly
stochastic matrix as
D(α) = (1−α)1+αDCompMut,
where 1 is the 400×400 unit matrix and α ∈ (0,1] is a preassigned real number. UD(α) (i, j)
is then defined to be the U-value (see Equation 4.1.1) of this transform.
In the following example, we demonstrate how the empirical pair distribution of a column
pair in an MSA is transformed with the doubly stochastic matrix to calculate corresponding
UD(α)-value.
Example: Let M be the input MSA and (k, l) be a column pair in M with empirical joint
distributions of amino acid pairs p̂(xi,yi) = p̂{X = xi,Y = yi}, x,y∈X, and i = 1,2, . . . ,20.
We write these pair probabilities p̂(xi,yi) in a P̂20×20 matrix.
y1 . . . y20 ∑
j
p̂(xi,y j)
x1 p̂(x1,y1) . . . p̂(x1,y20) p̂x(x1)
...
... . . .
...
...
x20 p̂(x20,y1) . . . p̂(x20,y20) p̂x(x20)
∑
i
p̂(xi,y j) p̂y(y1) . . . p̂y(y20) 1
Table 4.1: P̂20×20: Observed probabilities of amino acid pairs in column pair (k, l), where
xi,y j ∈ 20 amino acids(A,C,D,E,F,G,H,I,K,L,M,N,P,Q,R,S,T,V,W,Y ).
Then, the P̂20×20 matrix is converted in a vector~v of length 400 which is necessary to linearly
transform the associated pair distribution p̂(x,y) with doubly stochastic matrix DCompMut.
~v∗400 =~v×DCompMut (4.3.5)
After that the vector ~v∗400 is converted again in a P̂∗20×20 matrix to determine the novel
transformed marginal column distributions p̂∗(x), p̂∗(y) and pair distribution p̂∗(x,y).
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y1 . . . y20 ∑
j
p̂∗(xi,y j)
x1 p̂∗(x1,y1) . . . p̂∗(x1,y20) p̂∗x(x1)
...
... . . .
...
...
x20 p̂∗(x20,y1) . . . p̂∗(x20,y20) p̂∗x(x20)
∑
i
p̂∗(xi,y j) p̂∗y(y1) . . . p̂∗y(y20) 1
Table 4.2: P̂∗20×20: Transformed values of joint amino acid pair distribution
Finally, in order to calculate our new UD(α)-metric, we determine the individual column
entropies H(k∗) , H(l∗) and joint entropy H(k∗, l∗) based on the transformed distributions
p̂∗(x), p̂∗(y), p̂∗(x,y), respectively.




Having canonically carried over the definition of a significant site pair and of the connec-
tivity degree of a site to this case, a site i is called (UD(α),M)-significant, if i’s connectivity
degree with respect to the metric UD(α) is greater than or equal to the 90-th percentile.
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4.4 Discussion
To predict sites of structural or functional importance, we combine the known U-metric of
normalized mutual information [22] with our novel metric UD(i)(1) to enhance the influence
of dissimilar compensatory mutations when measuring covariation of two sites. We discuss
how we devised UD(1) introduced in the Section 4.3.
To learn the frequency of compensatory mutations, we took U-significant site pairs as train-
ing data. We did that for reasons of computation time regardless of the fact that these data
are biased. To deal with this bias, one could carry through the training in an iterative process,
with our training being the first iteration. For i> 0, in the (i+1)-th iteration of this modified
training, a doubly stochastic matrix D(i+1)CompMut is calculated based on UD(i)(1)-significant site
pairs. This is done until the training data are stable.
According to Birkhoff’s Theorem [84], every doubly stochastic matrix is a convex combi-
nation of permutation matrices. Moreover, from the Hardy-Littlewood-Pólya majorization
theorem [85] follows that transforming the probability mass function by a doubly stochas-
tic matrix increases entropy. Consequently, by linearly transforming the empirical amino
acid pair distribution of a site pair by D(1) before calculating the U-value, we penalized
those site pairs whose original distribution does not match the frequency pattern of formal
dissimilar compensatory mutations in the training data described in the Section 4.3.1.
The challenge was to separate the signal caused by structural and functional constraints
from the background and unrelated pair signal. To address this issue, we studied only
metrics µ that satisfy the following condition. The larger the µ(k, l)-value, the larger the
probability that the two sites k and l have co-evolved. Our critical assumptions were: i) the
µ(k, l)-values follow three different distributions, one for the signal, one for the noise, and
one for pairs of completely unrelated sites; ii) there is an MSA-dependent threshold below
which the metric µ does not fall with overwhelming probability, when it is applied to the
site pairs of functional or structural importance to which µ is sensitive; iii) there is an MSA-
dependent threshold significantly smaller then the one in (ii) such that with overwhelming
probability there are no µ(k, l)-values of pairs (k, l) of unrelated sites exceeding it.
In order to near-completely eliminate the noise, we filtered both our training and input data.
We calculated the significant pairs such that the preassigned false discovery rate was guar-
anteed by generalizing the Storey-Tibshirani procedure devised for multiple testing prob-
lems [27].
Our method to eliminate noise is orthogonal to the technique developed in [9]. Therein,
for every pair of sites the so-called average product correction (APC) is calculated as an
explicit noise measure, by which the mutual information is then decreased. Furthermore,
it generalizes the way Merkl and Zwick [22] as well as Gao et al. [23] cope with noise.
According to our judgment, taking only the top 75 high-scoring pairs or the top 25 pairs
into account as has been suggested in [22] and [23], respectively, is too conservative.
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We based our noise separation technique on rather weak distribution assumptions that are
standard practice in multiple hypothesis testing, instead of explicitly model the noise in
terms of a metric. We applied the connectivity degree technique due to Merkl and Zwick
[22] to significant site pairs with respect to our both metrics.
57
5 Applying quantum information theory for
the detection of functionally or structurally
important sites
In this chapter, we will develop our second model for the prediction of important sites
in proteins by applying quantum information theory. First, we give an introduction how
the notions of this theory are mapped onto those from bioinformatics. After that, we will
define two new metrics based on quantum Jensen-Shannon divergence in order identify
functionally and/or structurally important residue sites in MSAs.
We publish the context of this chapter in [5] (see Appendix B 9.2). The descriptions and
notations are based on this publication.
5.1 Notation mapping from quantum information theory in
protein bioinformatics
The 20 amino acids are associated with the standard basis vectors of a 20-dimensional real
vector space A of column vectors. It is important to note that, we only deal with real vector
spaces for our model.
As has been mentioned in the Section 3.2, in Dirac notation a column vector ψ is represented
by a ket |ψ〉. Thus, the 20 amino acids are associated with the basis |1〉 , |2〉 , . . . , |20〉 of
A, where |i〉 is the column vector whose j-th entry is equal to 1 if i = j, and equal to 0
otherwise.
In quantum mechanics unit-length vectors are the states of the system under study. The
larger the scalar product of states, the better they are aligned. Thus, we interpret the scalar
product of states as similarity measure. If in turn certain not necessarily orthogonal states
represent amino acids or amino acid pairs, this is a canonical way to include similarity.
A basis is orthonormal if it consists of states that are pairwise orthogonal. The basis
|1〉 , |2〉 , . . . , |20〉 is the standard orthonormal basis of A. To model amino acid pairs occur-
ring in MSA column pairs, we need two copies A1 and A2 of A. Pairs are then represented
as tensors |i j〉= |i〉⊗ | j〉 ∈ A1⊗A2 (i, j = 1,2, . . . ,20) which are Kronecker products of
the corresponding column vectors of dimension 20. For i, j = 1,2, . . . ,20, the column vector
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5.1 Notation mapping from quantum information theory in protein bioinformatics
|i j〉 has a dimension of 400, where exactly that entry is equal to 1 that corresponds to the
pair (i, j). All other coefficients are equal to 0.
The amino acid conservation of an MSA column pair is measured on grounds of its em-




i, j=1,2,...,20, where p̂i j is the relative frequency of
the pair of the i-th and the j-th amino acid in that column pair. If we choose a row of the
MSA column pair by pure chance, we get the amino acid pair (i, j) with probability p̂i j





p̂i j |i j〉〈i j| . (5.1.1)
The logarithm of ρ(p̂) (see Equation 5.1.1) is ∑20i, j=1 log p̂i j |i j〉〈i j|, where log p is set to 0
if p = 0. This entails−ρ(p̂) logρ(p̂) =−∑20i, j=1 p̂i j log p̂i j |i j〉〈i j| . Then, the entropy of the









p̂i j log p̂i j. (5.1.2)
Positive semi-definite operators of trace 1 are the most general form of density operators.
For taking amino acid pair similarity into account when modeling MSA column pairs, the






∣∣πi j〉〈πi j∣∣ , (5.1.3)
where
∣∣πi j〉 is a not necessarily orthonormal basis of states that represents the amino acids






reflects predefined similarities between the 400 amino acid pairs.






∣∣ξi j〉〈ξi j∣∣ , (5.1.5)
where the eigenvalues qi j ≥ 0 sum up to one. Then, we calculate the von Neumann entropy
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qi j logqi j. (5.1.6)
The difference between the Shannon entropy given by Equation 5.1.2 and the von Neu-
mann entropy defined by Equation 5.1.6 is that the more similar the vectors
∣∣πi j〉 appearing
in Equation 5.1.3 are, the less is the von Neumann entropy compared with the Shannon
entropy.
The predefined Gram matrix A (see Equation 5.1.4) does not fully determine the states
∣∣πi j〉,
for i, j = 1,2, . . . ,20. In order to be able to specify additional conditions for a consistent
amino acid pair model, we need measurements as another key notion of quantum mechanics.
To this end, let Pkl = |kl〉〈kl| be the orthogonal projection from A1⊗A2 onto the subspace
spanned by |kl〉 so that Pkl |ξ 〉= 〈kl|ξ 〉 |kl〉, where k, l = 1,2, . . . ,20, and |ξ 〉 ∈ A1⊗A2.
By definition, measuring a density matrix ρ given by Equation 5.1.3 with respect to the
standard basis |kl〉 (k, l = 1,2, . . . ,20) results in the density matrix ∑20k,l=1 PklρPkl . This mea-
surement determines the relative amino acid pair frequencies of the column pair under study.
That is why it is reasonable to require for all k, l = 1,2, . . . ,20
PklρPkl = p̂kl |kl〉〈kl| . (5.1.7)
We ensure that a density operator ρ satisfies these conditions having represented it with re-
spect to the standard basis |kl〉 (k, l = 1,2, . . . ,20). The relative amino acid pair frequencies
p̂kl have to appear on the main diagonal.
Amino acid pair distributions of MSA column pairs can be marginalized to get the amino
acid distributions of the MSA columns concerned. Thus, we use the partial trace which is
the analog way in quantum mechanics to observe the amino acid distributions of columns.
Let i and j denote the amino acids of the first column, and k and l the amino acids of the
second column. If ρ = ∑20i, j,k,l=1 γik jl |ik〉〈 jl| is a density operator that describes the amino
acid pair distribution of an MSA column pair including pair similarity, then the partial traces




























As we have explained in Section 3.2.1, partial traces of density operators are also density
operators. Here, they involve amino acid similarity schemes that are ”marginals” of the
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for (k = 1 . . .dimV ) do
for (l = 1 . . .dimW ) do
for (i = 1 . . .dimV ) do
for ( j = 1 . . .dimW ) do









for (k = 1 . . .dimV ) do
for (i = 1 . . .dimV ) do
tr1(ρ)[k][i]← 0
for ( j = 1 . . .dimW ) do








for (l = 1 . . .dimW ) do
for ( j = 1 . . .dimW ) do
tr2(ρ)[l][ j]← 0
for (i = 1 . . .dimV ) do





5 Applying quantum information theory
5.1.1 Calculating the Gram matrices Aent and Asep to be plugged into
Equation 5.1.4
We leverage the matrices Calt and Cnull (see Section 4.3.3) to calculate of the Gram matri-
ces. The entries of the two matrices are frequencies of pair substitutions: Calt models the
correlation signals between pair of amino acid pairs; Cnull reflects the background signals.
We define two significant pair substitution matrices Cent and Csep from Calt and Cnull which
form the basis of our new metrics Qent and Qsep (both metrics will be defined in Section 5.2).
The intuition behind Cent is that BLOSUM62-based pair similarities are rescaled, whereas






































(ai′ ,a j′),(ak′ ,al′)
) > Cnull((ai,a j),(ak,al))
∑i′, j′,k′,l′Cnull
(























= 1 if and only if either (ai,a j) = (ak,al) or Equation 5.1.10 is
satisfied.













range over all possible 160000 indices of pairs of amino acid pairs
including the main diagonal, and α ∈ (0,1) was appropriately chosen.
To ensure positive semi-definiteness, we finally set
A= BT B. (5.1.13)
That way we obtain Aent as well as Asep.
62
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5.1.2 Simultaneously ensuring Equations 5.1.3, 5.1.4, and 5.1.7
Having chosen the kets
∣∣πi j〉 that appear in Equation 5.1.3 so that the uniquely deter-
mined positive semi-definite square root
√
ρ of ρ equals ∑20i, j=1 q̂i j
∣∣πi j〉〈i j| , where q̂ =(
q̂i j
)
i, j=1,2,...,20 represents the amino acid pair distribution we wish to plug into ρ , Equation








q̂i j |gh〉〈i j| . (5.1.14)
Therein, A is either equal to Aent or equal to Asep. (Note, that Equation 5.1.14 corresponds
to an approach due to Johansson et al. [86] for MSA columns rather than MSA column
pairs.)









i, j=1,2,...,20. Since the square root (
√
ρ) of ρ is in particular






q̂i j |gh〉〈i j|. Comparing the latter with
Equation 5.1.14, Equation 5.1.4 follows.
5.2 Defining two new metrics Qent and Qsep
In the Section 4.3.3 a pair
(
(ai,a j),(ak,al)) of amino acid pairs is called a formal dissimilar
compensatory mutation, if the BLOSUM62-score of both (ai,ak) and (a j,al) is negative.
To define our first new metric Qent for a certain column pair of a given MSA, let q̂ =
p̂ ·DCompMut, where DCompMut is the 400×400 doubly stochastic matrix defined in Section
4.3.3, and p̂ is the empirical pair distribution of these two columns. Having determined ρent






It is the quantum Jensen-Shannon divergence of an entangled density matrix that incorpo-
rates rescaled amino acid pair similarity as well as dissimilar compensatory mutations with
a separable density operator representing the empirical amino acid pair frequencies.
Our second new metric Qsep replaces the U-metric introduced in the Section 4.1 by a mea-
sure that integrates a new amino acid pair similarity score into the framework of quantum
Jensen-Shannon divergence. To this end, let ρsep be defined by Equation 5.1.14, where q̂
is equal to the empirical amino acid pair distribution p̂ of the column pair under study, and













5 Applying quantum information theory
5.3 Discussion
Grosse et al. observed in [87] that the Jensen-Shannon divergence (JSD) can be interpreted
as mutual information between two (or more) random sources in a special setting partic-
ularly appropriate to discriminate between these sources. This is what we need when it
comes to predicting important protein sites in an MSA-based approach. It might explain
the findings of Capra and Singh [88] on the predictive power of JSD. These two articles en-
couraged us to utilize quantum Jensen-Shannon divergence (QJSD) in this thesis. As a side
effect, a normalization is not necessary, since quantum Jensen-Shannon divergence, like its
classical counterpart, ranges over the real interval [0,1].
Several studies have confirmed that detecting coupled MSA-columns is extremely useful in
the prediction of important protein sites (see e.g. [4,8,9,15–24]). When using information-
theoretic metrics, there is no doubt that it is reasonable to incorporate amino acid pair
dissimilarity as well as amino acid similarity in a consistent way such that similarity de-
creases entropy, whereas dissimilarity increases it. This kind of consistency is important,
since entropy is the fundamental building block for most of those metrics. In particular,
the Jensen-Shannon divergence between two probability mass functions p and q equals
H(1/2(p+q))−1/2(H(p)+H(q)).
In the Section 4.3 we have presented an amino acid pair dissimilarity model for compen-
satory mutations. A doubly stochastic matrix transforms the empirical amino acid pair
distribution of a column pair. Rescaled pair similarity of BLOSUM62-similar pairs is to
capture an aspect of coupled MSA column pairs orthogonal to the phenomenon of dissim-
ilar compensatory mutations. It models the amino acid pair transition preferences within
those column pairs on the average. As suggested by Caffrey et al. [89] as well as Johansson
et al. [86], it is promising to incorporate them within the framework of quantum information
theory. Therein, density matrices replace probability mass functions. The counterpart of the
entropy of a probability mass function is the von Neumann entropy (VNE) of a density
matrix (see Equation 5.1.6). QJSD corresponds then exactly to JSD.
The challenge was to complement the model presented in the Section 4.3 by additionally
incorporating amino acid pair similarity in a way that the two effects interfere but do not
interact. We model the 400 amino acid pairs by means of 400 not necessarily orthogonal
tensors spanning the tensor product of two copies of a 20-dimensional Hilbert space. This
provides us with the opportunity to utilize the notion of entanglement, which in turn is a
major resource of quantum information. Moreover, we are in a position to make use of
partial traces, which play the role of the marginals in the classical case. Pair similarity is
reflected by means of the Gram matrix of these tensors (see Equation 5.1.4). To ensure
positive definiteness, which is a key property of density matrices, we used transitivity of
similarity (see Equation 5.1.13). Since there is no transitivity of dissimilarity, we kept
dissimilarity apart from that Gram matrix. Instead, we carried over our previously defined
BLOSUM62-dissimilarity model which was used to develop UD(α)-metric (see Section 4.3).
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Gram matrix and transformed amino acid pair distribution are joined together by means of
Equation 5.1.14 in the final step of our density matrix design. That way we minimize the
interaction between the two effects of dissimilarity and similarity.
In order to eliminate the noise and to define an MSA-dependent threshold for significant
column pairs, we followed the line of the Section 4.2. The MSA-specific statistical model
presented there seems to be of universal applicability. The same is true for the connectivity
degree model introduced in the Section 4.2.2. Combining them results in a reliable and
robust method to determine significant residue sites.
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In this chapter, we will analyze important sites of the human epidermal growth factor recep-
tor (EGFR) protein and glucokinase (GCK) protein in order to demonstrate the functionality
of our both classical and quantum information theory based methods. We have selected both
proteins because their functionally and structurally important sites have been experimentally
well studied [29–40].
EGFR is a member of the ErbB (Erythroblastic Leukemia Viral Oncogene Homolog) family
receptors. Signaling through this receptor is a highly conserved mechanism from nematode
to humans involved in numerous processes, including proliferation, cell fate determination,
and tissue specification [90]. Furthermore, several studies have implicated that mutations
resulting in misregulation of the activity or action of EGFR led to multiple cancers, includ-
ing those of the brain, lung, mammary gland, and ovary [29–32].
GCK is a monomeric enzyme catalyzing phosphorylation of glucose to glucose-6-
phosphate, which is the first step in the utilization of glucose, at physiological glucose
concentration in pancreas and liver. Given the fact that GCK displays low affinity for
glucose, it acts as a glucose sensor playing an important role in the regulation of carbohy-
drate metabolism. Mutations of the GCK gene can lead to maturity onset diabetes of the
young (MODY) characterized by an autosomal dominant mode of inheritance and onset
early adulthood [37], or familial hyperinsulinemic hypoglycemia type 3 (HHF), which is
common cause of persistent hypoglycemia in infancy [91].
In Section 6.1, we will start with the introducing the structurally or functionally important
residue sites of these two human proteins. After that, in Section 6.2 we will go on analyzing
both proteins in detail with U-metric and UD(α)-metric presented in Chapter 4. In addition,
we will compare the functionality of these metrics with each other to evaluate their perfor-
mance statistically. In Section 6.3, we will predict the important sites of EGFR and GCK
proteins applying our quantum information theory based metrics Qent and Qsep presented in
the Chapter 5 and analyze the predicted sites in detail. Finally, in Section 6.4, we will make
a comparison between the results of both classical and quantum information theory based
methods.
We have previously published most of this chapter in [4] and [5] (see Appendix A 9.1 and
B 9.2).
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6.1 Essential sites of human EGFR and GCK protein
To evaluate the significant residue sites detected by our classical and quantum informa-
tion theory based methods, we have investigated essential sites of human EGFR (pdb entry
2J6M) and GCK (pdb entry 1V4S) proteins. The essential sites of both proteins have been
assigned into three main categories: i) the nsSNP positions and their adjacent sites; ii)
residue positions which are located at or near active sites, allosteric sites, or binding sites;
iii) residue positions which are nearby strictly conserved sites. Here, we have used "nearby"
definition of Nussinov et al. [62] and defined two residues as in contact or adjacent when
the distance between their major carbon atoms is less than 6 Å (for the distance calculation
see the Section 2.5.4). We have defined positions which are nearby nsSNPs as essential,
because several of them are also adjacent to active sites, allosteric sites, binding sites, or
strictly conserved sites. Thus, we refer to a significant residue site as "functionally or struc-
turally important" if it falls into one of these categories of essential sites.
6.1.1 MSAs and 3-D structures of human EGFR and GCK protein
We gathered the related MSAs of both proteins from the HSSP database (see Section
2.5.2) [54], and their corresponding 3-D structure information were downloaded from PDB
database (see Section 2.5.1) [2] which are necessary to determine the distance between
residues.
The human EGFR protein has a chain length of 306 residues and its related MSA contains
1551 sequences. Likewise, the human GCK protein has a chain length of 448 residues and
its related MSA contains 785 sequences. In Figure 6.1 and 6.2 , we illustrate positions of
residues in both proteins with corresponding residue sequence number in PDB files.
6.2 Applying the U-metric and the UD(α)-metric for the human
EGFR and GCK protein
We apply our classical information theory based method to predict functionally or struc-
turally important residue positions in two steps. First, we utilize the new MSA-specific sta-
tistical method presented in the Section 4.2 for the identification of significant MSA column
pairs with respect to either of the two metrics U and UD(α). Assuming that M is the MSA
under study, these pairs are annotated as (U,M)-significant and (UD(α),M)-significant, re-
spectively. Second, we utilized the connectivity degree of a residue site (see in the Section
4.2.2). Recall that the connectivity degree of a residue site indicates the number of its sig-
nificant coupled mutation pairs. In this case, a site is called (U,M)-significant when the
frequency of occurrence of this site in the set of (U,M)-significant pairs exceeds the 90-th
percentile. Having defined the concept of a (UD(α),M)-significant site analogously, a site
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Figure 6.1: The sequence of the human EGFR protein (PDB-Entry 2J6M) (image from
http://www.rscb.org [2], 05.08.2013).
is defined as CMF-significant8 with respect to M, when it is either (U,M)-significant or
(UD(α),M)-significant.
8We defined the predicted significant sites together as CMF-significant due to our corresponding publication
”Coupled Mutation Finder” [4].
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Figure 6.2: The sequence of the human GCK protein (PDB-Entry 1V4S) (image from
http://www.rscb.org [2], 05.08.2013).
We analyzed both proteins with a false discovery rate (FDR) of 1%. For EGFR, we defined
a total of 14339 out of 26079 non-conserved column pairs as significant. 11365 of these sig-
nificant pairs are detected as (U,M)-significant and 3798 pairs are observed as (UD(α),M)-
significant. Only 824 EGFR pairs are significant with respect to both metrics. On the other
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hand, for GCK, we identified a total of 32654 out of 69645 non-conserved column pairs as
significant where 18106 of them are U-significant and 16241 are UD(1)-significant. More-
over, 1693 pairs are defined as significant for both U and UD(1)-significant.
Applying the connectivity degree technique, we identified 22 and 36 residue positions as
U-significant for human EGFR and GCK proteins, respectively. Additionally, 21 positions
of EGFR and 36 positions of GCK were detected as UD(1)-significant. Finally, a total of 43
sites of EGFR and 72 of GCK were found as CMF-significant, and predicted as of structural
or functional importance (see Table 6.1 and 6.2). However, there have been no residue sites




























Residue Position Connectivity Degree Detected by Residue Position Connectivity Degree Detected by
S 720 170 U-metric Q 849 173 U-metric
T 725 178 U-metric K 860 113 UD(α)-metric
Y 727 169 U-metric G 863 170 U-metric
E 746 168 U-metric E 868 170 U-metric
A 755 177 U-metric E 872 170 U-metric
N 756 192 U-metric V 876 173 U-metric
E 758 121 UD(α)-metric K 879 109 UD(α)-metric
I 759 123 UD(α)-metric Y 891 120 UD(α)-metric
Y 764 174 U-metric T 892 175 UD(α)-metric
M 766 104 UD(α)-metric S 899 97 UD(α)-metric
A 767 173 U-metric Y 900 119 UD(α)-metric
H 773 125 UD(α)-metric T 909 158 UD(α)-metric
Q 791 198 UD(α)-metric S 912 174 U-metric
D 800 102 UD(α)-metric K 913 170 U-metric
N 816 176 U-metric D 916 181 U-metric
V 819 177 U-metric A 920 172 U-metric
Q 820 147 UD(α)-metric E 922 188 UD(α)-metric
G 824 99 UD(α)-metric S 924 176 U-metric
E 829 101 UD(α)-metric E 931 171 U-metric
D 830 95 UD(α)-metric R 932 95 UD(α)-metric
K 846 183 U-metric M 947 106 UD(α)-metric
T 847 164 UD(α)-metric





Residue Position Connectivity Degree Detected by Residue Position Connectivity Degree Detected by
L 25 229 U-metric G 264 258 U-metric
M 34 238 U-metric E 265 250 U-metric
R 36 238 U-metric L 266 246 U-metric
E 40 302 UD(α)-metric D 267 246 U-metric
T 60 305 UD(α)-metric E 268 242 U-metric
R 63 289 U-metric L 271 286 UD(α)-metric
T 65 213 U-metric S 281 286 UD(α)-metric
E 67 286 UD(α)-metric N 283 321 UD(α)-metric
T 82 318 UD(α)-metric Q 286 238 U-metric
N 83 312 UD(α)-metric Q 287 332 UD(α)-metric
G 92 224 U-metric G 294 265 UD(α)-metric
H 105 253 U-metric E 300 346 UD(α)-metric
M 107 276 U-metric E 331 241 U-metric
F 123 278 UD(α)-metric T 332 240 UD(α)-metric
C 129 217 U-metric R 333 223 U-metric
F 133 230 UD(α)-metric Q 337 221 U-metric
F 148 234 UD(α)-metric E 339 264 UD(α)-metric
T 149 277 UD(α)-metric D 341 299 UD(α)-metric
F 152 258 UD(α)-metric G 343 235 U-metric
H 156 334 UD(α)-metric D 363 300 UD(α)-metric
F 171 243 UD(α)-metric N 391 224 U-metric
N 180 320 UD(α)-metric E 395 270 U-metric
R 186 257 UD(α)-metric S 396 265 U-metric
T 206 297 UD(α)-metric T 405 264 U-metric
T 209 292 UD(α)-metric S 411 315 UD(α)-metric
C 213 263 U-metric K 414 318 UD(α)-metric
E 216 227 U-metric S 418 236 U-metric
D 217 241 UD(α)-metric F 419 226 UD(α)-metric
E 221 249 U-metric R 422 252 U-metric
T 228 282 UD(α)-metric H 424 250 U-metric
E 236 351 UD(α)-metric T 431 253 U-metric
V 244 240 U-metric S 433 224 U-metric
R 250 225 U-metric C 434 227 U-metric
F 260 237 UD(α)-metric I 439 221 U-metric
G 261 214 U-metric E 442 319 UD(α)-metric
D 262 295 UD(α)-metric E 443 315 UD(α)-metric
Table 6.2: 72 CMF-significant residue sites found by U and UD(α)-metric in human GCK protein.
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6.2.1 Position analysis of the Human Epidermal Growth Factor Receptor
(EGFR) protein
In order to detect essential mutation positions in the corresponding sequence of human
EGFR protein, we determined altogether 43 CMF-significant residue sites (see Table 6.1).
15 of these significant residue sites have been verified as nsSNP sites through the Ensembl
database annotation and they are illustrated in Figure 6.3.
Figure 6.3: CMF-significant nsSNP positions in human EGFR protein (PDB-Entry
2J6M). The red spheres correspond to structural localization of 15 different CMF-
significant nsSNP positions in the EGFR protein.
Additionally, the CMF-significant sites E746, Q791, and four of the nsSNP positions
(I759,Y764,M766 and K846) are also in contact with critical active site regions for the
gefitinib binding site in the wild type EGFR kinase [30, 33] (see Figure 6.4).
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Figure 6.4: CMF-significant residue positions are in contact with gefitinib binding sites
in human EGFR protein (PDB-Entry 2J6M ). Yellow spheres denote positions of the
gefitinib binding sites in the wild type kinase. Blue spheres show the localization of CMF-
significant adjacent residue positions which are in contact with these binding sites. Addi-
tionally, the CMF-significant sites I759, Y764, M766 and K846, shown with green spheres,
are already described as nsSNP positions and they are also in contact with gefitinib binding
sites E762 and M793, respectively. Circles indicate clusters of gefitinib binding sites and
their significant adjacent sites.
Moreover, we observed that 17 further CMF-significant positions are essential sites (see
Table 6.3). In total, we have established for EGFR protein the importance of 34 out of 43
CMF-significant residue sites via different resources [30, 33, 39, 40].
CMF-significant essential sites Nearby nsSNPs or strictly conserved sites Reference
Y 727 726c 743c -
Continued on next page
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Table 6.3 – continued from previous page
CMF-significant essential sites Nearby nsSNPs or strictly conserved sites References






V 876 877c -
K879 877c, 880c -
Y 891 892s, 895c [40]
S899 880c, 896c, 898c, 901c -
Y 900 898c, 901c -
T 909 906c, 936c -
S912 906c, 936c -
K913 914c -
D916 914c -
M947 901c, 950c -
Table 6.3: CMF-significant essential sites in human EGFR protein, which are nearby either
nsSNPs or strictly conserved sites. s : non-synonymous snp site, c : strictly conserved site.
Although the vast majority of CMF-significant sites are verified to be structurally or func-
tionally important in human EGFR protein, nine CMF-significant sites do not overlap with
essential sites. The reason for the high connectivity degree of these unconfirmed significant
sites and their role in the EGFR protein is unclear.
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6.2.2 Position analysis of the Human Glucokinase (GCK) protein
Applying our both metrics, we determined 72 CMF-significant residue sites to be struc-
turally or functionally important in human GCK protein (see Table 6.2). 16 of these signifi-
cant residue positions are related to disease associated nsSNP positions [34–36,39,40] (see
Figure 6.5).
Figure 6.5: CMF-significant nsSNP positions in human GCK protein (PDB-Entry
1V4S). Red spheres show the structural localization of 16 different CMF-significant nsSNP
positions in the GCK protein.
Furthermore, nine significant sites are found to be in contact with allosteric sites in the GCK
protein structure. Among these sites, the R63 is also allosteric site by itself [37] and T209,
C213 and E221 overlap with nsSNP regions (see Figure 6.6B). Moreover, the five significant
sites T149, F171, T206, Q287, and G294 interact with glucose binding sites K169, D204,




























Figure 6.6: CMF-significant residue positions are in contact with glucose binding site and allosteric site in human GCK
protein (PDB-Entry 1V4S). (A) Yellow spheres show the structural positions of glucose binding sites (active sites). Blue
spheres correspond to localization of CMF-significant adjacent residue positions which are in contact with these active sites.
(B) Orange spheres denote the allosteric sites. Blue spheres correspond to localization of just significant adjacent residue
positions and green spheres indicate the significant residue positions which are already described as nsSNP positions and in
contact with these allosteric sites. Additionally, the significant position R63 is allosteric site by itself and it is also in contact with




Besides this, there are further 30 CMF-significant essential sites which are nearby nsSNPs
or strictly conserved residue positions (see Table 6.4). Altogether, we showed the function-
ality of 57 positions out of 72 CMF-significant residue sites via different resources [34–40].
CMF-significant essential sites Nearby nsSNPs or strictly conserved sites References
M34 36s [39]
T 65 66c
E67 66c, 68c -
T 82 81c -
N83 81c, 108s, 110s [39]
H105 106s [34]
C129 131s, 132s [34, 39]
F133 131s, 132s [34, 39]
F148 147c, 150c,s [39]
F152 150c,s, 151c [39]
H156 162s [34]
N180 162s, 182s [34, 39]
F260 257s, 258c, 259s, 261s [39]
D262 259s, 261s, 264s [39, 92]
L266 261s, 264s, 265s [34, 39, 92]
D267 264s, 265s [34, 92]
L271 274c -
S281 278c, 279s [39]
Q286 259s [39]
E331 299c,s [39]




N391 392s [34, 39]




E443 444c, 445c -
Table 6.4: CMF-significant essential sites in human GCK protein, which are nearby either
nsSNPs or strictly conserved sites. s : non-synonymous snp site, c : strictly conserved site.
While we are able to establish the large number of CMF-significant sites as structurally or
functionally important in human GCK protein, 15 CMF-significant sites do not overlap with
essential sites. Their importance in the GCK protein and the reason of high connectivity
degree of these unconfirmed significant sites has not been determined yet.
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6.2.3 A comparison between U-metric and UD(α)-metric
Similarities in physical or biochemical properties of amino acids are likely to be crucial for
the detection of functionally or structurally important positions of a protein. In contrast to
the U-metric, which is a normalized mutual information that uses only the frequencies of
occurrences of amino acids in the MSA columns, the novel UD(α)-metric includes dissimi-
larities according to the BLOSUM62 matrix when calculating normalized mutual informa-
tion. As a result, the positions which have undergone dissimilar compensatory mutations
are upscaled.
Having applied the U-metric as well as the UD(α)-metric to human EGFR and GCK proteins,
the UD(α)-metric has shown better sensitivity and specificity. However, only when we use
the both metrics together, the sensitivity is significantly increased, whereas the specificity





Table 6.5: Comparison between U-metric and UD(α)-metric




6.3 Applying the Qent and the Qsep-metric for the human EGFR
and GCK proteins
In Section 4.2, we pointed out that column pair metric distributions on the interval [0,1]
can be modeled based on distributions of background signals F0, unrelated pair signals G1,
and significant pair signals G2, where F0 is a β -distribution. Let Q be one of the two new






, i = 1,2, . . . are uniformly
distributed over [0,1], if Q-values are F0-distributed. In contrast, p-values tend to zero
or one, if Q-values are G2-distributed or G1-distributed, respectively (see Figure 6.7). By
slightly generalizing the Storey-Tibshirani procedure devised for multiple testing problems
[27, 28, 75] to quantify the error made in terms of false discovery rate (FDR), we have
developed in our MSA-specific statistical model which successfully separates significant
signals of column pairs from background signals and unrelated pair signals. In order to
determine significant Q-values of column pairs, we also apply that model in this section.
After that, we utilized the connectivity degree technique (see Section 4.2.2) in order to
characterize the significance of individual residue sites.
Let M be an MSA, where the protein of interest is represented by M’s first row. The def-
inition of a (Q,M)-significant site pair (i, j) of the protein is completely analogous to the
corresponding notion presented in the previous Section 6.2. A residue site of the protein is
defined to be QCMF-significant9 with respect to the MSA M, if it is (Qent,M)-significant
or (Qsep,M)-significant and its connectivity degree cut-off exceeds the 90-th percentile in
(Qent,M)-significant or (Qsep,M)-significant pairs.
In order to compare the performance and functionality of our quantum information the-
ory based method with our classical information theory based method, we tested again
the same human proteins using their related MSAs for the evaluation of QCMF-significant
residue sites. Likewise, we define here a QCMF-significant residue site as "functionally or
structurally important" if it corresponds to one of the essential sites.
6.3.1 Position analysis of the Human EGFR protein
Using the MSA-specific statistical model with a false discovery rate (FDR) of 1% for both
Qent and Qsep-metrics, we first determined altogether 2688 out of 26079 non-conserved
column pairs as significant in corresponding MSA of human EGFR protein. 631 of these
significant pairs are detected by the Qent-metric and 2149 pairs are observed by the Qsep-
metric. Only 92 significant column pairs were detected by both metrics. After that, utilizing
the connectivity degree technique, we predicted a total of 33 residue sites in the correspond-
ing sequence of the human EGFR protein as QCMF-significant (see Table 6.6). 12 of them
9We defined the predicted significant sites together as QCMF-significant due to our corresponding publication
”Quantum Coupled Mutation Finder” [5].
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Figure 6.7: p-value distributions of Qent and Qsep-values for human EGFR protein
(PDB-Entry 2J6M). The blue bars illustrate the p-value distribution of the Qent-values
and red bars display the p-value distribution of the Qsep-values.
are only Qent-significant and 18 residue sites are Qsep-significant, the remaining 3 residue
sites (A839,A882 and V902) are determined both Qent-significant and Qsep-significant.
10 of the QCMF-significant residue sites are in contact with either catalytic residues or
critical active site regions for gefitinib binding site in wild type EGFR kinase [30, 33, 58]
(see Figure 6.8 and Figure 6.9). Among these sites, the A839 and R841 have been verified
as catalytic residue sites through Catalytic Site Atlas [58], the T854 is a gefitinib binding
site by itself and the residue sites V845 and A859 are also in contact with nsSNP positions
K846, T847 and K860 in human EGFR protein. Moreover, two out of all 33 significant
sites are related to disease associated nsSNP positions and their structural localization are
illustrated in Figure 6.8.
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Figure 6.8: QCMF-significant residue positions are in contact with catalytic residues in
human EGFR protein (PDB-Entry 2J6M). Red spheres denote positions of the catalytic
residues. Yellow spheres show the localization of QCMF-significant adjacent residue posi-
tions which are in contact with these catalytic residues. Moreover, the QCMF-significant
sites A839 and R841 are also catalytic residues by themselves. Green spheres show the
structural localization of QCMF-significant nsSNP positions in the EGFR protein. Circles























Residue Position Connectivity Degree Detected by Residue Position Connectivity Degree Detected by
G 729 62 Qsep-metric L 844 62 Qsep-metric
T 751 18 Qent-metric V 845 97 Qent-metric
N 771 57 Qsep-metric I 853 21 Qent-metric
G 779 70 Qsep-metric T 854 24 Qent-metric
Q 791 77 Qsep-metric A 859 24 Qent-metric
I 792 22 Qent-metric K 860 78 Qsep-metric
Q 820 69 Qsep-metric A 882∗ 26 Qent-metric
A 822 35 Qent-metric A 882∗ 54 Qsep-metric
G 824 89 Qsep-metric Y 891 113 Qsep-metric
M 825 72 Qsep-metric T 892 45 Qent-metric
Y 827 119 Qsep-metric Y 900 132 Qsep-metric
L 828 52 Qsep-metric V 902∗ 74 Qent-metric
V 834 54 Qent-metric V 902∗ 79 Qsep-metric
L 838 52 Qsep-metric T 909 42 Qent-metric
A 839∗ 43 Qent-metric G 911 66 Qsep-metric
A 839∗ 55 Qsep-metric L 927 24 Qent-metric
A 840 128 Qent-metric G 930 71 Qsep-metric
R 841 68 Qsep-metric Y 944 51 Qsep-metric
Table 6.6: 33 QCMF-significant residue sites found by Qent-metric and Qsep-metric in the human EGFR protein.
∗ denotes the residue sites are detected by both metrics Qent and Qsep as significant.
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Figure 6.9: QCMF-significant residue positions are in contact with gefitinib binding
sites in human EGFR protein (PDB-Entry 2J6M). Red spheres show the structural local-
ization of the gefitinib binding sites in the wild type kinase. Yellow spheres show signifi-
cant adjacent residue positions which are in contact with these binding sites. Moreover, the
QCMF-significant site T854 is also binding site by itself and interacts with gefitinib binding
sites D855. Circles indicate clusters of gefitinib binding sites and their significant adjacent
sites.
Additionally, 13 of out of all QCMF-significant sites are defined as essential sites since they
are either nearby strictly conserved residues or nsSNPs (see Table 6.7).
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QCMF-significant essential sites Nearby nsSNPs or strictly conserved sites References
N771 773s [40]
G824 773s [40]
Y 827 829s [40]
L828 829s [40]
V 834 835c, 836s,860s [40, 92]
Y 891 892s, 895c [40]
A822 861s [29, 39, 92]
V 844 796c, 798c, 852c -
A882 884c, 895c, 898c -
Y 900 898c, 901c -
V 902 880c, 901c -
T 909 906c, 936c -
G911 906c -
Table 6.7: QCMF-significant essential sites in human EGFR protein, which are nearby either
nsSNPs or strictly conserved sites. s : non-synonymous snp site, c : strictly conserved site.
According to the essential sites of human EGFR protein, we have shown altogether the
structural or functional importance of 25 QCMF-significant sites. The remaining 8 signif-
icant residue sites (G729, T851, G779, Q820, M825, L927, G930, Y944) do not fall into
essential sites and the reason for their significance and their importance in the EGFR protein
is currently unclear.
Finally, we compared the new QCMF-significant residue sites for human EGFR protein with
our previous CMF-significant residue sites. The new significant residue sites Q791, Q820,
G824, K860, Y891, T892, Y900, T909 overlap with CMF-significant residue sites. Inter-
estingly, one of the unconfirmed residue sites (Q820) has been predicted as both QCMF-
significant and CMF-significant.
6.3.2 Position analysis of the the Human GCK protein
Like human EGFR protein, applying the MSA-specific statistical model with a FDR of 1%
for both Qent and Qsep-metrics we identified a total of 9853 out of 69645 non-conserved
column pairs as significant in human GCK protein. 6070 of them are (Qent,M)-significant
and 4232 are detected as (Qsep,M)-significant. Only 449 column pairs are determined as
significant with respect to both metrics. Thereupon using the connectivity degree technique,
we determined altogether 64 residue sites in human GCK protein as QCMF-significant (see
Table 6.8). 30 of them are observed as Qent-significant and 30 significant residue sites are
detected as Qsep-significant. Only four residue sites (T82, G223, V253, G407) are defined





Residue Position Connectivity Degree Detected by Residue Position Connectivity Degree Detected by
M 37 75 Qsep-metric G 223∗ 97 Qsep-metric
T 60 177 Qent-metric G 223∗ 63 Qent-metric
Y 61 87 Qsep-metric T 228 310 Qent-metric
V 62 65 Qent-metric A 232 184 Qent-metric
S 76 297 Qent-metric C 233 241 Qent-metric
L 79 70 Qsep-metric E 236 153 Qsep-metric
T 82∗ 95 Qsep-metric V 253∗ 89 Qsep-metric
T 82∗ 318 Qent-metric V 253∗ 64 Qent-metric
N 83 108 Qsep-metric F 260 84 Qsep-metric
V 86 144 Qent-metric L 271 171 Qent-metric
V 89 67 Qent-metric V 277 107 Qent-metric
F 123 161 Qsep-metric S 281 99 Qsep-metric
S 127 296 Qent-metric N 283 91 Qsep-metric
F 148 101 Qsep-metric Q 287 96 Qsep-metric
T 149 318 Qent-metric G 294 62 Qent-metric
F 152 207 Qsep-metric Y 297 178 Qsep-metric
P 153 95 Qsep-metric M 298 81 Qsep-metric
H 156 68 Qsep-metric E 300 82 Qsep-metric
G 162 95 Qsep-metric T 332 89 Qent-metric
G 170 82 Qsep-metric V 374 182 Qent-metric
F 171 144 Qsep-metric A 378 302 Qent-metric
G 175 90 Qsep-metric A 379 292 Qent-metric
A 176 63 Qent-metric S 383 198 Qent-metric
G 178 125 Qsep-metric A 384 55 Qent-metric
N 180 76 Qsep-metric A 387 59 Qent-metric
L 185 96 Qsep-metric G 388 70 Qent-metric
A 201 308 Qent-metric G 407∗ 75 Qsep-metric
M 202 105 Qent-metric G 407∗ 143 Qent-metric
T 206 300 Qent-metric V 412 218 Qent-metric
V 207 303 Qent-metric F 419 110 Qsep-metric
A 208 145 Qsep-metric E 443 110 Qsep-metric
T 209 319 Qent-metric G 446 86 Qsep-metric
M 210 85 Qsep-metric L 451 63 Qent-metric
Y 215 104 Qsep-metric S 453 317 Qent-metric
Table 6.8: 64 QCMF-significant residue sites found by Qent-metric and Qsep-metric in human GCK protein.
∗ denotes the residue sites are detected by both metrics Qent and Qsep as significant.
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13 out of all QCMF-significant residue sites are in contact with allosteric sites V62, R63,
M210, I211, Y214, Y215, M235, V452, V455 and A456 in human GCK protein. Among
these significant sites, the V 62, M210, Y 215 are allosteric sites by themselves [37] and the
T209M, G223S and S453del are related to disease associated nsSNP positions. In addition,
there are further five QCMF-significant sites F123L, G162D, G175R, T228M and E300K,Q
that have been verified as nsSNP positions through annotation databases and previous exper-
imental studies [34–36,38,39,93]. The structural localization of these 18 QCMF-significant
residue sites (contact sites and nsSNPs positions) are illustrated in Figure 6.10.
Additionally, eight QCMF-significant sites T149, G170, F171, T206, V207, A208, Q287
and G294 interact with glucose binding sites (active sites) T168, K169, D204, D205 and
E290 in human GCK protein [37] (see Figure 6.11) where V207 and A208 are also in
contact with allosteric sites M210 and I211.
Moreover, we have observed that 38 QCMF-significant sites are further included in essential
sites since they are near nsSNPs or strictly conserved residues in human GCK protein (see
Table 6.9).
QCMF-significant essential sites Nearby nsSNPs or strictly conserved sites References
M37 36s, 39s, 40s [34, 35, 39, 93]
S76 147c -
L79 78c, 80c, 150c -
T 82 81c -
N83 81c, 108s, 110s [39, 93]
V 86 85c, 106s [34]
S127 130s [36]
F148 147c, 150c,s [34, 35, 39, 93]
F152 150c,s, 151c [35, 39, 93]
P153 154s [35]
H156 154s [35]
A176 119s, 175s [39]
G178 164c -
N180 162s, 182s [34, 35, 39],
L185 182s, 188s [35, 39, 93]
A201 147c, 453c -
M202 147c, 203s [39]
A232 223s, 231c [35, 36, 93]
C233 223s, 234c, 235c [35, 36, 93]
V 253 234c, 254c -
F260 257s, 258c, 259s, 261s [35, 39]
L271 274c -
V 277 274c, 278c, 279s [39]
S281 278c, 279s [39]
Y 297 291c, 295c, 299c, 300s [39]
M298 295c, 299c, 300s [39]
T 332 295c, 299c -
Continued on next page
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Table 6.9 – continued from previous page
QCMF-significant essential sites Nearby nsSNPs or strictly conserved sites References
V 374 377c -
A378 377c, 382s [39]
A379 377c, 382s [39]
S383 382s, 385s [39]
A384 382s, 385s [39]
A387 385s [39]
S388 385s, 392s [34, 39]
V 412 226s, 227c, 410c, 414s, 416s [36, 39]
F419 416s [36]
E443 444c, 445c, 447s [35]
G446 444c, 445c, 447s, 448c, 449c [35]
Table 6.9: QCMF-significant essential sites in human GCK protein, which are nearby either
nsSNPs or strictly conserved sites. s : non-synonymous snp site, c : strictly conserved site.
In total, we have demonstrated here that according to the essential sites, 62 out of 64 QCMF-
significant residue sites are functionally or structurally important for human GCK protein.
The remaining two significant residue sites V89, N283 do not overlap with essential sites
and the reason for their significance and their role in the GCK protein has not been deter-
mined yet.
Lastly, we compared the new QCMF-significant residue sites with the previous CMF-
significant sites. The unconfirmed residue site N283 and further 23 significant sites (T60,
T82, N83, F123, F148, T149, F152, H156, F171, N180, T206, T209, T228, E236, G260,
L271, S281, Q287, G294, E300, T332, F419 and E443) were also determined by the previ-
ous method as significant.
6.4 A Comparison between CMF-significant sites and
QCMF-significant sites
To further investigate the performance of our methods, we made a statistical comparison
between classical information theory based CMF and quantum information theory based
QCMF. The CMF method mainly focuses on significant BLOSUM62-dissimilar amino acid
signals as a model of compensatory mutations and integrates them in the calculation of
metrics. As a consequence of only taking into account dissimilar amino acid signals, an
important part of its significant sites are verified as disease associated nsSNP positions and
just a small part of them were located at or near other essential sites in both proteins. In
contrast, considerung simultinously BLOSUM62-similar and dissimilar amino acid signals,
the result of our new quantum information theory based method is more sensible to catalytic
sites, allosteric sites and binding sites.
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Figure 6.10: QCMF-significant positions that are either in contact with allosteric sites
or related to nsSNPs in human GCK protein (PDB-Entry 1V4S). Yellow spheres corre-
spond to structural localization of ten QCMF-significant residue sites which are in contact
with allosteric sites where the V62, M210, Y215 are denoted as allosteric sites by them-
selves and they are also in contact with an other allosteric sites. Green spheres indicate eight
QCMF-significant nsSNP positions in the GCK protein. Three of them (T209M, G223S and
S453del) are further in contact with allosteric sites M210, I211, V452, V455 and A456.
89
6 Results
Moreover, when statistically evaluating both methods, we have observed that the new quan-
tum information theory based method significantly outperforms the previous method. The
new method reaches an improved performance in identifying essential sites from MSAs of
both proteins with a significantly higher Matthews correlation coefficient (MCC) value of
0.215 whereas the previous CMF method reaches only a MCC value of 0.133.
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Figure 6.11: QCMF-significant residue positions are in contact with glucose binding
site in human GCK protein (PDB-Entry 1V4S). (A) Red spheres show the structural
positions of the glucose binding sites (active sites) and yellow spheres show the localization
of QCMF-significant adjacent residue positions which are in contact with these active sites.
The circles indicate clusters of glucose binding sites and their significant adjacent sites.
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In this chapter, we will discuss the reason for setting 90-th percentile cut-off for the connec-
tivity degree to evaluate results of our both classical and quantum information theory based
methods. Afterwards, we discuss the results presented in the previous chapter in the context
of related work.
7.1 Connectivity Degree Cut-off
The connectivity degree technique was introduced by Merkl and Zwick in [22] to character-
ize an individual residue site. In their study, they used the U-metric, presented in the Section
4.1 and focused on only 75 columns pairs with the highest U(k, l)-values as significant for
each MSA. As a result of taking into account only certain number of significant column
pair for each MSA, they set a fixed connectivity degree cut-off value of 3 for each MSA
under investigation. It means if the connectivity degree of a residue site is equal or more
than three, the residue is accepted as significant in [22].
However, after applying our MSA-specific significant model, only considering a fixed cut-
off value for connectivity degree is too conservative and not suitable anymore. Hence, we
have further developed the connectivity degree technique by utilizing a confidence inter-
val method to identify a new cut-off value based on the Matthews correlation coefficient
(MCC).
We have determined for the CMF and QCMF-significant residue sites going through all
possible n-th percentiles for n = 80,81, . . . ,99, the MCC of a joint prediction for human
EGFR and GCK protein. The maximal value of MCC is reached for CMF-significant sites
if n= 90 and likewise, the maximal value of MCC is reached if n= 88 for QCMF-significant
sites. Although we achieve the best MCC with n = 88 for the QCMF-significant sites, we
used in the result section 90%-th percentile cut-off for the biological evaluation of these
significant sites. In this way, we were able to compare both CMF and QCMF-significant
residue sites fairly. In Table 7.1 and 7.2 we present the specificity, sensitivity and MCC
values of all possible n-th percentiles for result of both methods.
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Cut-off Specificity Sensitivity MCC Cut-off Specificity Sensitivity MCC
99% 99.53% 3.16% 0.086 89% 86.38% 23.11% 0.112
98% 97.65% 5.10% 0.065 88% 84.97% 25.30% 0.118
97% 96.24% 6.81% 0.062 87% 82.15% 26.52% 0.096
96% 94.83% 9.00% 0.068 86% 79.34% 27.73% 0.077
95% 93.42% 10.70% 0.067 85% 77.93% 29.68% 0.081
94% 93.42% 13.62% 0.105 84% 76.05% 31.38% 0.077
93% 91.07% 15.08% 0.086 83% 73.23% 32.84% 0.062
92% 90.14% 17.51% 0.101 82% 70.89% 34.06% 0.050
91% 88.73% 19.22% 0.101 81% 69.01% 35.76% 0.047
90% 88.73% 22.14% 0.133 80% 67.13% 37.22% 0.043
Table 7.1: Statistical evaluation of CMF-significant residue sites for both human EGFR and
GCK proteins. If connectivity degree cut-off is 90-percentile, our classical information
theory based method reaches its maximal MCC-value.
Cut-off Specificity Sensitivity MCC Cut-off Specificity Sensitivity MCC
99% 100% 3.16% 0.105 89% 94.83% 22.38% 0.219
98% 100% 5.10 % 0.134 88% 94.36% 24.33% 0.231
97% 100% 8.02% 0.170 87% 92.95% 25.30% 0.220
96% 99.06% 9.73% 0.166 86% 91.54% 26.52% 0.212
95% 98.12% 11.43% 0.165 85% 90.14% 27.49% 0.203
94% 97.65% 13.86% 0.182 84% 89.67% 28.22% 0.204
93% 97.18% 15.81% 0.194 83% 89.20% 29.68% 0.212
92% 96.24% 17.51% 0.195 82% 88.73% 31.87% 0.226
91% 96.24% 19.22% 0.211 81% 87.32% 32.84% 0.218
90% 95.30% 21.163% 0.215 80% 86.38% 34.54% 0.222
Table 7.2: Statistical evaluation of QCMF-significant residue sites for both human EGFR
and GCK proteins. If connectivity degree cut-off is 88-percentile, our quantum information
theory based method reaches its maximal MCC-value.
7.2 CMF-significant residue sites
Our results for human EGFR and GCK protein suggest that the large majority of CMF-
significant compensatory mutation sites are in agreement with previous experimental studies
regarding the functions and stability of these proteins. 15 and 16 CMF-significant sites
in human EGRF and GCK proteins, respectively, are verified as disease associated nsSNP
positions (see Figures 6.3 and 6.5) where most amino acid substitutions in protein sequences
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damage structural stability of proteins [41,42,94]. Moreover, we have observed that in both
proteins some of CMF-significant nsSNP positions are nearby allosteric sites, binding sites,
or catalytic sites each of which are considered to be functionally important [95,96]. Disease
associated mutations at these nearby positions are likely to affect protein function [43, 97].
Despite the large number of CMF-significant sites demonstrated to be structurally or func-
tionally important for both of the proteins, 9 and 15 significant sites in human EGFR and
GCK proteins, respectively, are not included in the essential sites. However, we hypothe-
size that most of the novel significant sites may play a critical role in both proteins notwith-
standing the absence of previous experimental data. Therefore, further progress from the
molecular and structural biology end is required not only to assess the importance of these
sites, but also for a future perspective on a deeper understanding of the protein structure.
Because we have also used the U-metric, we compared our tool with H2r presented in [22]
rather than with those methods developed in [23]. This way, we studied the impact of ap-
plying the Storey-Tibshirani procedure in combination with the effect of using the 90-th
percentile cut-off for the connectivity degree. We have applied H2r without adding pseudo
counts to the human EGFR and GCK protein. For EGFR, the 14 sites T725, A755, N756,
A767, Q791, V802, N816, V819, K846, V876, M881, K913, D916, and E931 are iden-
tified as significant. Out of these significant sites, ten of these residue sites T725, A755,
N756, A767, Q791,K846, V876, M881, K913, and D916 are essential sites. On the other
hand, for GCK, H2r identified the 15 residue positions L25, R36, R63, M107, C213, V226,
G261, D262, G264, L266, D267, E268, T405, K414, and H416 as significant. Twelve of
these sites, namely R36, R63, M107, C213, V226, G261,D262, G264, L266, D267, K414,
and H416, are essential sites. However, when using the H2r Web service (http://www-
bioinf.uni-regensburg.de/) to analyze EGFR and GCK proteins, sensitivity is de-
creased, while precision is increased. By this service only eight sites for EGFR and nine
sites for GCK were found to be significant. Moreover, only five and eight of them are ver-
ified as functionally or structurally important for EGFR and GCK proteins, respectively.
This difference stems from the fact that the H2r Web service tightens the filtering of the
columns. In addition to this, statistically evaluating H2r for EGFR and GCK proteins, we
observed a sensitivity of 5.4%, specificity of 96.7%, and a MCC value of 0.047.
The results of this comparison show that a vast majority of functionally or structurally im-
portant residue positions cannot be detected without using our novel MSA specific model
and both metrics (U and UD(1)) together.
7.3 QCMF-significant residue sites
The results of our new quantum information theory based method presented in the Sec-
tion 6.3 show that the vast majority of QCMF-significant residue sites are closely related
to functionality and structural stability of both human EGFR and GCK proteins. 10 signif-
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icant residue sites in EGFR and 19 significant sites in GCK are established as functionally
important since they are directly located at or close to catalytic sites, allosteric sites and
binding sites which are crucial for maintaining protein functions and for understanding the
underlying molecular mechanism (see Figures 6.8, 6.9, 6.10, 6.11). Additionally, 2 signif-
icant sites in EGFR and 8 significant sites in GCK (three of them are also in contact with
allosteric sites in GCK) are related to disease associated nsSNP regions of both proteins.
As has been noted for the result of CMF-significant sites, most disease-causing mutations
at these positions in corresponding sequences destroy structural features of proteins, thus
affecting protein stability and often results in loss of protein function.
Although the importance of almost all QCMF-significant sites are verified through essential
sites of both human proteins, there are still eight and two unconfirmed significant sites in
EGFR and GCK proteins, respectively, which do not fall into essential sites. It is interesting
to note that some of these unconfirmed sites are also referred as CMF-significant. We there-
fore believe that most of these unconfirmed sites identified by our present method may have
an importance for the function and structural stability of both proteins notwithstanding the
absence of previous experimental data. A further comparison reveals that the overlaps be-
tween the present QCMF-significant sites and previous CMF-significant sites are quite low,
indicating that our both quantum and classical information theory based methods detect
considerably different sets of residue sites as functionally and structurally important. The
comparison result clearly shows that considering similar and dissimilar amino acid signals
simultaneously, our present quantum information theory based method is more sensible to
catalytic, allosteric and binding sites, while only focusing on dissimilar signals our previous
classical information theory based method deals successfully with nsSNP positions in pro-
teins. A final comparison between the methods is made based on their connectivity degree
cut-off. As has been mentioned before, we initially set the connectivity degree cut-off value
to the 90-th percentile at which the previous method reaches its maximal MCC value. How-
ever, going through all possible n-th percentiles for n = 80,81, . . . ,99, our present method
reaches its maximal MCC value of 0.231 if n = 88 (see Table 7.2).
Although the QCMF shows a better performance than CMF, the comparison study indicates
that the result of the QCMF complements the result of CMF. The simultaneous usage of
both methods can significantly improve the identification of important sites of proteins.
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8 Conclusion
In the final chapter of this thesis, we summarize our findings and contributions. Further-
more, we give an outlook on future work in this research direction.
8.1 Summary
In this thesis, we reported two new methods based on classical information theory and
quantum information theory for the identification of functionally or structurally important
non-conserved residue sites by analyzing compensatory mutations in MSAs. In addition, we
developed an MSA-specific statistical model by slightly generalizing the Storey-Tibshirani
procedure devised for multiple testing problems. This model separates method-based sig-
nificant compensatory mutation signals from background noise and quantifies further the
error made in terms of the false discovery rate.
Our first method (see Chapter 4) is based on classical information theory and includes two
metrics. While the first metric (developed by Merkl and Zwick in [22]) does not consider
the biochemical constraints of amino acids, the second metric focuses on significant and
BLOSUM62-dissimilar amino acid signals as a model of compensatory mutations. In addi-
tion, these signals are integrated in calculation of its metric using a doubly stochastic matrix
to transform the empirical pair distribution of the column pair. Using this approach, we
can show how dissimilar compensatory mutations have affected genomic sequences in the
course of evolution.
In contrast to the first method, applying principles of quantum information theory, our sec-
ond method (see Chapter 5) simultaneously models similar and dissimilar amino acid pair
signals in the detection of functionally or structurally important sites. This method also
includes two metrics: the first metric measures compensatory mutations between pairs of
columns; the second metric considers the sequence conservation of columns.
Applying the MSA-specific statistical model for our classical and quantum information the-
ory based methods, we determined for each method as well as each metric the amount of
significant compensatory mutation signals in MSAs of two human proteins. To demon-
strate the performance and functionality of our methods, we analyzed the structurally or
functionally important positions of these proteins. The results show that overlaps between
two information theory based methods are quite low, indicating that both methods detect
considerably different sets of residue sites as functionally and structurally important. Only
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focusing on dissimilar signals, the first method successfully deals with nsSNP positions. In
contrast, simultaneously considering similar and dissimilar amino acid signals, our second
method is more sensible to catalytic, allosteric and binding sites than those found by the
first method.
8.2 Outlook
Although we developed two information theory based methods and one statistical model
for the identification of functionally and structurally important sites of proteins, there is still
need for a method to replace the 90-th percentile cut-off by an MSA-dependent threshold for
the connectivity degree. The extension of the connectivity degree technique would provide
opportunities for future studies, which could also be applied for several biological network
analysis.
Another interesting extension of this thesis would be the construction of the matrices, intro-
duced in Section 4.3, taking into account only either functionally or structurally important
sites in MSAs. In this thesis, we constructed these matrices simultaneously using function-
ally and structurally important sites. However, considering them individually for the matrix
construction could provide us to measure the effect of biochemical constraints of amino
acids in the identification of important residue sites.
Furthermore, in order to get an improved performance in identifying important sites in pro-
teins, our both classical information theory and quantum information theory based methods
could be combined using a machine learning model, such as random forests, support vector
machine, or other comparable models. The combination of both methods with a suitable
machine learning model would result in a significantly better performance for the identifi-
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Coupled mutation finder: A new entropy-
based method quantifying phylogenetic noise
for the detection of compensatory mutations
Mehmet Gültas1*, Martin Haubrock2, Nesrin Tüysüz3 and Stephan Waack1*
Abstract
Background: The detection of significant compensatory mutation signals in multiple sequence alignments (MSAs) is
often complicated by noise. A challenging problem in bioinformatics is remains the separation of significant signals
between two or more non-conserved residue sites from the phylogenetic noise and unrelated pair signals.
Determination of these non-conserved residue sites is as important as the recognition of strictly conserved positions
for understanding of the structural basis of protein functions and identification of functionally important residue
regions. In this study, we developed a new method, the Coupled Mutation Finder (CMF) quantifying the phylogenetic
noise for the detection of compensatory mutations.
Results: To demonstrate the effectiveness of this method, we analyzed essential sites of two human proteins:
epidermal growth factor receptor (EGFR) and glucokinase (GCK). Our results suggest that the CMF is able to separate
significant compensatory mutation signals from the phylogenetic noise and unrelated pair signals. The vast majority
of compensatory mutation sites found by the CMF are related to essential sites of both proteins and they are likely to
affect protein stability or functionality.
Conclusions: The CMF is a new method, which includes an MSA-specific statistical model based on multiple testing
procedures that quantify the error made in terms of the false discovery rate and a novel entropy-based metric to
upscale BLOSUM62 dissimilar compensatory mutations. Therefore, it is a helpful tool to predict and investigate
compensatory mutation sites of structural or functional importance in proteins. We suggest that the CMF could be
used as a novel automated function prediction tool that is required for a better understanding of the structural basis
of proteins. The CMF server is freely accessible at http://cmf.bioinf.med.uni-goettingen.de.
Background
A multiple sequence alignment (MSA) of proteins con-
tains a set of aligned amino acid sequences in which
homologous residues of different sequences are placed
in same columns. Therefore, functionally or structurally
important amino acids and their positions both of which
are often strictly conserved are easily detectable with
MSAs [1-3]. On the other hand, detection of impor-
tant non-conserved residue positions related to several
*Correspondence: gueltas@cs.uni-goettingen.de;
waack@cs.uni-goettingen.de
1Institute of Computer Science, University of Göttingen, Goldschmidtstr. 7,
37077, Göttingen, Germany
Full list of author information is available at the end of the article
essential conserved residues requires a more sophisti-
cated approach. The usage of methods such as correla-
tion analysis allow the identification of important non-
conserved residue positions based on their correlated
mutation manners [4,5] due to functional coupling of
mutation positions. This coupling might stem from one
mutation in a certain site affecting a compensating muta-
tion at another site, even if both related residue sites are
distantly positioned in the protein structure. Moreover,
these coupled mutations can result from spatial, physi-
cal, or chemical restrictions or signaling of allostery [4,5].
Thus, determination of these positions is as crucial as the
recognition of strictly conserved positions for the under-
standing of the structural basis of protein functions, and
for the identification of functionally important residue
regions which might be disease associated, responsible for
© 2012 Gültas et al.; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly cited.
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the maintenance of internal protein volume, or possibly
form key sites for interactions within or between proteins
[6-9].
Until now, a variety of studies have employed
Pearson’s correlation coefficient methods [10-12], per-
turbation based methods [9,13] and mutual information
(MI) based methods [6,14-17] because of their simplicity
and efficiency for the detection of coupled mutations in
MSAs. However, due to background noise, all of these
methods interfere with the identification of compen-
satory mutation signals [14,18,19]. Hence, the significant
compensatory mutation signals must be separated from
the background noise that might occur as a result of: i)
false signals arising from insufficient data; ii) sites with
low or high conservation biasing the signal; iii) phylo-
genetic noise. While the first two types of noise can be
easily overcome by appropriately filtering the data [16],
phylogenetic noise can only be eliminated to some extent
by excluding highly similar sequences from the MSA [19].
Recently, several methods such as bootstrapping, sim-
ulation or randomization methods have been utilized in
order to minimize the influence of phylogenetic linkage
and stochastic noise [15,20,21]. Dunn et al. [19] have
introduced the average product correction (APC), to adjust
MI for background effects. Merkl and Zwick, in their
study, [16] have used a normalized MI (see Equation 1)
and focused on only 75 residue pairs with the highest
normalized MI values as significant for each MSA. Gao
et al. [17] have pursued a similar approach, where they
have replaced the metric used in [16] with the amino acid
background distribution (MIB). While the reduction of
background noise in the model of Dunn et al. is not quan-
tified, the approaches of Gao et al. and Merkl and Zwick
appear to be over-conservative, yet specific.
Despite the presence of a variety of different meth-
ods as mentioned above, to date there is still need for
a method to deal with the noise as well as for powerful
metrics to improve the sensitivity. In this study, we have
developed such a method called Coupled Mutation Finder
(CMF). The CMF includes an MSA-specific statistical
model based on multiple testing procedures described in
[22,23] and a novel entropy-based metric to upscale dis-
similar compensatory mutations and also to complement
the normalized MI metric used in [16]. Unlike previous
normalized MI based studies [16,17], we have separated
metric-based significant compensatory mutation signals
from background noise with respect to our MSA specific
statistical model that quantifies the error made in terms of
the false discovery rate.
To demonstrate the performance and functionality of
the CMF, we analyzed the structurally or functionally
important positions of two human proteins, namely epi-
dermal growth factor receptor (EGFR) and glucokinase
(GCK). The proteins have been chosen because their
functionally and structurally important positions have
been experimentally well studied previously [24-35]. As
a result, the CMF detects in these two proteins disease
associated amino acid mutations (non-synonymous single
nucleotide polymorphisms (nsSNPs)), not strictly con-
served catalytic or binding sites, and residues that are
nearby one of these sites or in the close neighborhood of
a strictly conserved positions, which are likely to affect
protein stability or functionality [36-38].
Results
Our method to predict functionally or structurally impor-
tant residue positions is composed of two steps. First, we
have devised a new MSA-specific statistical method for
the identification of significant MSA column pairs with
respect to either of the two metrics U and UD(α). Assume
that M is the MSA under study, these pairs are annotated
as (U, M)-significant and (UD(α), M)-significant, respec-
tively. Second, we utilized the connectivity degree of a
residue site with respect to a metric introduced in [16].
The connectivity degree of a residue site indicates the
number of its significant coupled mutation pairs. In this
case, a site is called (U,M)-significant when the frequency
of occurrence of this site in the set of (U, M)-significant
pairs exceeds the 90-th percentile. Having defined the
concept of a (UD(α), M)-significant site analogously, a site
is defined as CMF-significant with respect to M, when it
is either (U, M)-significant or (UD(α), M)-significant.
In this study, we analyzed human EGFR (pdb entry
2J6M) and GCK (pdb entry 1V4S) proteins with a false
discovery rate (FDR) of 1%. For the preceding one, we
defined a total of 14339 out of 26079 non-conserved
column pairs as significant. 11365 of these significant
pairs are detected as (U, M)-significant and 3798 pairs are
observed as (UD(α), M)-significant. Only 824 EGFR pairs
are significant with respect to both metrics. On the other
hand, for GCK, we identified a total of 32654 out of 69645
non-conserved column pairs as significant where 18106
of them are U-significant and 16241 are UD(1)-significant.
Moreover, 1693 pairs are defined as significant for both U
and UD(1)-significant.
Applying the connectivity degree technique, we iden-
tified 22 and 36 residue positions as U-significant for
human EGFR and GCK proteins, respectively. Addition-
ally, 21 positions of EGFR and 36 positions of GCK were
detected as UD(1)-significant. Finally, a total of 43 sites of
EGFR and 72 of GCK were found as CMF-significant, and
predicted as of structural or functional importance. How-
ever, there have been no residue sites defined as significant
with respect to either metric.
Essential sites of human EGFR and GCK proteins
To evaluate the CMF-significant residue sites, we have
investigated essential sites of human EGFR (pdb entry
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2J6M) and GCK (pdb entry 1V4S) proteins. The essen-
tial sites of both proteins have been assigned into three
main categories: i) the nsSNP positions and their adja-
cent sites; ii) residue positions which are located at or
near active sites, allosteric sites, or binding sites; iii)
residue positions which are nearby strictly conserved
sites. Here, we have used “nearby” definition of Nussinov
et al. [39] and defined two residues as in contact or
adjacent when the distance between their major carbon
atoms is less than 6 Å. We have defined positions which
are nearby nsSNPs as essential, because several of them
are also adjacent to active sites, allosteric sites, bind-
ing sites, or strictly conserved sites. Thus, we refer to
a CMF-significant residue site as “functionally or struc-
turally important” if it falls into one of these categories of
essential sites.
Position analysis of the Human Epidermal Growth Factor
Receptor (EGFR) protein
The epidermal growth factor receptor (EGFR) is a mem-
ber of the ErbB (Erythroblastic Leukemia Viral Oncogene
Homolog) family receptors. Signaling through this recep-
tor is a highly conserved mechanism from nematode to
humans involved in numerous processes, including pro-
liferation, cell fate determination, and tissue specification
[40]. Furthermore, several studies have implicated that
mutations resulting in misregulation of the activity or
action of EGFR led to multiple cancers, including those
of the brain, lung, mammary gland, and ovary [24-27].
Here, in order to detect essential mutation positions
in corresponding sequence of human EGFR protein, we
determined altogether 43 CMF-significant residue sites
(see Additional file 1). 15 of these significant residue sites
have been verified as nsSNP sites through the Ensembl
database annotation and they are illustrated in Figure 1.
Additionally, the significant sites E746, Q791, and four
of the nsSNP positions (I759,Y764,M766 and K846) are
also in contact with critical active site regions for gefi-
tinib binding site in the wild type EGFR kinase [25,28] (see
Figure 2).
Moreover, we observed that 17 further CMF-significant
positions are essential sites (see Table 1). In total, we
Figure 1 CMF-significant nsSNP positions in human EGFR protein (PDB-Entry 2J6M). The red spheres correspond to structural localization of
15 different nsSNP positions found by CMF as significant in the EGFR protein.
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Figure 2 CMF-significant residue positions are in contact with gefitinib binding sites in human EGFR protein (PDB-Entry 2J6M ). Yellow
spheres denote positions of the gefitinib binding sites in the wild type kinase. Blue spheres show the localization of significant adjacent residue
positions found by CMF which are in contact with these binding sites. Moreover, the CMF-significant sites I759, Y764, M766 and K846, shown with
green spheres, are already described as nsSNP positions and they are also in contact with gefitinib binding sites E762 and M793, respectively. The
circles indicate clusters of gefitinib binding sites and their significant adjacent sites.
have established here for EGFR protein the importance
of 34 out of 43 CMF-significant residue sites via different
resources [25,28,35].
Although the vast majority of CMF-significant sites are
verified to be structurally or functionally important in
human EGFR protein, nine CMF-significant sites do not
overlap with essential sites. The reason for the high con-
nectivity degree of these unconfirmed significant sites and
their role in the EGFR protein is unclear.
Position analysis of the Human Glucokinase (GCK) protein
Glucokinase (GCK) is a monomeric enzyme catalyz-
ing phosphorylation of glucose to glucose-6-phosphate,
which is the first step in the utilization of glucose, at
physiological glucose concentration in pancreas and liver.
Given the fact that GCK displays low affinity for glu-
cose, it acts as a glucose sensor playing an important
role in the regulation of carbohydrate metabolism. Muta-
tions of the GCK gene can lead to maturity onset diabetes
of the young (MODY) characterized by an autosomal
dominant mode of inheritance and onset early adulthood
[32], or familial hyperinsulinemic hypoglycemia type 3
(HHF), common cause of persistent hypoglycemia in
infancy [41].
Applying our method, we found 72 CMF-significant
sites to be structurally or functionally important in human
GCK protein (see Additional file 2). 16 of these significant
residue positions are related to disease associated nsSNP
positions [29-31,34,35] (see Figure 3).
Furthermore, nine significant sites are found to be in
contact with allosteric sites in the GCK protein struc-
ture. Among these sites, the R63 is also allosteric site by
itself [32] and T209, C213 and E221 overlap with nsSNP
regions (see Figure 4B). Moreover, the five significant sites
T149, F171, T206, Q287, and G294 interact with glu-
cose binding sites K169, D204, N205, and E290 [32] (see
Figure 4A).
Besides this, there are further 30 CMF-significant essen-
tial sites which are nearby nsSNPs or strictly conserved
residue positions (see Table 2). Altogether, we showed the
functionality of 57 positions out of 72 CMF-significant
residue sites via different resources [29-35].
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Table 1 CMF-significant essential sites in human EGFR




Nearby nsSNPs, or strictly
conserved sites
Reference
Y727 726c 743c -







K879 877c , 880c -
Y891 892s , 895c [35]
S899 880c , 896c , 898c , 901c -
Y900 898c , 901c -
T909 906c , 936c -
S912 906c , 936c -
K913 914c -
D916 914c -
M947 901c , 950c -
s : non-synonymous snp site, c : strictly conserved site.
While we are able to establish the large number of CMF-
significant sites as structurally or functionally important
in human GCK protein, 15 CMF-significant sites do not
overlap with essential sites. Their importance in the GCK
protein and the reason of high connectivity degree of
these unconfirmed significant sites has not been explicitly
determined yet.
A comparison between U-metric and UD(α)-metric
Similarities in physical or biochemical properties of amino
acids are likely to be crucial for the detection of function-
ally or structurally important positions of a protein. In
contrast to the U-metric, which is a normalized mutual
information that uses only the frequencies of occur-
rences of amino acids in the MSA columns, the novel
UD(α)-metric includes dissimilarities according to the
BLOSUM62 matrix when calculating normalized mutual
information. As a result the positions which have under-
gone dissimilar compensatory mutations are upscaled.
Having applied the U-metric as well as the UD(α)-metric
to human EGFR and GCK proteins, the UD(α)-metric has
shown better sensitivity and specificity. However, only
when we use the both metrics together, the sensitiv-
ity is significantly increased, whereas the specificity is
only moderately decreased. The details are presented in
Table 3.
It is important to note that the two metrics complement
each other. Thus, we propose to use them together.
CMF as a Web service
We have implemented a CMF Web service (http://cmf.
bioinf.med.uni-goettingen.de) that takes an MSA in mul-
tiple FASTA format and a real number from (0, 1) inter-
preted as false discovery rate as input. It reports the results
via email.
Discussion
To predict sites of structural or functional importance,
we combine the known U-metric of normalized mutual
information [16] with a novel metric UD(i)(1) to enhance
the influence of dissimilar compensatory mutations when
measuring covariation of two sites. We discuss how we
devised UD(1) in Methods section.
To learn the frequency of compensatory mutations, we
took U-significant site pairs as training data. We did that
for reasons of computation time regardless of the fact
that these data are biased. To deal with this bias, one
could carry through the training in an iterative process,
with our training being the first iteration. For i > 0,
in the (i + 1)-th iteration of this modified training, a
doubly stochastic matrix D(i+1)CompMut is calculated based
on UD(i)(1)-significant site pairs. This is done until the
training data are stable.
According to Birkhoff’s Theorem [43], every doubly
stochastic matrix is a convex combination of permutation
matrices. Moreover, from the Hardy-Littlewood-Pólya
majorization theorem [44] follows that transforming the
probability mass function by a doubly stochastic matrix
increases entropy. Consequently, by linearly transform-
ing the empirical amino acid pair distribution of a site
pair by D(1) before calculating the U-value, we penalized
those site pairs whose original distribution does not match
the frequency pattern of formal dissimilar compensatory
mutations in the training data described in the Methods
section.
The challenge was to separate the signal caused by struc-
tural and functional constraints from the background. To
address this issue, we studied only metrics μ that sat-
isfy the following condition. The larger the μ(k, l)-value,
the larger the probability that the two sites k and l have
co-evolved. Our critical assumptions were: i) the μ(k, l)-
values follow three different distributions, one for the
signal, one for the noise, and one for pairs of completely
unrelated sites; ii) there is an MSA-dependent threshold
below which the metric μ does not fall with overwhelming
probability, when it is applied to the site pairs of functional
or structural importance to which μ is sensitive; iii) there
is an MSA-dependent threshold significantly smaller then
the one in (ii) such that with overwhelming probability
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Figure 3 CMF-significant nsSNP positions in human GCK protein (PDB-Entry 1V4S). Red spheres show the structural localization of 16
different nsSNP positions found by CMF as significant in the GCK protein.
Figure 4 CMF-significant residue positions are in contact with glucose binding site and allosteric site in human GCK protein (PDB-Entry
1V4S). (A) Yellow spheres show the structural positions of the glucose binding sites (active sites). Blue spheres correspond to localization of
significant adjacent residue positions found by CMF which are in contact with these active sites. (B) Orange spheres denote the allosteric sites. Blue
spheres correspond to localization of just significant adjacent residue positions and green spheres indicate the significant residue positions which
are already described as nsSNP position and in contact with these allosteric site. Additionally, the significant position R63 is allosteric site by itself
and it is also in contact with an other allosteric site. The circles indicate clusters of glucose binding sites (A), allosteric sites (B), and their significant
adjacent sites.
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Table 2 CMF-significant essential sites in human GCK









E67 66c , 68c -
T82 81c -
N83 81c , 108s , 110s [34]
H105 106s [29]
C129 131s , 132s [29,34]
F133 131s , 132s [29,34]
F148 147c , 150c,s [34]
F152 150c,s , 151c [34]
H156 162s [29]
N180 162s , 182s [29,34]
F260 257s , 258c , 259s , 261s [34]
D262 259s , 261s , 264s [34,42]
L266 261s , 264s , 265s [29,34,42]
D267 264s , 265s [29,42]
L271 274c -
S281 278c , 279s [34]
Q286 259s [34]
E331 299c,s [34]









E443 444c , 445c -
s : non-synonymous snp site, c : strictly conserved site.
there are no μ(k, l)-values of pairs (k,l) of unrelated sites
exceeding it.
In order to near-completely eliminate the noise, we fil-
tered both our training and input data. We calculated the
significant pairs such that the preassigned false discovery
rate was guaranteed by generalizing the Storey-Tibshirani
procedure devised for multiple testing problems [22].
Our method to eliminate noise is orthogonal to the tech-
nique developed in [19]. Therein, for every pair of sites the
so-called average product correction (APC) is calculated
as an explicit noise measure, by which the mutual infor-
mation is then decreased. Furthermore, it generalizes the
way Merkl and Zwick [16] as well as Gao et al. [17] cope
with noise. According to our judgment, taking only the top
75 high-scoring pairs or the top 25 pairs into account as
done in [16,17], respectively, is too conservative.
We based our noise separation technique on rather
weak distribution assumptions that are standard practice
in multiple hypothesis testing, instead of explicitly model
the noise in terms of a metric. We applied the connectivity
degree technique due to Merkl and Zwick [16] to signif-
icant site pairs with respect to our metrics. The cut-off
for the connectivity degree was set to the 90-th percentile.
That way we defined significant sites. Finally, a site was
defined to be CMF-significant, if it was μ-significant,
where μ is either U or UD(1).
Why did we set the cut-off value for the connectivity
degree to the 90-th percentile? Going through all possible
n-th percentiles for n = 80, 81, . . . , 99, the Matthews cor-
relation coefficient (MCC) of a joint prediction for human
EGFR and GCK proteins is maximal if n = 90.
It is plausible that the number of functionally or struc-
turally important sites does not only depend on the length
of the protein. Therefore, the 90-th percentile cut-off
should be replaced by an MSA-dependent threshold in
future studies.
Our results for human EGFR and GCK proteins suggest
that the large majority of significant compensatory muta-
tion sites found by CMF are in agreement with previous
experimental studies regarding the functions and stabil-
ity of these proteins. 15 and 16 CMF-significant sites in
human EGRF and GCK proteins, respectively, are verified
as disease associated nsSNP positions (see Figures 1 and 2)
where most amino acid substitutions in protein sequences
damage structural stability of proteins [36,37,45]. More-
over, we have observed that in both proteins some of
CMF-significant nsSNP positions are nearby allosteric
sites, binding sites or catalytic sites each of which are con-
sidered to be functionally important [46,47] (see Figures 2
and 4). Disease associated mutations at these nearby posi-
tions are likely to affect protein function [38,48].
Despite the large number of CMF-significant sites
demonstrated to be structurally or functionally impor-
tant for both of the proteins, 9 and 15 significant sites
in human EGFR and GCK proteins, respectively, are not
included in essential sites. However, we hypothesize that
most of the novel significant sites may play a critical role
in both proteins notwithstanding the absence of previous
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experimental data. Therefore, further progress from the
molecular and structural biology end is required not only
to assess the importance of these sites, but also for a
future perspective on a deeper understanding of protein
structure.
Because we have also used the U-metric, we compared
our tool with H2r presented in [16] rather than with
those methods developed in [17]. This way, we studied
the impact of applying the Storey-Tibshirani procedure in
combination with the effect of using the 90-th percentile
cut-off for the connectivity degree. We have applied H2r
without adding pseudo counts to the human EGFR and
GCK protein. For EGFR, the 14 sites T725, A755, N756,
A767, Q791, V802, N816, V819, K846, V876, M881, K913,
D916, and E931 are identified as significant. Out of these
significant sites, ten of these residue sites T725, A755,
N756, A767, Q791,K846, V876, M881, K913, and D916 are
essential sites. On the other hand, for GCK, H2r identi-
fied the 15 residue positions L25, R36, R63, M107, C213,
V226, G261, D262, G264, L266, D267, E268, T405, K414,
and H416 as significant. Twelve of these sites, namely R36,
R63, M107, C213, V226, G261,D262, G264, L266, D267,
K414, and H416, are essential sites. However, when using
the H2r Web service (http://www-bioinf.uni-regensburg.
de/) to analyze EGFR and GCK proteins, sensitivity is
decreased, while precision is increased. By this service
only eight sites for EGFR and nine sites for GCK were
found to be significant. Moreover, only five and eight of
them are verified as functionally or structurally important
for EGFR and GCK proteins, respectively. This difference
stems from the fact that the H2r Web service tightens
the filtering of the columns. In addition to this, statis-
tically evaluating H2r for EGFR and GCK proteins, we
observed a sensitivity of 5.4%, specificity of 96.7%, preci-
sion of 75.9%, and a Matthews correlation coefficient value
of 0.047. On the other hand, the CMF reaches precision
of 79.1%, and a Matthews correlation coefficiant value of
0.133. For sensitivity and specificity of the CMF refer to
the last row of Table 3.
The results of this comparison show that a vast majority
of functionally or structurally important residue positions
cannot be detected without using our novel MSA specific
model and both metrics (U and UD(1)) together.
Conclusions
The CMF is a new method which includes an MSA-
specific statistical model based on multiple testing pro-
cedures that quantifies the error made in terms of the
false discovery rate and a novel entropy-based metric to
upscale BLOSUM62 dissimilar compensatory mutations.
Hence, it shows how dissimilar compensatory mutations
have affected genomic sequences in the course of evo-
lution. The method is able to predict significant com-
pensatory mutation positions in protein sequences. We
suggest that CMF could be used as a novel automated
function prediction tool that is required for a better
understanding of the structural basis of proteins.
Methods
In this section we describe the training data used and the
methods applied and partly developed. Our descriptions
follows the structure of Figure 5, i.e. we start with the data
Figure 5 Flowchart of the CMF-analysis.
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and the preprocessing and systemically work towards the
CMF-significant site prediction.
Training data set and pre-processing
We used a redundancy free set of more than 35000 pro-
tein structures computed in Rainer Merkl’s Lab at the
University of Regensburg in the following way. The
protein structures were taken from the protein data
base (http://www.pdb.org/). The PISCES services [49]
was applied to assess proteins on sequence similarity
and equality of 3D-data. The related MSAs were gath-
ered from the HSSP data base (http://swift.cmbi.ru.nl/gv/
hssp/).
Taking pattern from [16], we filtered every MSA
obtained as follows. First, highly similar and dissimi-
lar sequences were deleted to ensure that the sequence
identity between any two sequences is at least 20%
and no more than 90%. Second, we removed strictly
conserved residue columns, where the percentage of
identical residues is greater than 95%. Third, we elimi-
nated the residue columns which contain more than 25%
gaps. Finally, we discarded all MSAs with less than 125
sequences. More than 17000 MSAs survived the last filter-
ing step. We used approximately 1700 MSAs as training
data which we randomly chose from this set. The pdb
entries of the corresponding protein structures are listed
in Additional file 3.
Detecting compensatory mutations by the U-metric
In [16] a normalized measure of mutual information rang-
ing over the interval [ 0, 1] is successfully used to detect
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is their joint entropy.
We determine an MSA-dependent threshold τ above
which U-values are defined as significant. Let M be the
MSA for the protein under investigation. We extend a
standard approach of multiple testing theory [22,50,51]
with the following assumptions in mind. M’s U (k, l)-
values follow three different distributions. The null dis-
tribution F0 represents background signals. The distribu-
tions G1 and G2 model the unrelated pairs and the signal
pairs, respectively.
We assume F0 to be a β-distribution, and M’s U (k, l)-
values U1, U2, . . . , Uμ to be an independent and identi-
cally distributed (iid) sample.
Let Xι := 1 − F0(Uι) be the p-value of Uι with respect to
F0. If Uι is F0-distributed, then Xι is uniform over [ 0, 1].
However, if Uι is G1-distributed or G2-distributed, then
Xι is skewed to 1 or to 0 (see Figure 6). According to
[22,23], the fraction γ of the Uι’s that are F0-distributed is
estimated by
γ̂ := number of p-values in [ λ1, λ2]
μ(λ2 − λ1) .
The tuning parameters λ1 and λ2 are chosen such that the
fraction of not uniformly distributed p-values that fall into
[ λ1, λ2] is negligible.
We call a pair of sites (i, j) of the protein under study





is less than or equal to τ , for a threshold τ ≤ λ1 that
ensures the input false discovery rate FDR, which in turn
can be estimated by
F̂DR(τ ) = γ̂ μτ
number of p-values ≤ τ .
In order to determine the parameters of the β-
distribution F0, it is sufficient to estimate the expected
value and the variance. The expected value is estimated
by the sample mean of all U-values of M. As for the vari-
ance, we take pattern from [52]. Having drawn an iid
sample (C1, C′1), (C2, C′2), . . . , (Cν , C′ν) of random column
pairs of a sufficient size whose U-values fall in a preas-
signed subinterval of [ 0, 1], we calculate D1, D2, . . . , Dν
by randomly shuffling C′ι for every ι = 1, 2, . . . , ν. The
variance is then estimated as the sample variance of
(C1, D1), (C2, D2), . . . , (Cν , Dν).
The connectivity degree of a site i with respect to the
metric U and the MSA M is defined as number of sites j
such that (i, j) is (U, M)-significant [16]. Site i is defined
to be (U, M)-significant, if i’s connectivity degree with
respect to U and M is greater than or equal to the 90-th
percentile. The (U, M)-significant sites of a protein do not
coincide with those predicted by H2r [16]. The connectiv-
ity degrees attained and the threshold used substantially
differ. In particular, the latter one is data-dependent rather
than constant.




(ai, aj), (ak , al)
)
of amino acid pairs is defined
to be a formal dissimilar compensatory mutation, if the
BLOSUM62 score both of (ai, ak) and (aj, al) is negative.
We use the training data set of approximately 1700
MSAs described above to estimate a 400 × 400 doubly
stochastic matrix DCompMut. This matrix is our mathe-
matical model of how dissimilar compensatory mutations
have affected genomic sequences in the course of evolu-
tion. Its training consists of five phases.
Phase 1. We calculate a signal and a null set of column
pairs. The signal set consists of all (U, M)-significant
column pairs, where M ranges over all training MSA.
The null set consists of sufficiently many column pairs
Gültas et al. BMC Bioinformatics 2012, 13:225 Page 10 of 12
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Figure 6 Four p-value distributions of (transformed) normalized mutual information values for human GCK and EFGR proteins having
PDB-ID 1V4S and 2J6M, respectively. The bar charts illustrate the two steps of our model: i) blue bars show the p-value distribution of the
U (i, j)-scores; ii) red bars display the p-value distribution of the UD(1) (i, j)-values. The p-values close to zero represent the significant pairs by means
of which we assess the individual residue position. As one can see, within [ 0.25, 0.70] these four distributions are approximately uniform.
randomly chosen from every training MSA. For both
the signal set and the null set we compute a symmetric
400 × 400 integer-valued matrix of frequencies of pair
substitutions Calt and Cnull. To this end, the method used
to compute BLOSUM62 matrices [53] is applied to count
residue pair substitutions in MSA column pairs rather
than residue substitution in columns.



















(ai, aj), (ak , al)
) = 1 if and only if (ai, aj) =
(ak , al) or
Calt
(













(ai′ , aj′), (ak′ , al′)
) .
Phase 3. We set all entries of the matrix Csig outside
the main diagonal that do not represent a formal dissim-
ilar compensatory mutation to zero. This results in the
matrix CCompMut. By normalizing CCompMut, we obtain a
symmetric matrix PCompMut. For ai, aj, ak , al ranging over
all amino acids, PCompMut
(
(ai, aj), (ak , al)
)
represents an
empirical probability distribution on pairs of amino
acid pairs.




















is the marginal distribution of
PCompMut.
Phase 5. We set all negative entries of SCompMut to zero.
Then we compute the doubly stochastic matrix DCompMut
by means of the canonical iterated row-column normal-
ization procedure [54].
Now we define our new UD(α)-metric based on
DCompMut. For every column pair (i, j) of the input MSA
M, we linearly transform the associated empirical pair
distribution with the doubly stochastic matrix
D(α) := (1 − α)1 + αDCompMut
where 1 is the 400×400 unit matrix, DCompMut is the result





is then defined to be the U-value (see
Equation 1) of this transform.
Having canonically carried over the definition of a sig-
nificant site pair and of the connectivity degree of a site to
this case, a site i is called (UD(α), M)-significant, if i’s con-
nectivity degree with respect to the metric UD(α) is greater
than or equal to the 90-th percentile.
Finally, a site is defined to be CMF-significant with
respect to the MSA M, if it is (U, M)-significant or
(UD(α), M)-significant. The CMF-significant sites are pre-
dicted as functionally or structurally important ones.
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Principally, the controlling parameter α ∈ (0, 1] can be
adjusted by the user. We set α to 1 to allow the two sets of
(U, M)-significant and (UD(α), M)-significant positions to
complement each other.
Note, that the matrix SCompMut could be replaced with
another scoring matrix meaningful in this context.
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Quantum coupled mutation finder: predicting
functionally or structurally important sites in
proteins using quantum Jensen-Shannon
divergence and CUDA programming
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Abstract
Background: The identification of functionally or structurally important non-conserved residue sites in protein MSAs
is an important challenge for understanding the structural basis and molecular mechanism of protein functions.
Despite the rich literature on compensatory mutations as well as sequence conservation analysis for the detection of
those important residues, previous methods often rely on classical information-theoretic measures. However, these
measures usually do not take into account dis/similarities of amino acids which are likely to be crucial for those
residues. In this study, we present a new method, the Quantum Coupled Mutation Finder (QCMF) that incorporates
significant dis/similar amino acid pair signals in the prediction of functionally or structurally important sites.
Results: The result of this study is twofold. First, using the essential sites of two human proteins, namely epidermal
growth factor receptor (EGFR) and glucokinase (GCK), we tested the QCMF-method. The QCMF includes two metrics
based on quantum Jensen-Shannon divergence to measure both sequence conservation and compensatory
mutations. We found that the QCMF reaches an improved performance in identifying essential sites from MSAs of
both proteins with a significantly higher Matthews correlation coefficient (MCC) value in comparison to previous
methods. Second, using a data set of 153 proteins, we made a pairwise comparison between QCMF and three
conventional methods. This comparison study strongly suggests that QCMF complements the conventional methods
for the identification of correlated mutations in MSAs.
Conclusions: QCMF utilizes the notion of entanglement, which is a major resource of quantum information, to
model significant dissimilar and similar amino acid pair signals in the detection of functionally or structurally
important sites. Our results suggest that on the one hand QCMF significantly outperforms the previous method,
which mainly focuses on dissimilar amino acid signals, to detect essential sites in proteins. On the other hand, it is
complementary to the existing methods for the identification of correlated mutations. The method of QCMF is
computationally intensive. To ensure a feasible computation time of the QCMF’s algorithm, we leveraged Compute
Unified Device Architecture (CUDA).
The QCMF server is freely accessible at http://qcmf.informatik.uni-goettingen.de/.
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Background
Multiple sequence alignments (MSAs) of homologous
protein sequences give us information about two major
features of the proteins of interest. The first one consists
of easily detectable highly conserved residue sites that are
obviously important for the structure and/or the func-
tion of the protein; while the second one corresponds to
compensatory (coupled) mutations between two or more
residue sites that also contain crucial information on the
structural and functional basis of proteins [1]. These com-
pensatory mutations occur according to the functional
coupling of mutation positions which might be explained
as one mutation in a certain site affecting a compensat-
ing mutation at another site, even if both related residue
sites are distantly positioned in the protein structure
[2-5]. In particular, such mutations at essential residue
sites are likely to destroy protein structure which often
results in loss of the protein function [6,7]. Thus, recog-
nition of these residue sites is as important as the strictly
conserved positions for the understanding of the struc-
tural basis of protein functions and for the identification
of functionally important residue positions [5,8,9].
Although the strictly conserved residue sites are easily
detectable and interpretable in MSAs, the detection of
important non-conserved compensatory mutation sites
needs more complex approaches. Today, due to the
simplicity and efficiency, the mutual-information-based
metrics (MI-metrics) are often used to measure the co-
evolutionary relationship between residue sites in MSAs
[4-6,10-13]. However, the MI-metrics strongly depend
on the amino acid distributions observed in the MSA
columns rather than on physical or biochemical con-
straints of amino acids that are likely to be crucial for
the detection of functionally or structurally important
compensatory mutations in a protein sequence. Further,
according to the phylogenetic relationship of protein
sequences and background noise, there is always a MI-
value between each column pair in an MSA. Therefore,
the challenging problems in bioinformatics for the detec-
tion of significant compensatory mutation signals are: i)
the minimization of the influence of phylogenetic rela-
tionships of protein sequences by incorporating physical
or biochemical properties of amino acids in the calcu-
lation; ii) the separation of significant signals from the
background noise or unrelated pair signals.
In order to eliminate the influence of phylogeny and
noise effects of MI, Dunn et al. [6] have introduced the
average product correction (APC). Subtracting APC from
MI, they obtained their MIp metric. However, in their
model the reduction of background noise is not quanti-
fied. On the other hand, Gao et al. [13] have integrated
amino acid background distribution (MIB) in the calcu-
lation of their MI-metric and focused on only 25 column
pairs of each MSA with the highest normalized MI values
as significant to reduce noisy effect which seems to be
over-conservative, yet specific.
Large efforts have been made in the last few years to
improve local-correlation-measure-based approaches to
residue co-evolution when it comes to modeling effects
that rely on spatial proximity (see [14] for an overview). In
this case, it is necessary to disentangle direct and indirect
correlations. Classical mutual information, for example,
is high not only if the two sites under study are close in
3D space. Quite the contrary, any local measure of cor-
relation, not just mutual information, is limited by the
transitivity effect.
To overcome this problem, global statistical models of
protein families are employed. The direct-coupling anal-
ysis (DCA) works as follows. Maximizing the entropy
subject to preserving the single and pair residue fre-
quencies observed, a joint probability distribution on all
possible members of the protein family is derived. Utiliz-
ing this distribution, considerable progress in predicting
residue-residue contacts in 3-dimensional protein struc-
tures was made [15-17]. Protein Sparse Inverse Covari-
ance (PSICOV) [18] achieves disentanglement of direct
and indirect correlations by inverting a residue-residue
covariance matrix. In [19] further progress was made by
integrating structural context and sequence co-evolution
information.
There is merely a small number of methods that incor-
porate amino acid similarity in the prediction of func-
tionally or structurally important sites. In this context,
it is natural to partition the amino acids into chemically
similar groups before applying an information-theoretic
measure like the Shannon entropy [20,21]. It was reported
that many other methods fail to outperform this simple
partition approach [22]. However, quantum information
theory supplies a well-studied and powerful framework
to integrate such similarity, where the classical Shannon
entropy is swapped for the von Neumann entropy (VNE).
Caffrey et al. [23] and Johansson et al. [24] have firstly
introduced VNE to multiple sequence alignment analysis
although they did not treat amino acid pair similarity.
Recently, a new method called Coupled Mutation Finder
(CMF) has been introduced by Gültas et al. [5] to deal
with phylogenetic noise as well as background signals and
to quantify the error made in terms of the false discovery
rate. The CMF method only focuses on BLOSUM62-
dissimilar amino acid pairs as a model of compensatory
mutations and integrated them in the calculation of nor-
malized MI-metrics using a doubly stochastic matrix to
transform the empirical pair distribution of the column
pair. However, the CMF disregards amino acid pair sim-
ilarity which can be also crucial for the detection of
functionally or structurally important sites in MSAs.
Gültas et al. BMC Bioinformatics 2014, 15:96 Page 3 of 17
http://www.biomedcentral.com/1471-2105/15/96
In this study, we present a new method called Quan-
tum Coupled Mutation Finder (QCMF) which extends the
CMF algorithm [5] by additionally incorporating amino
acid pair similarity. To this end, the QCMF invokes prin-
ciples from quantum information theory, in particular for
the first time in the context of MSA analysis quantum
entanglement as a major resource of quantum informa-
tion. Amino acid pair distributions are replaced by entan-
gled density matrices from quantum mechanics which
encompass in our case both empirical pair distributions,
possibly transformed by the doubly stochastic matrix used
in [5], and pair similarity. Following Capra and Singh [22]
who pointed out that it is hard to improve upon metrics
based on Jensen-Shannon divergences, we quantify the
effect of both amino acid pair similarity and amino acid
pair dissimilarity by the quantum Jensen-Shannon diver-
gence between an entangled density matrix and the one
that simply represents the amino acid pair frequencies.
The QCMF algorithm is strongly based on the matrix
operations that are computationally intensive. When ana-
lyzing a single MSA, the computational time of these
matrix operations rise very quickly due to the huge num-
ber of column pairs. In order to speed up the running
time of the QCMF, we implemented its algorithm using
Compute Unified Device Architecture (CUDA). CUDA is
an efficient parallel computing architecture developed by
NVIDIA that utilizes graphic processing units (GPUs) for
general-purpose scientific and engineering applications
[25]. Nowadays, GPUs are often used for computation-
ally challenging problems in bioinformatics [26-29] and
several other scientific fields [30-32].
Results
Our main focus in this study was to investigate whether
quantum information theory based measures could con-
tribute beyond conventional measures to the identifi-
cation of important residue sites. The Results section
of this work twofold. First, to test the functionality of
QCMF-significant individual residue sites we analysed the
essential sites of two human proteins: epidermal growth
factor receptor (EGFR) (pdb entry 2J6M) and glucokinase
(GCK) (pdb entry 1V4S). The functionally and struc-
turally important sites of both proteins have been experi-
mentally investigated in several studies previously [33-44]
and their positions were summarized in [5] as essential
sites. The essential sites of these proteins consist of sev-
eral non-conserved residue sites which are directly located
at or near disease associated amino acid mutation (non-
synonymous single nucleotide polymorphisms (nsSNPs))
sites, catalytic sites, protein binding sites and so on, each
of which are likely to affect protein stability or function-
ality (see [5] and references therein). In addition, residue
sites are defined to be in contact according to the “nearby”
definition of Nussinov et al. [45] if their carbon major
atoms have a distance of less than or equal to 6 Å. Con-
sequently, we defined an individual QCMF-significant
residue site as “functionally or structurally important” if it
corresponds to one of these essential sites.
Second, to further investigate the performance of
QCMF and to make a comparison with the previous meth-
ods (CMF [5], MIp [6], and PSICOV [18]), we selected
a non-redundant set of proteins prepared by Janda
et al. [46]. Although the dataset contains 216 proteins, we
eliminated a few proteins due to inconsistency between
corresponding MSAs and PDB files, so that we finally
ended up with a dataset of 153 proteins (see Additional
file 1).
The MSAs for each protein, which contain after fil-
tering at least 125 independent sequences, were derived
from the HSSP-database [47] that merges primary struc-
ture information and tertiary structure information of
proteins.
Finally, we define QCMF-significant sites as follows. Let
M be an MSA, with the protein of interest being the first
row of M. A site pair as well as an individual site of the
protein are said to be QCMF-significant with respect to
the MSA M, if they are (Qent, M)-significant or (Qsep, M)-
significant. The latter two notions and the underlying two
co-evolutionary column pair metrics Qent and Qsep are
defined in the Methods section. If the MSA M is fixed, we
speak of Qent-significance and Qsep-significance, rather
than of (Qent, M)-significance and (Qsep, M)-significance,
respectively.
QCMF-significant residue sites in the Human Epidermal
Growth Factor Receptor (EGFR) protein
Using the MSA-specific statistical model with a false dis-
covery rate (FDR) of 1% for both QCMF-metrics, we first
determined altogether 2688 out of 26079 non-conserved
column pairs as significant in corresponding MSA of
human EGFR protein. 631 of these significant pairs were
detected by Qent-metric, and 2149 pairs were detected
by Qsep-metric. Only 92 significant column pairs were
detected by both metrics. After that, utilizing the connec-
tivity degree technique, we predicted in total 33 residue
sites in corresponding sequence of human EGFR protein
as QCMF-significant (see Additional file 2). 12 of them
are only Qent-significant and 18 residue sites are Qsep-
significant, the remaining 3 residue sites (A839, A882 and
V902) are both Qent-significant and Qsep-significant.
10 of the QCMF-significant residue sites are in con-
tact with either catalytic residues or critical active site
regions for gefitinib binding site in wild type EGFR kinase
[34,37,48] (see Figure 1 and Figure 2). Among these sites,
the A839 and R841 have been verified as catalytic residue
sites through the Catalytic Site Atlas [48]. The T854 is a
gefitinib binding site by itself and the residue sites V845
and A859 are also in contact with nsSNP positions K846,
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Figure 1 QCMF-significant residue positions are in contact with catalytic residues in human EGFR protein (PDB-Entry 2J6M). Red spheres
denote positions of the catalytic residues. Yellow spheres show the localization of significant adjacent residue positions found by QCMF which are in
contact with these catalytic residues. Moreover, the QCMF-significant sites A839 and R841 are also catalytic residues by themselves. Green spheres
show the structural localization of nsSNP positions found by QCMF as significant in the EGFR protein. The circles indicate clusters of catalytic residue
sites and their significant adjacent sites.
T847 and K860 in human EGFR protein. Moreover, two
out of all 33 significant sites are related to disease associ-
ated nsSNP positions and their structural localization are
illustrated in Figure 1.
Additionally, 13 out of all QCMF-significant sites are
referred to as essential sites, each of them are either
nearby strictly conserved residues or nsSNPs (see Table 1).
According to the essential sites of human EGFR protein,
published in [5], we have shown altogether the structural
or functional importance of 25 QCMF-significant sites.
The remaining 8 significant residue sites (G729, T851,
G779, Q820, M825, L927, G930, Y944) do not fall into
essential sites and the reason for their significance and
their importance in the EGFR protein is currently unclear.
QCMF-significant residue sites in the Human Glucokinase
(GCK) protein
Like human EGFR protein, applying the MSA-specific sta-
tistical model with a FDR of 1% for both QCMF-metrics
we identified a total of 9853 out of 69645 non-conserved
column pairs as significant in the human GCK protein
(pdb entry 1V4S). 6070 of them were (Qent, M)-significant
and 4232 were detected as (Qsep, M)-significant. Only 449
column pairs were detected as significant with respect to
both metrics. Thereupon using the connectivity degree
technique, we determined altogether 64 residue sites
in the human GCK protein as QCMF-significant (see
Additional file 3). 30 of them are determined as Qent-
significant and further 30 significant residue sites are
determined as Qsep-significant. Only four residue sites
(T82, G223, V253, and G407) are significant based on both
metrics.
13 of QCMF-significant sites are in contact with
allosteric sites V62, R63, M210, I211, Y214, Y215,
M235, V452, V455 and A456 in the human GCK pro-
tein. Among these significant sites, the V 62, M210,
Y 215 are allosteric sites by themselves [41] and the
T209M, G223S and S453del are related to disease asso-
ciated nsSNP positions. In addition, there are further
five QCMF-significant sites (F123L, G162D, G175R,
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Figure 2 QCMF-significant residue positions are in contact with gefitinib binding sites in human EGFR protein (PDB-Entry 2J6M). Red
spheres show the structural localization of the gefitinib binding sites in the wild type kinase. Yellow spheres show QCMF-significant adjacent residue
positions which are in contact with these binding sites. Moreover, the QCMF-significant site T854 is also a binding site by itself and interacts with
gefitinib binding site D855. The circles indicate clusters of gefitinib binding sites and their significant adjacent sites.
Table 1 QCMF-significant essential sites in the human
EGFR protein, which are nearby either nsSNPs or strictly
conserved sites
QCMF-significant Nearby nsSNPs, or strictly Reference





V834 835c , 836s , 860s [44,49]
Y891 892s , 895c [44]
A822 861s [43,49,50]
V844 796c , 798c , 852c -
A882 884c , 895c , 898c -
Y900 898c , 901c -
V902 880c , 901c -
T909 906c , 936c -
G911 906c -
s : non-synonymous snp site, c : strictly conserved site.
T228M, and E300K,Q) that have been verified as
nsSNP positions through annotation databases and pre-
vious experimental studies [38-40,42,43,51]. The struc-
tural localization of these 18 QCMF-significant sites
(contact sites and nsSNPs positions) are illustrated in
Figure 3.
Additionally, eight significant sites T149, G170, F171,
T206, V207, A208, Q287 and G294 in contact with glu-
cose binding sites (active sites) T168, K169, D204, D205
and E290 in human GCK protein [41] (see Figure 4) where
V207 and A208 are also in contact with the allosteric sites
M210 and I211.
Moreover, we have also observed that 38 QCMF-
significant sites are further included in essential sites since
they are nearby nsSNPs or strictly conserved residues in
human GCK protein (see Table 2).
In total, we have demonstrated here that according to
the essential sites of GCK, 62 out of 64 QCMF- significant
sites are functionally or structurally important for human
GCK protein. The remaining two significant residue sites
V89 and N283 do not overlap with essential sites and the
reason for their significance and their role in the GCK
protein is still unclear.
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Figure 3 QCMF-significant positions that are either in contact with allosteric sites or related to nsSNPs in human GCK protein (PDB-Entry
1V4S). Yellow spheres correspond to structural localization of ten significant residue sites which are in contact with allosteric sites where V62, M210,
and Y215 are denoted as allosteric sites by themselves and they are also in contact with an other allosteric sites. Green spheres indicate eight
significant nsSNP positions in the GCK protein. Three of them (T209M, G223S and S453del) are further in contact with allosteric sites M210, I211,
V452, V455 and A456.
Individual residue site comparison between
QCMF-significant sites and previous CMF-significant sites
We compared QCMF-significant residue sites for both
human EGFR and GCK proteins with the significant
residue sites given in [5] of the previous CMF-method.
The CMF-method detected for both human proteins, 43
sites in EGFR and 72 sites in GCK as significant.
For the EGFR protein we found that the QCMF-
significant residue sites Q791, Q820, G824, K860, Y891,
T892, Y900, T909 overlap with results of the CMF-
method. Interestingly, one of the unconfirmed residue
sites, the Q820, has been predicted by both QCMF-
method and CMF-method as significant.
For GCK protein, we observed that in total 24 QCMF-
significant sites (T60, T82, N83, F123, F148, T149, F152,
H156, F171, N180, T206, T209, T228, E236, G260, L271,
S281, N283, Q287, G294, E300, T332, F419 and E443)
were also determined by the CMF-method as signifi-
cant. Although both methods detected residue site N283
as significant, it corresponds to one of the unconfirmed
residue sites for GCK, currently.
The CMF has been developed using normalized mutual
information (MI) measures in order to detect important
residue positions in MSAs. The method mainly focuses on
significant BLOSUM62-dissimilar amino acid signals as
a model of compensatory mutations and integrates them
in the calculation of normalized MI-metrics. As a con-
sequence of mainly taking into account dissimilar amino
acid signals, an important part of CMF-significant sites
were verified as disease associated nsSNP positions and
just a small part of them were located at or near the
catalytic sites, allosteric sites and binding sites in both
proteins.
Moreover, when statistically evaluating both meth-
ods, we have observed that the QCMF significantly
outperforms the QCMF-method. The QCMF reaches
an improved performance in identifying essential sites
from MSAs of both proteins with a significantly higher
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Figure 4 QCMF-significant residue positions are in contact with glucose binding site in human GCK protein (PDB-Entry 1V4S). (A) Red
spheres show the structural positions of the glucose binding sites (active sites) and yellow spheres show the localization of significant adjacent
residue positions found by QCMF which are in contact with these active sites. The circles indicate clusters of glucose binding sites and their
significant adjacent sites.
Matthews correlation coefficient (MCC) value of 0.215
whereas the CMF reaches only a MCC value of 0.133.
Significant residue pair comparison
To analyze whether the quantum-information-theory-
based measures proposed in this study complements the
coventional methods for the detection of correlated (co-
evolutionary) mutations, we made pairwise comparisons
between our new QCMF, MIp [6], PSICOV [18], and
CMF [5].
All four methods take as input an MSA satisfying cer-
tain admissibility criteria. The problem is that QCMF
and CMF output the set of QCMF-significant sites and
CMF-significant sites of M’s reference protein, respec-
tively, whereas PSICOV and MIp result in sets of impor-
tant residue pairs. To make these outputs comparable, we
extend them in all cases.
Let VQCMF denote the output of QCMF on any admissi-
ble MSA M. We extend this set to what we call the QCMF-




of M as follows. Any two elements of VQCMF are
connected by an undirected edge belonging to EQCMF
if and only if the corresponding column pair is QCMF-
significant.
The CMF-significant residue network NCMF is analo-
gously defined.
In order to get a sufficiently large number MIp-
significant and PSICOV-significant residue pairs, for
every input MSA we simply took the top-ranking
10% as MIp-significant and PSICOV-significant,
respectively.
We then utilized the connectivity degree technique in
the same way as we did for CMF and QCMF to calcu-
late the set of MIp-significant sites VMIp and the set of
PSICOV-significant sites VPSICOV.
For all four methods we used the 90th, the 95th and the
99th percentile as cut-off values.
Finally, the edge sets EMIp and EPSICOV were deter-
mined by full analogy with the calculation of EQCMF and
ECMF. Thus we obtained the MIp-significant residue net-
work NMIp and the PSICOV-significant residue network
NPSICOV.
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Table 2 QCMF-significant essential sites in the human GCK
protein, which are nearby either nsSNPs or strictly
conserved sites
QCMF-significant Nearby nsSNPs or strictly Reference
essential sites conserved sites
M37 36s , 39s , 40s [38,39,43,51]
S76 147c
L79 78c , 80c , 150c -
T82 81c -
N83 81c , 108s , 110s [43,51]
V86 85c , 106s [38]
S127 130s [40]
F148 147c , 150c,s [38,39,43,51]
F152 150c,s , 151c [39,43,51]
P153 154s [39]
H156 154s [39]
A176 119s , 175s [43]
G178 164c
N180 162s , 182s [38,39,43],
L185 182s , 188s [39,43,51]
A201 147c , 453c
M202 147c , 203s [43]
A232 223s , 231c [39,40,51]
C233 223s , 234c , 235c [39,40,51]
V253 234c , 254c
F260 257s , 258c , 259s , 261s [39,43]
L271 274c
V277 274c , 278c , 279s [43]
S281 278c , 279s [43]
Y297 291c , 295c , 299c , 300s [43]
M298 295c , 299c , 300s [43]
T332 295c , 299c
V374 377c
A378 377c , 382s [43]
A379 377c , 382s [43]
S383 382s , 385s [43]
A384 382s , 385s [43]
A387 385s [43]
S388 385s , 392s [38,43]
V412 226s , 227c , 410c , 414s , 416s [40,43]
F419 416s [40]
E443 444c , 445c , 447s [39]
G446 444c , 445c , 447s , 448c , 449c [39]
s : non-synonymous snp site, c : strictly conserved site.
We performed the method comparison edge-
oriented, with the number of overlapping edges as
measure. We applied all four methods to the 153
MSAs (see Additional files 1) described at the very
beginning of this section and calculated the numbers∣∣∣E (i)QCMF∣∣∣, ∣∣∣E (i)CMF∣∣∣, ∣∣∣E (i)PSICOV∣∣∣, ∣∣∣E (i)MIp∣∣∣, ∣∣∣E (i)QCMF ∩ E (i)MIp∣∣∣,∣∣∣E (i)QCMF ∩ E (i)PSICOV∣∣∣, ∣∣∣E (i)QCMF ∩ E (i)CMF∣∣∣, ∣∣∣E (i)MIp ∩ E (i)PSICOV∣∣∣,∣∣∣E (i)MIp ∩ E (i)CMF∣∣∣ and ∣∣∣E (i)PSICOV ∩ E (i)CMF∣∣∣ on each of them,
where the connectivity cut-off ranges over the 90th,
the 95th and the 99th percentile, and i = 1, 2, . . . , 153.
Summing up the 153 numbers in each of these groups
results in the numbers
∑153
i=1
∣∣∣E (i)QCMF∣∣∣, ∑153i=1 ∣∣∣E (i)CMF∣∣∣,∑153
i=1
∣∣∣E (i)PSICOV∣∣∣, ∑153i=1 ∣∣∣E (i)MIp∣∣∣, ∑153i=1 ∣∣∣E (i)QCMF ∩ E (i)MIp∣∣∣,∑153
i=1
∣∣∣E (i)QCMF ∩ E (i)PSICOV∣∣∣, ∑153i=1 ∣∣∣E (i)QCMF ∩ E (i)CMF∣∣∣,∑153
i=1
∣∣∣E (i)MIp ∩ E (i)PSICOV∣∣∣, ∑153i=1 ∣∣∣E (i)MIp ∩ E (i)CMF∣∣∣ and∑153
i=1
∣∣∣E (i)PSICOV ∩ E (i)CMF∣∣∣, which are displayed in Tables 3
and 4.
Table 3 shows that all methods detect with the same
connectivity degree cut-off a comparable number of edges
in the corresponding significant residue network.
Table 4 highly suggests that all four methods carry
distinct information. The overlap between any two of
them is less than or equal to 10%. This indicates that,
under the assumption that each of them models important
aspects of co-evolution, they complement each other per-
fectly. In particular, this is true for QCMF as a quantum-
information-science-based service compared with the
other three established tools that are based on conven-
tional methods.
Implementation of QCMF: Parallel computing using CUDA
The computation of both QCMF metrics (Equations 7
and 8) is strongly based on matrix operations. Therefore,
we implement QCMF algorithm using CUDA [25] which
is very suitable to perform large number of vector and
matrix operations in real time. This results in a dramatic
reduction of computational time of QCMF.
In this study, we use the CUDA 4.0 architecture
(Toolkit) with several linear algebra libraries such as
MAGMA [52], LAPACK [53], BLAS [54], GotoBLAS [55],
CUBLAS [25] together (see Figure 5) to speed up the run-
ning time of the QCMF algorithm. Since our program
requires a cooperative multi threading to not fall in any
asynchronicity or locks we extended the magma library
with dynamic scheduling features according to [56]. Fur-
ther, in order to be able to compare the performance, we
also implemented the QCMF algorithm onto CPU archi-
tecture alone. Both implementations were performed on
an Intel Core™ i7-3770K Processor operating at 3.9GHz,
with 16 GB of DDR3 RAM and a GeForce GTX 680
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Table 3 Total number of edges in method-dependent significant residue networks with respect to various connectivity
degree cut-offs
Total number of edges in significant residue networks
Connectivy degree cut-off 90%th percentile 95%th percentile 99%th percentile∑153
i=1
∣∣∣E(i)QCMF∣∣∣ 82561 20411 435∑153
i=1
∣∣∣E(i)MIp∣∣∣ 90636 24094 1454∑153
i=1
∣∣∣E(i)PSICOV∣∣∣ 80489 21596 1088∑153
i=1
∣∣∣E(i)CMF∣∣∣ 87208 23893 936
graphics card using the Ubuntu 13.04 operating system
(64-bit version).
Applying the QCMF algorithm for human EGFR pro-
tein with CPU alone and with CUDA acceleration, the
average computational time of a column pair was 0.7117
seconds and 0.0301 seconds, respectively. Similarly, for
human GCK protein, the average computational time of
a column pair was 0.6977 seconds with CPU alone and
0.0299 seconds with CUDA acceleration. Consequently,
the algorithm took ∼ 310 minutes for human EGFR pro-
tein and ∼ 811 minutes for GCK protein with CPU alone.
On the other hand, applying the CUDA acceleration it
took only ∼ 13 minutes for EGFR and ∼ 39 minutes for
GCK protein. The comparison between the average times
indicates that the required computational time of QCM-
Falgorithm with the CUDA acceleration was significantly
faster than with CPU alone (approximately more than 23
times faster).
Methods
We predict important sites of a protein by detect-
ing co-evolving residues. Our measures of co-evolution
are quantum-Jensen-Shannon-divergence-based metrics
of column pairs of a multiple sequence alignment, with the
protein under study being the reference row. The quantum
Jensen-Shannon divergence in turn has the von Neumann
entropy as main building block.
The von Neumann entropy was originally defined in the
framework of quantum mechanics. We elucidate it in the
subsequent section as far as it is necessary to understand
our methods. Researchers interested in learning more are
referred to the excellent textbook due to Vedral [57]. A
comprehensive reference book was published by Nielsen
and Chuang [58].
This section is organized as follows. In the first four
subsections we recapitulate techniques developed in [5]
which we leverage in this study. This concerns the defini-
tion of significant site pairs and of significant individual
sites, the preparation of the training data set used, and the
computation of a doubly stochastic matrix D as our model
of compensatory mutations on grounds of two counting
matrices Calt and Cnull. These two matrices also form the
basis of the two amino acid pair similarity matrices Aent
and Asep, which in turn give rise to our new quantum-
information-science-based metrics Qent and Qsep. The
last four subsection are dedicated to their definitions.
Significant column pairs and significant position with
respect to a certain metric
Let M be an MSA, where the protein of interest is rep-
resented by M’s first row, and let E be a metric which
assigns to every MSA column pair (γ1, γ2) a real num-
ber E (γ1, γ2) ∈[ 0, 1]. We call E a co-evolutionary col-
umn pair metric if it models a biologically meaningful
co-evolutionary signal: The larger the metric value on
(γ1, γ2), the more likely co-evolution between position γ1
and position γ2 has occurred.
Let p̂(i,j) be the empirical relative amino acid pair fre-
quency of the i-th and the j-th amino acid in column pair
(γ1, γ2), where i, j = 1, 2, . . . , 20. (When choosing a row of
Table 4 Total number of edges in two networks of different type with respect to various connectivity degree cut-offs
Total number of common edges in two networks of different type
Connectivy degree cut-off 90%th percentile 95%th percentile 99%th percentile∑153
i=1
∣∣∣E(i)QCMF ∩ E(i)MIp∣∣∣ 898 77 0∑153
i=1
∣∣∣E(i)QCMF ∩ E(i)PSICOV∣∣∣ 735 64 0∑153
i=1
∣∣∣E(i)QCMF ∩ E(i)CMF∣∣∣ 4036 474 1∑153
i=1
∣∣∣E(i)MIp ∩ E(i)PSICOV∣∣∣ 9094 1488 11∑153
i=1
∣∣∣E(i)MIp ∩ E(i)CMF∣∣∣ 3343 474 6∑153
i=1
∣∣∣E(i)PSICOV ∩ E(i)CMF∣∣∣ 2618 368 2
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Figure 5 Linking of the CUDA environment using C++.
this column pair by pure chance, acid pair (i, j) is drawn
with probability p̂(i,j).) In the subsequent subsection we
recapitulate the way developed in [5] to identify significant
columns and significant column pairs with respect to E.
A well-studied example (see [5,12]) of a co-evolutionary
column pair metric is the normalized mutual information
U(γ1, γ2) := 2 · H(γ1) + H(γ2) − H(γ1, γ2)H(γ2 + Hγ2) , (1)
where H(γ1, γ2), H(γ1), and H(γ2) denote the Shannon





of the column pair (γ1, γ2) and its two marginals.
In order to identify significant column pairs of the MSA
under study with respect to the metric E, in [5] we have
pointed out, that the distribution of E can be regarded as
a mixture of a background β-distribution F0, an unrelated
pair distribution G1, and a distribution G2 of presumably
co-evolving pairs.
The p-values 1 − F0 (E) are then uniformly dis-
tributed over [0, 1] given the underlying E-values are
F0-distributed. In contrast, p-values tend to zero or one,
if E-values are G2-distributed or G1-distributed, respec-
tively.
If, moreover, there is a sub-interval of [0, 1] which con-
tains only data from the background distribution, on
grounds of a result due to Storey and Tibshirani [59,60]
we determined in [5] an MSA-dependent threshold for E-
values. A column pair is said to be (E, M)-significant, if its
E-value is above the threshold, where the false discovery
rate is bounded by a predefined constant.
Figure 6 is a typical pictorial representation of met-
ric distributions which can be treated that way to detect
significant pairs.
We applied that model in this study.
We utilized the connectivity degree technique, intro-
duced in [12] and developed further in [5], in order
to define the (E, M)-significance of individual residue
sites. The connectivity degree of a position γ1 is the
number of positions γ2 so that the site pair (γ1, γ2) is
(E, M)-significant. A site of the protein of interest is then
called (E, M)-significant, if its connectivity degree cut-off
exceeds the 90-th percentile.
Training data set and pre-processing
Following [5], a redundancy free set of more than 35000
protein structures is our starting point. This collection
was compiled in Rainer Merkl’s Lab at the University of
Regensburg. The protein structures were taken from the
protein data base (http://www.pdb.org/). The PISCES ser-
vices [61] was applied to assess proteins on sequence
similarity and equality of 3D-data. The related MSAs were
gathered from the HSSP data base (http://swift.cmbi.ru.
nl/gv/hssp/).
Taking pattern from [12], we filtered every MSA
obtained as follows. First, highly similar and dissimi-
lar sequences were deleted to ensure that the sequence
identity between any two sequences is at least 20%
and no more than 90%. Second, we removed strictly
conserved residue columns, where the percentage of
identical residues is greater than 95%. Third, we elimi-
nated the residue columns which contain more than 25%
gaps. Finally, we discarded all MSAs with less than 125
sequences. More than 17000 MSAs survived the last fil-
tering step. We used approximately 1700 MSAs published
in [5] as our training data set which we randomly chose
from this set.
Setting up the counting matrices Calt and Cnull
The entries of the two matrices are frequencies of
pair substitutions calculated from our training data set
described in the foregoing subsection. Informally spoken,
matrix Calt models the signal, whereas Cnull reflects the
background.
In line with [5], we calculated a signal and a null set
of column pairs. The signal set consists of all (U , M)-
significant column pairs, where M ranges over all training
MSA. The null set consists of sufficiently many column
pairs randomly chosen from every training MSA. For both
the signal set and the null set we computed a symmet-
ric 400 × 400 integer-valued matrix of frequencies of pair
substitutions Calt and Cnull. To this end, the method used
to compute BLOSUM62 matrices [62] is applied to count
residue pair substitutions in MSA column pairs rather
than residue substitution in columns.
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Figure 6 p-value distributions of Qent and Qsep-values for human EGFR protein (PDB-Entry 2J6M). The blue bars illustrate the p-value
distribution of the Qent-values and red bars display the p-value distribution of the Qsep-values.
Computing a doubly stochastic matrix D
According to [5], a pair
(
(ai, aj), (ak , al)
)
of amino acid
pairs is said to be a formal dissimilar compensatory muta-
tion, if the BLOSUM62 score both of (ai, ak) and (aj, al) is
negative.
Using Calt and Cnull, we define the matrix CCompMut by
CCompMut
(















(ai, aj), (ak , al)
) = 1 if and only if either
(ai, aj) = (ak , al) or
(
(ai, aj), (ak , al)
)

















(ai′ , aj′), (ak′ , al′)
) .
By normalizing CCompMut, we obtain a symmetric
matrix PCompMut. For ai, aj, ak , al ranging over all amino
acids, PCompMut
(
(ai, aj), (ak , al)
)
represents an empirical
probability distribution on pairs of amino acid pairs.




















is the marginal distribution of
PCompMut.
Having set all negative entries of SCompMut to zero, the
doubly stochastic matrix D is computed by means of the
canonical iterated row-column normalization procedure
[63].
The doubly stochastic D is used to linearly transform
empirical amino acid pair distributions of column pairs.
If the pair distribution is regarded as a 400-dimensional
row vector, matrix D is multiplied from the right. If then,
for example, the resulting distribution is plugged into
Equation 1, column pairs containing formal dissimilar
compensatory mutations the D-transition probability of
which is relatively large tend to be up-scaled.
The idea of the subsequent subsections is to design a
model of MSA column pairs that takes formal dissimilar
compensatory mutations regarded as pair dissimilarities
as well as pair similarities into account. The challenge is
to implement this in a way such that these two effects
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interfere but do not interact. This is necessary since a sim-
ilarity relation is transitive, whereas a dissimilarity relation
is not.
Setting up the two counting matrices Cent and Csep
We set up two significant pair substitution matrices Cent
and Csep from Calt and Cnull which form the basis of our
new metrics Qent and Qsep. The intuition behind Cent is
that the component-wise BLOSUM62-based pair similar-



















(ai, aj), (ak , al)
) = 1 if and only if either
(ai, aj) = (ak , al) or the following two conditions are sat-
isfied. First, the amino acids ai and ak as well as the amino
acids aj and al are BLOSUM62-similar. Second,
Calt
(
































(ai, aj), (ak , al)
) = 1 if and only if either
(ai, aj) = (ak , al) or Equation 2 is satisfied.
Calculating the two amino acid pair similarity matrices
Aent and Asep
Recall that a matrix A is positive definite (positive semi-
definite), if there is an orthogonal matrix U (defining
property U−1 = UT ) such that U AUT is a diagonal
matrix, where the coefficients in the main diagonal are
strictly positive (non-negative).
Let us call a 400 × 400-matrix A a amino acid pair simi-
larity matrix, if A is positive definite and the entries in the
main diagonal are equal to 1, whereas the off-diagonal ele-
ments A(g,h),(i,j) ((g, h) = (i, j)) are greater than or equal to
0, but less than 1.
The entries of an amino acid pair similarity matrix A are
interpreted as follows. The closer A(g,h),(i,j) to 1, the more
similar are the amino acid pairs (g, h) and (i, j).








(g, h), (i, j)
)
ranges over all possible 160000 indices
of pairs of amino acid pairs including the main diagonal,
and α ∈ (0, 1) was set to 0.1 in order to enhance the effect
of similarity.
Because of the fact, that matrix B is not in any case
positive definite, we finally set
A := BT B, (3)
which is justified by the transitivity of similarity. That
way the amino acid similarity matrices Aent and Asep
are obtained from the counting matrices Cent and Csep,
respectively.
Amino acid pair similarity matrices generalize amino
acid similarity matrices used by Johansson et al. [24] for
evaluating amino acid conservation.
Modeling MSA column pairs and single columns by means
of density matrices





i,j=1,2,...,20 be the empirical amino acid pair









i,j=1,2,...,20 by the doubly stochas-
tic matrix D, and let A be an amino acid pair similarity
matrix.
Recall, that the trace of a matrix is the sum of its
coefficients in the main diagonal.
Taking pattern from quantum mechanics, we model
column pair (γ1, γ2) by a positive semi-definite 400×400-
matrix the trace of which is equal to 1, a so-called density









i,j = 1,2,...,20 as 400 × 400-diagonal matrices the
main diagonal of which are formed by the probabili-
ties p̂(i,j) and q̂(i,j), respectively, we integrate the classical
model into the quantum-mechanics-based one.
Generalizing the approach for amino acid used in [24]
to amino acid pairs, our density matrices are of the shape






g,h,i,j = 1,2,...,20 , (4)
where r̂(i,j) is either p̂(i,j) or q̂(i,j) (i, j = 1, 2, . . . , 20). Using
this denotation, the diagonal density matrices considered
in the preceding paragraph are equal to some ρ (̂r,1),
where 1 is the 400 × 400-identity matrix.
In this study, we regard individual MSA columns
only as components of column pairs. In the classical
case, where MSA-column pair (γ1, γ2) is modeled by an
MSA-dependent amino acid pair distribution r̂ (either(̂
p(i,j)
)
i,j = 1,2,...,20 or some derivative), the columns γ1 and
γ2 are represented by the corresponding marginals r̂1 and
r̂2 of r̂.
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In quantum information science, the counter part of the
marginals r̂1 and r̂2 of r̂ are the partial traces tr2(ρ) and








where i, j = 1, 2 . . . , 20. As opposed to the indices of
the marginals, matrix tr1(ρ) models column γ2, whereas
matrix tr2(ρ) represents column γ1.
Defining our two new metrics Qent and Qsep
To begin with, we define the von Neumann entropy
VNE(ρ) of a diagonal density matrix ρ as the Shannon
entropy of its main diagonal coefficients regarded as a
probability distribution.
The crucial property of a density matrix ρ is that
there exists an orthogonal matrix U such that UρUT is
a diagonal density matrix, where the diagonal elements
are uniquely determined up to their order. Thus we are
justified to finally define





where U is an orthogonal matrix diagonalizing ρ in a way
just mentioned.
In principle, the following holds true. The larger
the off-diagonal coefficients of the similarity matrix A,
the smaller the von Neumann entropy of the density
matrix according to Equation 4 compared with the Shan-
non entropy of the probability distribution r̂(i,j) (i, j =
1, 2, . . . , 20).
In order to compare two density matrices ρ and σ of
the same dimension, we make use of the quantum Jensen-
Shannon divergence:
QJSD(ρ‖σ) :=VNE ((ρ + σ)/2)−(VNE(ρ)+VNE(σ )) /2.
(6)
It can be shown that 0 ≤ QJSD(ρ‖σ) ≤ 1, where 0 is
attained if and only if the two density matrices ρ and σ are
equal. As oppose to the case of Equation 1, we have thus
avoided a normalization.
We are now in a position to define our new two metrics
for a certain column pair of a given MSA. As before, the
amino acid pair distribution q̂ is given by p̂ · D, where D is
the 400 × 400 doubly stochastic matrix described above,
p̂ is the empirical pair distribution of these two columns,
and 1 is the 400 × 400-identity matrix.
Then our first metric Qent is defined by
Qent := QJSD (ρ (̂q, Aent) ‖ρ (̂p,1)) (7)
(see Equation 4). This metric measures the difference
between a density matrix combining rescaled amino acid
pair similarity with dissimilar compensatory mutations
and the empirical amino acid pair distribution. The index
“ent” indicates that here we make use of quantum entan-
glement, which in turn is a major resource of quantum
information science. (Entangled 400 × 400-density matri-
ces are those that cannot be represented as a convex
combination of Kronecker products of 20 × 20-density
matrices. Note, that the Kronecker product of density
matrices is the analog of the classical product of probabil-
ity distributions).








)) ‖tr2 (ρ (̂p, Asep))) .
(8)





ever, before finally calculating the metric, we separate
the columns of the pair by applying the two partial trace
operators.
Using the example of the human EGFR protein (PDB-
Entry 2J6M), Figure 6 illustrates that the method we
developed in [5] to determine significant column pairs is
well-applicable for both Qent and Qsep. The results pre-
sented in this work prove that Qent as well as Qsep are
powerful co-evolutionary column pair metrics.
Discussion
Grosse et al. observed in [64] that the Jensen-Shannon
divergence (JSD) can be interpreted as mutual informa-
tion between two (or more) random sources in a special
setting particularly appropriate to discriminate between
these sources. This is what we need when it comes
to predicting important protein sites in an MSA-based
approach. It might explain the findings of Capra and Singh
[22] on the predictive power of JSD. These two arti-
cles encouraged us to utilize quantum Jensen-Shannon
divergence (QJSD) in this study. As a side effect, a normal-
ization is not necessary, since quantum Jensen-Shannon
divergence, like its classical counterpart, ranges over the
real interval [0, 1].
Several studies have confirmed the fact that detecting
coupled MSA-columns is extremely useful in the predic-
tion of important protein sites (see e.g. [4-6,10-13,65-70]).
When using information-theoretic metrics, there is no
doubt that it is reasonable to incorporate amino acid pair
dissimilarity as well as amino acid similarity in a consistent
way such that similarity decreases entropy, whereas dis-
similarity increases it. This kind of consistency is impor-
tant, since entropy is the fundamental building block for
most of those metrics. In particular, the Jensen-Shannon
divergence between two probability mass functions (pmfs)
p and q equals H(1/2(p + q)) − 1/2(H(p) + H(q)).
In [5] an amino acid pair dissimilarity model for com-
pensatory mutations is presented. A doubly stochastic
matrix transforms the empirical amino acid pair distribu-
tion of a column pair.
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Rescaled pair similarity of BLOSUM62-similar pairs
is to capture an aspect of coupled MSA column pairs
orthogonal to the phenomenon of dissimilar compen-
satory mutations. It models the amino acid pair transition
preferences within those column pairs on the average.
As suggested by Caffrey et al. [23] as well as Johansson
et al. [24], it is promising to incorporate them within the
framework of quantum information theory. Therein, den-
sity matrices replace pmfs. The counterpart of the entropy
of a pmf is the von Neumann entropy (VNE) of a density
matrix (see Equation 5). QJSD corresponds then exactly to
JSD (see Equation 6).
The challenge was to complement the model presented
in [5] by additionally incorporating amino acid pair sim-
ilarity in a way that the two effects interfere but do not
interact. We model an MSA column pair by means of a
400 × 400-density matrix, rather than amino acid pair
distributions. This provides us with the opportunity to
utilize the notion of entanglement, which in turn is a
major resource of quantum information. In our model,
partial traces play the role of the marginals in the classi-
cal case. Pair similarity is reflected by means of positive
definite pair similarity matrices (see Equation 3), where
positive definiteness, which is a key property of density
matrices, can only be ensured by using transitivity of simi-
larity. Since there is no transitivity of dissimilarity, we kept
dissimilarity apart from that similarity matrix. Instead, we
carried over the CMF dissimilarity model of [5]. Similarity
matrix and transformed amino acid pair distribution are
joined together by means of Equation 4 in the final step
of our density matrix design. That way we minimize the
interaction between the two effects of dissimilarity and
similarity.
In order to eliminate the noise and to define an MSA-
dependent threshold for significant column pairs, we fol-
lowed the line of [5]. The model presented there seems
to be of universal applicability. The same is true for the
connectivity degree model introduced in [12] and further
developed in [5]. Combining them results in a reliable and
robust method to determine significant residues.
The results we present in this study show that the vast
majority of QCMF-significant residue sites are closely
related to functionality and structural stability of both
human EGFR and GCK proteins. 10 significant residue
sites in EGFR and 19 significant sites in GCK are estab-
lished as functionally important since they are directly
located at or close to catalytic sites, allosteric sites and
binding sites which are crucial for maintaining protein
functions and for understanding the underlying molecular
mechanism (see Figures 1,2,3,4). Additionally, 2 signifi-
cant sites in EGFR and 8 significant sites in GCK (three
of them are also in contact with allosteric sites in GCK)
are related to disease associated nsSNP regions of both
proteins. As has been noted in [5], most disease-causing
mutations at these positions in corresponding sequences
destroy structural features of proteins, thus affecting pro-
tein stability and often results in loss of protein function.
Although the importance of almost all QCMF-
significant sites are verified through essential sites of
both human proteins, there are still eight and two uncon-
firmed significant sites in EGFR and GCK proteins,
respectively, which do not fall into essential sites. It is
interesting to note that some of these unconfirmed sites
are also referred as significant by CMF [5]. We therefore
believe that most of these unconfirmed sites identified
by our present method may have an importance for the
function and structural stability of both proteins notwith-
standing the absence of previous experimental data. A
further comparison reveals that the overlaps between
the results of the QCMF method and the CMF method
are quite low, indicating that both methods detect con-
siderably different sets of residue sites as functionally
and structurally important. The comparison results
clearly show that considering similar and dissimilar
amino acid signals simultaneously, our present method
is more sensible to catalytic, allosteric and binding sites,
while only focusing on dissimilar signals the previ-
ous method deals successfully with nsSNP positions in
proteins.
The final comparison between QCMF and CMF on
EGFR and GCK proteins is made by inspecting several
connectivity degree cut-offs. We initially set it to the 90-
th percentile at which CMF reaches its maximal MCC
value. Going through all possible n-th percentiles for n =
80, 81, . . . , 99, QCMF reaches its maximal MCC value of
0.231 if n = 88. What we got can be summarized as
follows. On the one hand QCMF shows a better perfor-
mance than CMF in identifying important residue sites.
On the other hand QCMF complements CMF. This is
because of the fact that the method of QCMF is more
information rich than that of CMF. QCMF simultane-
ously uses similar and dissimilar amino acid pair signals,
whereas CMF’s method focuses only on amino acid pair
dissimilarity.
To confirm the educated guess that QCMF comple-
ments conventional methods both from information the-
ory and statistics, we applied QCMF, CMF [5], MIp [6]
and PSICOV [18] to the 153 MSAs described at the begin-
ning of the Results section. In sum, each of these methods
detects different residue pairs as important, where the
pairwise overlap is bounded from above by 10%. The rea-
son for that is that the four methods model different
aspects of amino acid pair co-evolution. Consequently,
they carry distinct information.
To further improve the specificity of QCMF it is promis-
ing to combine its quantum-information-theory-based
framework with the direct pair distribution derived in
DCA (see e.g. [15] or [16]).
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Conclusions
In this work, we report a new method, QCMF, apply-
ing principles of quantum information theory. In contrast
to the previous method CMF which focused on dissim-
ilar amino acid signals, QCMF simultaneously models
similar and dissimilar amino acid pair signals in the detec-
tion of functionally or structurally important sites. QCMF
includes two metrics based on quantum Jensen-Shannon
divergence. While the first metric measures compen-
satory mutations between pairs of columns, the second
metric considers the sequence conservation of columns.
Results show that QCMF reaches an improved perfor-
mance in identifying important sites from MSAs and it
predicts a quite different set of residue sites as functionally
and structurally important (in comparison to the previ-
ous method). Further, results indicate that the residue
sites found by QCMF are more sensible to catalytic sites,
allosteric sites and binding sites than those found by the
previous method. On the top of that, a pairwise compar-
ison with existing methods shows that QCMF is comple-
mentary to them when it comes to predicting co-evolving
residue site pairs.
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Table 9.1: Pdb enteries of training MSAs.
2V 4EA 1CKTA 2EOFA 1TO9A 3BQ7A 3EWSA 2V MQA 1CO8A
1ZY EA 1DUNA 2HW5A 2GBRA 4GTUA 1GGOA 1KY 9A 1YY 9A
2ET 1A 2BHJA 1CL7H 1HV 9A 1NMLA 1PZ1A 3C05A 2NQMA
2R0OA 2WFQA 3CY FA 1UN3A 2OTUB 1INDL 3ESYA 1BMTA
2Q3OA 2DJQA 1MCIA 1PT QA 1Y 65A 2J0IA 1OV 9A 2JJYA
1Y KKB 2V XLA 1CQGA 1UDCA 2A0WA 1FY T B 1BL3A 1R36A
2P79A 2PT 6A 1AQKL 1IRBA 3DGZA 2IFYA 1KENL 1I88A
1RUZH 3D5TA 1BUHB 3B84A 1WHIA 2ISSA 2CUBA 2QQNH
2DWBA 2EAOA 1S9PA 2EMXA 2FT SA 2FEMA 1W1B1 1NPKA
1QKWA 1XQCA 2B1UA 3F9PA 1ZUTA 2Y RHA 2GOYA 2FFYA
1TY BE 1R9NA 3BT 8A 2V 8QE 1SJJA 2IY 0B 2ZJBA 1UMNA
1PT ZA 1IOLA 2R4RH 2CPUA 2EOHA 1T 5BA 5BJ3A 1D6MA
1V HPA 1IFVA 1QORA 3FF1A 2D5YA 1MXSA 2QAPA 2GIXA
5REQA 2FGQX 2IPMA 1O4RA 3BEAA 1Y IUA 2RHEA 1T 5XA
3CSWA 2Z2YA 1WYOA 2E9UA 1P3OB 1C0FA 1CYWA 2HQKA
1PRGA 2OWGA 1AW2A 1Z1DB 2V 3XA 5NLLA 2F3LA 1CUKA
2ET RA 2GIVA 1V LZB 2V FHA 2BA0E 1PKUA 1OUIA 1AW8E
2HANA 1SSMA 1NEKC 1PPAA 1AY M4 3HXPA 2K5SA 3F0UX
2RFJA 1UGAA 1OMWG 1P4SA 3D01A 2ADAA 1H25C 2V SUC
1T 2QL 1A5EA 2Z83A 1P4WA 2ITWA 1QTWA 1U8SA 1DJEA
3GL1A 2AY MA 3D8XA 1FHJA 3GKEA 2V PJA 1R8ME 2BIOA
2JB9A 8CA2A 2CHGA 2P71A 1PMTA 1J2EA 1V P7A 3CZMA
1IAGA 2OGHA 2CH4W 2V MKA 1TABI 1B5ZA 2R69H 1CS8A
1B8IB 1B50A 1JDIA 2K1ZA 1GV LA 2V L9A 2UW1B 1I92A
1Y 62A 1F2ZA 1HV FA 1CCUA 2GZOA 1AG9A 2BBLA 1NFIE
1MEXL 1GFGA 1T ZPA 3BW3A 1BBIA 1ZS6A 1A5ZA 2QEJC
1UHEB 1BAFH 1QQJA 3B9JB 2ZM1A 1L3WA 1GF6A 2Q4PA
2V FBA 1EJIA 3FLCO 1WSZA 2F91A 2FSVC 1IQ3A 1MJ8L
1OJXA 2JFPA 1OVAA 1FAIL 1A2XA 1PKRA 3CLUD 3EDYA
1M93C 1QKFA 2DNMA 1A6TA 1Y MGA 1T 3IA 1ZL9A 3BQYA
1HBRB 1K8XB 2ED3A 1B8GA 1YAGA 1G9XA 2RG3A 1YACA
2P77A 2RIV B 2PBIB 1HVUA 1QF5A 2V 36A 1F4DA 2ODBB
2PAEA 2OT GC 2IPCA 1Q3IA 1HW7A 1BPVA 3G3DA 1QOGA
2A9HA 1Y 7TA 1LBBA 1NG9A 3D5FA 3CWBA 2EW8A 1DT GA
1CL7L 1E20A 1GN6A 2P6BB 1USMA 2MASA 1ECFA 2QL9B
2QQUA 3D21A 3HLUA 3HY GA 2QOBA 1F54A 1CTAA 2H79A
Continued on next page
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2W2NE 1NQBA 1ZH9A 2E2RA 1HWUA 2HZIA 1FKOA 2BW4A
1BIZA 1RV FL 2HY 0A 1M40A 1MF8B 1Z95A 2ZD2A 2IUFA
2GRRA 3CT ZA 1O3SA 1FSKB 2JO6A 1LDLA 3DOKA 1MP5A
2O36A 1MY 5A 1J19A 1M7NA 1C5CL 1V H7A 1JI8A 1J8Y F
1GQRA 2J58A 1XHGA 2H88A 1RT 3B 1KZ9A 2HZLA 2UZCA
1AN2A 1CGPA 1ND9A 2V S4A 1IRDA 2V 55B 2F7XE 3MATA
1ATYA 1X7ZA 1BCZA 2W69A 2ER8A 1U6ZA 2W72A 2NT 8A
1O2FB 3HMMA 1QL9A 1FSAA 1T MF3 2QV 1C 2W1VA 1AT NA
3CBJA 1QJOA 2P91A 1XF7A 1GY PA 1GROA 1AD1A 2P4VA
2ON5A 2ZPBA 1QGKB 1BWWA 2AQMA 2BM1A 2JNPA 1W0ZU
2QPUA 1X7AL 3PBHA 2E09A 1Y 59T 1RHSA 1IH0A 1Y JRA
1FI3A 1Y FDA 2B3HA 1W0TA 3FY SA 1PKLA 3F6UL 1Y DBA
3HHHA 3EPF3 1IQQA 2CCGA 1V 2XA 1N0EA 2V H9A 2K79A
2V GLS 3BV 6A 1ISNA 2QRZA 3BZXB 2KBOA 1AW8A 2GOLA
2Y QCA 1Q6OA 2JLJA 2HLPA 2BDQA 3C5QA 2G38A 1P4CA
3BDMD 2APSA 1MZBA 2GJ3A 3E22A 1Y I8B 1XY KA 2FVCA
2QQNL 2OPOA 3GKAA 1EJRC 1TWYA 1A6V H 1WCDJ 3B6BA
1UHFA 2EOLA 1JPT L 1Q5XA 3E7CA 2QIEA 2ESNA 2ET JA
1Y BZA 1OSPO 3I8VA 1UZ6E 1ZBRA 3GFTA 2H1VA 1E3IA
2Z26A 2Q3YA 1P7KA 2NY BA 2O5KA 3AIGA 1I7HA 2UW2A
1Z8Y J 1HL4A 1SI2A 1IN0A 1Y X5B 2VV 6A 1W74A 1NW2A
1N0XH 1T MOA 3D3PA 2UUMX 1UGKA 1OXSC 3I4SA 3FWYA
1DDKA 2GH9A 2QSQA 2JUZA 1Z3SA 3HNNA 3HJBA 1Z7Z1
2GI4A 1MHWA 2AXYA 2FHTA 2SNWA 1ES0A 2GQQA 2HDCA
1K9UA 2Z39A 2G6AA 2BH8A 1JZ8A 1AT GA 2RD1A 1TA8A
3DDKA 1W9JA 1SNOA 2QV 1A 1P5JA 1T ZAA 3DAJA 1GWTA
1SAUA 1WG2A 2GV 0A 3C3TA 1J95A 2GMLA 1LH0A 2DJ6A
2IUEA 1KT BA 1S1TA 3GLBA 1GQ2A 1RDAA 1S3IA 1L8BA
1T 13A 1YCLA 1V JAU 2ASCA 2GQRA 2OMZA 2IV 1A 2HFGL
2ZURX 1YABA 3G3NA 3DLPX 1I5EA 1SV XB 2FL5A 1KZMA
1T X2A 2IO0B 3HHFA 3B3DA 2V EDA 2P2BA 1C1EH 2DP3A
1NTYA 2BZRA 2BIGA 3DEXA 3ERHA 1W8BL 1SY IA 1C2OA
3HP7A 1UFVA 1D3AA 1SW1A 1MODA 3BNDA 2F9OA 1A6FA
1FRBA 1DEJA 3DZY D 2RGDA 1BV KB 1ZD9A 3BC7A 3D9AL
1Z3IX 1E1DA 1G7JA 1E9EA 1DB3A 1SV IA 1R64A 1Z07A
1EQ2A 5CA2A 1J6YA 1JNRB 2JOTA 2OAXA 2HEDA 2CU7A
1CGJI 1PCAA 3GL6A 1UN2A 2EIGA 2ZHGA 1Y 791 1ZG4A
1Z7BA 1PE0A 1FPSA 1NBMD 2CBYA 1SJ1A 1BRMA 2NRLA
4PBGA 1Y KT B 1Q52A 1AG8A 1T 11A 1M8VA 2QW7A 2NZDC
1QACA 2PCJA 2EP0A 3DQGA 2JEXA 2EPVA 3CX5J 2C5LA
1DGFA 1C6RA 2QCUA 2RGXA 2I24N 1NEEA 1FNDA 1Y 4RB
2B8TA 2V IIA 2Z6QA 2QMXA 2IU8A 1F99B 1B0TA 2Z5II
1EAEA 1KT RL 2T ECI 3FS2A 2ID4A 3IY 7A 1H8BA 2PIAA
1M5AB 2BMOA 1QDEA 3FKWA 2ZA7A 1A0JA 1Y EZA 1UEKA
1RV XB 1Q7JA 1V S3A 1K1CA 1JO8A 2AUVA 1JBBA 1O9PA
2ZOKA 3HOAA 1MM3A 3DRSA 2ENCA 1KDCA 3EC5A 1CRKA
1IS8A 3HILA 2OF2A 1N1JA 3CX5C 1PY 5A 2NWLA 1XD8A
Continued on next page
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1KAWA 1ULQA 1KEAA 2QO4A 3GKNA 2Q66A 2IF2A 1QHHA
1E1CA 2MHAA 1CMZA 1BPTA 2V D2A 1NCAH 3IL8A 1T SZA
2DQ3A 2BQHA 1T M1I 1FPOA 2F0IA 1BIYA 3C1YA 2PT QA
1HV EA 2DFBA 1A40A 2P6KA 1KT RH 1H8SA 1IY 9A 1CMIA
2QBUA 1D4M2 1MPSM 2HLEA 1GP6A 1GP7A 3EDT B 2QDYA
1SROA 1PSKL 2V 6OA 3BQVA 2AWGA 2EOOA 2HHEB 1BJGA
2AA2A 2ECNA 1OUBA 3EANA 2EXYA 3DCTA 1TOZA 1BZZA
1J3DA 2JIDA 2P2CA 2ECUA 3H02A 3DJNB 1AJJA 1FLJA
2FY 9A 2O3FA 2Y SSB 2D3EA 2OZPA 3ERZA 1CICA 2AF5A
1QT MA 1NEKD 1UN8A 1BHYA 2DFEA 1CNKA 1UV QA 1BFTA
2JPBA 1AQAA 1CHV S 2BURB 3HMUA 2JXBA 3EG7A 1FT SA
2NQAA 1DOTA 2J41A 1CJCA 1U07A 1ZGKA 1W4HA 1K1AA
1B4SA 1BQ0A 1JY MA 2IT 6A 2IBAA 2J8MA 2P9YA 3COVA
2EK7A 1QN2A 2PWZA 1H2V Z 1UUEA 1Y IVA 2BEMA 3G9YA
1OSEA 1KNQA 1Y GSA 2ARJB 1V ZYA 1HW3A 3GNLA 2QJXA
2WIOA 1QXOA 1BW9A 2K6WA 2JXMB 1L4ZA 1LO0L 3EO0A
2ZREA 2F1EA 1V IOA 1EIAA 1CS3A 1AT PE 2DVWB 2GT NA
2AZHA 1JNLL 2Z8WC 1H1HA 2ESBA 1QZ8A 1JWIB 1PPJD
1ZT 7A 1GT IA 2D0SA 1MEYC 1I3DA 1X3SA 1Y NLH 1OGWA
1KHUD 1Q6UA 2H8FA 1FDDA 1DVAL 1HI6A 1AHPA 1OAKL
1D5BB 1WUIS 1BC8C 3B8KA 1PJZA 2A7VA 1QFKL 1MY 7A
2H3LA 1Y 69K 2PILA 2BJYA 1HK0X 1JO0A 1NBUA 2P5MA
2IFFY 1RDBA 1NDUA 1CPJA 1GX3A 3HMFA 2PPTA 1IV 0A
1R3RA 3E8JA 1DI2A 3DGVA 2YWLA 1Y 6WA 1ZC3A 1QGHA
2DGTA 1DRBA 1WA5A 1FSEA 2RA3A 2HHOB 2SPOA 1UD7A
1W54A 1FFT B 1Y ZGA 1AE1A 1BXWA 1K82A 3BJFA 3BRPA
1AD9B 1BLUA 1QCNA 1MQOA 1G79A 1IYUA 3G7LA 2J65A
3C90X 2G9MA 1OPCA 1NGGA 1FY 7A 3D5KA 1K5VA 1G4UR
2CH7A 2A3VA 2DJ7A 1D7AA 2RIPA 2NU8A 1MU2A 2AABL
2DDYA 1ZV 8A 1ZOVA 1DXQA 9PAIA 2BS3A 1D9ZA 1DR8A
1CGHA 1OPHA 1U9LA 2EY 2A 2BV 5A 3CB0A 3EY MA 2NLLB
1C6SA 2QWTA 1FORL 1ZBA1 2DLUA 1DKKA 1OI7A 3GPDR
2DBYA 1BLLE 2FQ3A 2V 4JC 2PPYA 2OXBA 1AV HA 1EG5A
2V 7HA 1RUE1 2OXFA 2V 4OA 2CKFB 1UFYA 1D4ZA 1E4XI
2JFNA 1T 46A 2Q81A 1DO1A 1DE0A 1FXLA 1K25A 3H4JA
1QDUA 2DLHA 2O5XH 2ENPA 1JBAA 1EV TC 1AB0A 1MQIA
1Y PHE 1Y NWA 3BWTA 1H1ZA 1RV JL 3BQDA 2EKXA 2YV 4A
1BWVA 1HNAA 1B1BA 1GQ8A 1HKOA 1CH9A 1NMEB 1T FBA
2A83A 2Y QDA 1RCIA 2EMLA 1KQFA 1RD5A 3A0IX 3H43A
1HX0A 2V R6A 1JY 0A 1Z7WA 2NNYA 1FIGL 1GGWA 1VY DA
1ZM6A 1A0NB 1DV IA 1UI8A 1LKY B 2GMIA 3EXBA 1ZPEA
2NMV B 2R8SL 2P2XA 1JG8A 1EQ4A 1PWKA 2OP2A 1Y S4A
1GWOA 5CHYA 3BWUD 2ZV 3A 3BO9A 2R31A 2F2EA 1ROEA
2JXWA 2NT FA 2KCXA 1HCHA 1HY RB 1FBIH 3E0OA 2C7LB
1CEEA 2UYOA 2FOLA 1E21A 2IW9A 1J36A 1J7MA 3BZ6A
1AABA 1C30B 1C1JA 2DJBA 1Y MAA 1PIZA 1NSUA 1EBDC
1KZLA 1EUGA 1O6LA 1SLMA 2EPZA 1A14L 2K9NA 1EW2A
Continued on next page
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1I3OB 2CJ3A 1CRWG 1N2SA 2CZ8A 1I8KB 1TCWA 2DWWA
2MEBA 2Q20A 1SHMB 1BMGA 1Y IBA 3DO6A 1Y FSA 1KI1A
1AUUA 1R8QA 2F1VA 1TW0A 1WOHA 1V 67A 1ZAAC 3D4DA
3CRRA 3DX6A 1MJXA 1NG6A 3BSZL 1K4QA 2MCG1 1V Z0A
2VWSA 3BCQA 1NN7A 2D3AA 2YV 1A 1WESA 2A77L 2V D8A
1PS8A 1BX0A 2CW2A 2V XPA 2QMCB 1Q41A 1B3RA 3ENSA
1F9MA 2C7WA 2YWWA 2GHJA 1EAH4 1QOJA 1H5QA 2E3HA
1IJYA 2IM5A 2OSSA 3CG0A 1Z9DA 1UJ0A 1FD9A 3BA7A
1QPDA 1FDQA 2ELIA 1YV FA 3BK8A 1GYCA 1HLKA 1HAXB
1TAHA 1T E0A 1JGLL 2ELZA 1R4PA 3E70C 2YUJA 1DOZA
2V RPB 2Q6GA 1OIDA 1AR61 3BCOA 1BTYA 2J0FA 1AB6A
1I7QA 1DXHA 2V 09A 2QHNA 2ESWA 2E74B 9PAPA 1OAUL
1KNOA 3B8EA 1KV 0A 1T JRA 2B1KA 1V RPA 1YUCA 2Q5WD
1UWAA 2OS0A 1I1ZA 2CU8A 1SB6A 2JMMA 1L0HA 1R5PA
1I7GA 1AIHA 2C2VC 7FD1A 1E93A 2PHCB 3BIGA 1DXUB
2W1GA 1ES1A 2D31A 3BA4A 3GA5A 2R751 1ZMUA 1HFSA
2P5CA 2GT DA 1H1TA 2WGJA 1DZRA 2HI9A 2V 7AA 1CIAA
1MJSA 3GF4A 1HROA 1JXSA 1S17A 2QOFA 1O6AA 3EMNX
2DI2A 1O1JB 2HHLA 3IY 3B 2OS1A 1BJJA 1L7T H 1T F3A
2DKRA 3I5TA 3BOSA 4MDHA 1QS0A 2GGMA 3CZJA 1EEPA
966CA 1B89A 1F11A 2BPQA 1JHEA 3I6VA 3GL3A 1J1LA
2ZRUA 2H8FB 3GHZA 1MQ1A 1XGQB 2RIWA 1X09A 1RRPA
1IOQA 1RJ5A 1FCSA 1LW0B 2HF1A 2OWDA 1FCYA 1DWKA
3BH0A 3HJWA 2POIA 1XFRA 1Y FKA 1MX2A 1EV 5A 2EEHA
3EWFA 3E02A 1BA0A 3HFML 1DPJA 2C0RA 2DUWA 1E6UA
2JBMA 1EV FA 2FWLA 2HGMA 2IG2H 1C83A 2GIMA 1F62A
1NSKR 3F4LA 1CC5A 1V K2A 2GOUA 1ROVA 1PYOA 1DF1A
1Q0XH 2FS2A 1IBEA 2C1NA 1CT 2I 2Z10A 1MHLA 2I3HA
1D3WA 3CT QA 1JST B 2JQHA 1H9SB 1F6NL 1Y S9A 2JNVA
2A6HC 1HFPA 2ZOMA 3C5JB 8ATCB 2Q3BA 1V PCA 1HJ5A
1C1BB 1RW7A 3EPYA 1CFPA 1ZCNA 1IX8A 1E4EA 1COV 4
1XM5A 2B1XB 3EZPA 2ZUQC 1Y ZLA 1IX9A 2DMLA 1AT LA
2OQ3A 2DZTA 2POVA 3BF0A 1XT TA 3BSXA 3BLMA 1U4JA
1OAQL 1QM0A 2BUWB 1T 47A 2A0LC 2OB4A 1SUPA 2V GGA
6CCPA 3DHXA 1QG4A 1KT QA 2J5PA 2W9DH 1Y 4AI 3BQUD
1F00I 1PB1A 2D1XA 1ABOA 3BKWA 3D09A 1K2FA 2IC9A
1EWLA 2GP6A 1MHY D 3FIFA 1P52A 2C4MA 1GP2G 2R9SA
2EMHA 2V J3A 1CMY B 2W2GA 3B2NA 1RDO1 1CVAA 1P3JA
1QSFA 2V H1A 2DPNA 1RSRA 2AT XA 1KJ3H 1AUWA 2A02A
1MHSA 1AS0A 2RGPA 1IR9A 1V 11A 3GL5A 3CHVA 1PUZA
1MBEA 3DHQA 1ZL3A 1MUTA 1NI5A 1GFJA 3HH1A 1HBAB
1FOD4 1UIEA 3FL0A 1CB9A 2F7LA 2A7SA 1CSYA 2NSHA
1ZUXA 1F4HA 1F6LL 2DMOA 1I9EA 2V G5A 1XECA 2BJDA
1A9EA 3C00B 6FABL 2R4FA 1GXSB 1PMRA 1LOFD 2A66A
1BF3A 1X0MA 2DKFA 2D4VA 1SQNA 1NDHA 1QV 6A 3E64A
1US5A 1KKTA 1KOLA 1DSXA 2PT JA 1Q2XA 1NCQB 1EK6A
1EZOA 1S2JA 1RT TA 2BO1A 1YC7A 2RN2A 3CYYA 3DRMA
Continued on next page
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3BZTA 1FRFS 2GFYA 2H1OA 1GZ3A 3B5JA 1EX2A 1O6DA
2NXIA 2PCPA 1LPQA 1A9ZA 3B3FA 3DFGA 3EPD3 2DJ1A
1SU0B 1L7IL 1ND4A 1HV DA 3CZCA 2G9HA 2H0PA 2Y XWA
3IY 5A 1OXNA 2O3KA 1X5SA 1UEXC 1XHFA 1DT SA 1Y NJD
3RSPA 2Q1ZA 2GDNA 1IP7A 2QO9A 2DKSA 1HJRA 2J4WD
3D54B 3CW0A 1V JWA 1JLAA 1MIQA 1M04A 3BDMB 1T XAA
3BOWA 1JWQA 1UT XA 2H75A 1BKMA 2AX9A 3FR4A 2BIMA
1V IIA 2RNJA 1AKNA 1LAJA 1F05A 2BLFA 1BIIA 2DLYA
1WMVA 1JJEA 2CFYA 2IS8A 1DOSA 1HVAA 2QO7A 1IAOB
1NI2A 1V HUA 1U06A 1UMRC 1L1DA 1CT LA 1MZAA 3ES3A
1JY SA 1OSFA 1L9QA 2ITVA 1EGJH 1XY 0A 2E54A 1EUJA
2EY 5A 2NV 6A 1UDOA 1JGY M 1Z91A 1ZHCA 1UGBA 2QXCA
1R57A 2IOVA 1S96A 2QE0A 1HJ8A 2RJTA 1UULA 1M57C
2D2QA 1NT GA 3EMOC 2PF0A 2C6NA 1T 1TA 1LI9A 1AY ZA
2DA2A 1JCAA 2KJKA 1IBDA 1V ZUA 2K91B 3DK7A 1F91A
2EOIA 2B1ZA 1DI0A 1Z8RA 2I4QA 3C5WA 1DD4C 2DNPA
1IGJA 1Y P1A 2RHZA 1F8EA 3CF6R 1FTCA 2PSYA 2O2CA
1Y 0SA 1ULNA 1EKSA 2NLJC 1BKLA 4T MKA 2UZ9A 2T GIA
3EKOA 1KA9H 1EGWA 2BOYA 1F3OA 4UBPB 2AQQA 2OX4A
2I7GA 2OGIA 2ENIA 2ORBH 1GNGA 1EA5A 2Q6NA 2A7RA
1WH3A 1ZY SA 2NL8A 1DPEA 2E2AA 2ZQQA 3ET PA 2NS1B
1FVCA 2Q3RA 1POUA 3BU2A 2T BSA 2P3UB 2AFPA 1QBZA
1D2AA 1QQDB 3G5LA 2VULA 2CT 2A 1MZRA 1X3XA 1HILB
2V SLA 1T 2MA 3CLNA 1AAMA 3D4MA 1RV T H 1F1AA 1SNNA
3DD4A 3DPRE 1NYOA 1G2SA 2KCPA 2CX4A 1KN1A 3EUB2
1A5MC 1M2IA 2QWOB 3E3BX 3FGHA 1Y NYA 1W5CF 2HKYA
2GFWA 3C9WA 2BJMH 1D0QA 1N3BA 2VCQA 1ZVVW 1HIXA
1I2AA 3DGEA 1QHHD 2FMKA 1I5SA 3D57A 1KJQA 1LKJA
1P8DA 3D66A 1E28A 1MA3A 1GH4A 1UHCA 2WGMA 2C0DA
2P4BA 3CPIG 2DXSA 2B0LA 2FT NA 3HCSA 1H85A 2HFPA
2RMLA 1MREL 2CCSA 1AV 8A 2DAOA 1UEGA 1RL2A 2GNCA
1F66D 1Q8IA 2JPCA 2Z43A 3E2YA 1G16A 1FL5A 1G5ZA
2AWTA 1JR9A 1OD6A 1O7JA 1I5DA 2A1WH 1YY HA 2HC8A
1WEJH 2QJRA 1EGAA 2QGUA 1CV EA 1GEJA 2QE7D 1H6KZ
1ASGA 1JUDA 1Y NIA 1Q98A 1XGUB 1BO0A 2JEJA 1O78A
1M3KA 2FMJA 1UW9A 2KL5A 1D8YA 3DUUA 8PRKA 2F2BA
1P8PA 1POHA 1Z3NA 1QFWL 5CPAA 2HW0A 2Y XRA 1CE2A
1PY TC 1QWDA 1L8QA 3BW4A 2WA8A 3EGV B 3BA1A 2P8WS
2RGNC 3C4CA 2WGXA 1P2HA 1NUCA 1JBOB 1LJYA 2DK2A
3FT TA 1PKDA 1ZNCA 1PYCA 2JK6A 2G0FA 3HEIA 1DN0A
1OY 5A 3HOFA 1QS0B 1H9QA 3B9YA 1X0AA 1FWGC 1G8OA
1PVC1 1PR3A 1O12A 2OT GA 2EDYA 3PMGA 1FUEA 2D4AB
2GRXC 1CDOA 2DT 1A 1Z8PA 3G4DA 1JTOA 3BEWA 3IY 3A
1LQWA 3IY 2B 1P4LB 2K48A 1T 2KA 1BUPA 1A4IA
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